id	sid	tid	token	lemma	pos
ajlsi-3081	1	1	pa	pa	PROPN
ajlsi-3081	1	2	ge	ge	PROPN
ajlsi-3081	1	3	1	1	NUM
ajlsi-3081	1	4	pa	pa	PROPN
ajlsi-3081	1	5	ge	ge	PROPN
ajlsi-3081	1	6	57	57	NUM
ajlsi-3081	1	7	american	american	PROPN
ajlsi-3081	1	8	journal	journal	PROPN
ajlsi-3081	1	9	of	of	ADP
ajlsi-3081	1	10	life	life	NOUN
ajlsi-3081	1	11	science	science	NOUN
ajlsi-3081	1	12	and	and	CCONJ
ajlsi-3081	1	13	innovation	innovation	NOUN
ajlsi-3081	1	14	(	(	PUNCT
ajlsi-3081	1	15	ajlsi	ajlsi	NOUN
ajlsi-3081	1	16	)	)	PUNCT
ajlsi-3081	1	17	demographics	demographic	NOUN
ajlsi-3081	1	18	and	and	CCONJ
ajlsi-3081	1	19	outcomes	outcome	NOUN
ajlsi-3081	1	20	of	of	ADP
ajlsi-3081	1	21	testicular	testicular	ADJ
ajlsi-3081	1	22	tumors	tumor	NOUN
ajlsi-3081	1	23	in	in	ADP
ajlsi-3081	1	24	patients	patient	NOUN
ajlsi-3081	1	25	treated	treat	VERB
ajlsi-3081	1	26	at	at	ADP
ajlsi-3081	1	27	king	king	PROPN
ajlsi-3081	1	28	faisal	faisal	PROPN
ajlsi-3081	1	29	specialist	specialist	PROPN
ajlsi-3081	1	30	hospital	hospital	PROPN
ajlsi-3081	1	31	and	and	CCONJ
ajlsi-3081	1	32	research	research	NOUN
ajlsi-3081	1	33	centre	centre	NOUN
ajlsi-3081	1	34	,	,	PUNCT
ajlsi-3081	1	35	riyadh	riyadh	PROPN
ajlsi-3081	1	36	sultan	sultan	PROPN
ajlsi-3081	1	37	saud	saud	PROPN
ajlsi-3081	1	38	alkhateeb1	alkhateeb1	PROPN
ajlsi-3081	1	39	*	*	PUNCT
ajlsi-3081	1	40	,	,	PUNCT
ajlsi-3081	1	41	majed	majed	PROPN
ajlsi-3081	1	42	alrumayyan1	alrumayyan1	X
ajlsi-3081	1	43	,	,	PUNCT
ajlsi-3081	1	44	mohammed	mohammed	PROPN
ajlsi-3081	1	45	faihan	faihan	PROPN
ajlsi-3081	1	46	alotaibi1	alotaibi1	PROPN
ajlsi-3081	1	47	volume	volume	NOUN
ajlsi-3081	1	48	3	3	NUM
ajlsi-3081	1	49	issue	issue	NOUN
ajlsi-3081	1	50	2	2	NUM
ajlsi-3081	1	51	,	,	PUNCT
ajlsi-3081	1	52	year	year	NOUN
ajlsi-3081	1	53	2024	2024	NUM
ajlsi-3081	1	54	issn	issn	X
ajlsi-3081	1	55	:	:	PUNCT
ajlsi-3081	1	56	2833	2833	NUM
ajlsi-3081	1	57	-	-	SYM
ajlsi-3081	1	58	1397	1397	NUM
ajlsi-3081	1	59	(	(	PUNCT
ajlsi-3081	1	60	online	online	ADJ
ajlsi-3081	1	61	)	)	PUNCT
ajlsi-3081	1	62	doi	doi	NOUN
ajlsi-3081	1	63	:	:	PUNCT
ajlsi-3081	1	64	https://doi.org/10.54536/ajlsi.v3i2.3081	https://doi.org/10.54536/ajlsi.v3i2.3081	PROPN
ajlsi-3081	1	65	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-3081	1	66	article	article	NOUN
ajlsi-3081	1	67	information	information	NOUN
ajlsi-3081	1	68	abstract	abstract	ADV
ajlsi-3081	1	69	received	receive	VERB
ajlsi-3081	1	70	:	:	PUNCT
ajlsi-3081	1	71	june	june	PROPN
ajlsi-3081	1	72	02	02	NUM
ajlsi-3081	1	73	,	,	PUNCT
ajlsi-3081	1	74	2024	2024	NUM
ajlsi-3081	1	75	accepted	accept	VERB
ajlsi-3081	1	76	:	:	PUNCT
ajlsi-3081	1	77	july	july	PROPN
ajlsi-3081	1	78	12	12	NUM
ajlsi-3081	1	79	,	,	PUNCT
ajlsi-3081	1	80	2024	2024	NUM
ajlsi-3081	1	81	published	publish	VERB
ajlsi-3081	1	82	:	:	PUNCT
ajlsi-3081	1	83	november	november	PROPN
ajlsi-3081	1	84	21	21	NUM
ajlsi-3081	1	85	,	,	PUNCT
ajlsi-3081	1	86	2024	2024	NUM
ajlsi-3081	1	87	testicular	testicular	NOUN
ajlsi-3081	1	88	cancer	cancer	NOUN
ajlsi-3081	1	89	is	be	AUX
ajlsi-3081	1	90	a	a	DET
ajlsi-3081	1	91	relatively	relatively	ADV
ajlsi-3081	1	92	rare	rare	ADJ
ajlsi-3081	1	93	but	but	CCONJ
ajlsi-3081	1	94	significant	significant	ADJ
ajlsi-3081	1	95	malignancy	malignancy	NOUN
ajlsi-3081	1	96	,	,	PUNCT
ajlsi-3081	1	97	primarily	primarily	ADV
ajlsi-3081	1	98	affecting	affect	VERB
ajlsi-3081	1	99	males	male	NOUN
ajlsi-3081	1	100	between	between	ADP
ajlsi-3081	1	101	the	the	DET
ajlsi-3081	1	102	ages	age	NOUN
ajlsi-3081	1	103	of	of	ADP
ajlsi-3081	1	104	15	15	NUM
ajlsi-3081	1	105	and	and	CCONJ
ajlsi-3081	1	106	35	35	NUM
ajlsi-3081	1	107	.	.	PUNCT
ajlsi-3081	2	1	the	the	DET
ajlsi-3081	2	2	incidence	incidence	NOUN
ajlsi-3081	2	3	and	and	CCONJ
ajlsi-3081	2	4	epidemiological	epidemiological	ADJ
ajlsi-3081	2	5	patterns	pattern	NOUN
ajlsi-3081	2	6	of	of	ADP
ajlsi-3081	2	7	testicular	testicular	ADJ
ajlsi-3081	2	8	cancer	cancer	NOUN
ajlsi-3081	2	9	vary	vary	VERB
ajlsi-3081	2	10	across	across	ADP
ajlsi-3081	2	11	different	different	ADJ
ajlsi-3081	2	12	geographic	geographic	ADJ
ajlsi-3081	2	13	regions	region	NOUN
ajlsi-3081	2	14	.	.	PUNCT
ajlsi-3081	3	1	this	this	DET
ajlsi-3081	3	2	study	study	NOUN
ajlsi-3081	3	3	aims	aim	VERB
ajlsi-3081	3	4	to	to	PART
ajlsi-3081	3	5	describe	describe	VERB
ajlsi-3081	3	6	the	the	DET
ajlsi-3081	3	7	demographics	demographic	NOUN
ajlsi-3081	3	8	and	and	CCONJ
ajlsi-3081	3	9	outcomes	outcome	NOUN
ajlsi-3081	3	10	of	of	ADP
ajlsi-3081	3	11	testicular	testicular	ADJ
ajlsi-3081	3	12	tumors	tumor	NOUN
ajlsi-3081	3	13	in	in	ADP
ajlsi-3081	3	14	patients	patient	NOUN
ajlsi-3081	3	15	treated	treat	VERB
ajlsi-3081	3	16	in	in	ADP
ajlsi-3081	3	17	a	a	DET
ajlsi-3081	3	18	tertiary	tertiary	ADJ
ajlsi-3081	3	19	setting	setting	NOUN
ajlsi-3081	3	20	at	at	ADP
ajlsi-3081	3	21	king	king	PROPN
ajlsi-3081	3	22	faisal	faisal	PROPN
ajlsi-3081	3	23	specialist	specialist	PROPN
ajlsi-3081	3	24	hospital	hospital	PROPN
ajlsi-3081	3	25	and	and	CCONJ
ajlsi-3081	3	26	research	research	NOUN
ajlsi-3081	3	27	centre	centre	NOUN
ajlsi-3081	3	28	in	in	ADP
ajlsi-3081	3	29	riyadh	riyadh	PROPN
ajlsi-3081	3	30	.	.	PUNCT
ajlsi-3081	4	1	this	this	DET
ajlsi-3081	4	2	retrospective	retrospective	ADJ
ajlsi-3081	4	3	cohort	cohort	NOUN
ajlsi-3081	4	4	study	study	NOUN
ajlsi-3081	4	5	was	be	AUX
ajlsi-3081	4	6	conducted	conduct	VERB
ajlsi-3081	4	7	at	at	ADP
ajlsi-3081	4	8	king	king	PROPN
ajlsi-3081	4	9	faisal	faisal	PROPN
ajlsi-3081	4	10	specialist	specialist	PROPN
ajlsi-3081	4	11	hospital	hospital	PROPN
ajlsi-3081	4	12	and	and	CCONJ
ajlsi-3081	4	13	research	research	NOUN
ajlsi-3081	4	14	centre	centre	NOUN
ajlsi-3081	4	15	(	(	PUNCT
ajlsi-3081	4	16	kfshrc	kfshrc	PROPN
ajlsi-3081	4	17	)	)	PUNCT
ajlsi-3081	4	18	,	,	PUNCT
ajlsi-3081	4	19	focusing	focus	VERB
ajlsi-3081	4	20	on	on	ADP
ajlsi-3081	4	21	patients	patient	NOUN
ajlsi-3081	4	22	across	across	ADP
ajlsi-3081	4	23	various	various	ADJ
ajlsi-3081	4	24	regions	region	NOUN
ajlsi-3081	4	25	in	in	ADP
ajlsi-3081	4	26	the	the	DET
ajlsi-3081	4	27	kingdom	kingdom	NOUN
ajlsi-3081	4	28	from	from	ADP
ajlsi-3081	4	29	2000	2000	NUM
ajlsi-3081	4	30	to	to	ADP
ajlsi-3081	4	31	2017	2017	NUM
ajlsi-3081	4	32	.	.	PUNCT
ajlsi-3081	5	1	the	the	DET
ajlsi-3081	5	2	research	research	NOUN
ajlsi-3081	5	3	offers	offer	VERB
ajlsi-3081	5	4	a	a	DET
ajlsi-3081	5	5	comprehensive	comprehensive	ADJ
ajlsi-3081	5	6	retrospective	retrospective	ADJ
ajlsi-3081	5	7	analysis	analysis	NOUN
ajlsi-3081	5	8	.	.	PUNCT
ajlsi-3081	6	1	the	the	DET
ajlsi-3081	6	2	records	record	NOUN
ajlsi-3081	6	3	of	of	ADP
ajlsi-3081	6	4	125	125	NUM
ajlsi-3081	6	5	males	male	NOUN
ajlsi-3081	6	6	diagnosed	diagnose	VERB
ajlsi-3081	6	7	and	and	CCONJ
ajlsi-3081	6	8	treated	treat	VERB
ajlsi-3081	6	9	with	with	ADP
ajlsi-3081	6	10	testicular	testicular	ADJ
ajlsi-3081	6	11	cancers	cancer	NOUN
ajlsi-3081	6	12	with	with	ADP
ajlsi-3081	6	13	an	an	DET
ajlsi-3081	6	14	age	age	NOUN
ajlsi-3081	6	15	bracket	bracket	NOUN
ajlsi-3081	6	16	of	of	ADP
ajlsi-3081	6	17	14	14	NUM
ajlsi-3081	6	18	-	-	SYM
ajlsi-3081	6	19	35	35	NUM
ajlsi-3081	6	20	years	year	NOUN
ajlsi-3081	6	21	were	be	AUX
ajlsi-3081	6	22	examined	examine	VERB
ajlsi-3081	6	23	.	.	PUNCT
ajlsi-3081	7	1	it	it	PRON
ajlsi-3081	7	2	was	be	AUX
ajlsi-3081	7	3	observed	observe	VERB
ajlsi-3081	7	4	that	that	SCONJ
ajlsi-3081	7	5	males	male	NOUN
ajlsi-3081	7	6	aged	age	VERB
ajlsi-3081	7	7	26	26	NUM
ajlsi-3081	7	8	-	-	SYM
ajlsi-3081	7	9	35	35	NUM
ajlsi-3081	7	10	showed	show	VERB
ajlsi-3081	7	11	the	the	DET
ajlsi-3081	7	12	highest	high	ADJ
ajlsi-3081	7	13	rate	rate	NOUN
ajlsi-3081	7	14	of	of	ADP
ajlsi-3081	7	15	incidence	incidence	NOUN
ajlsi-3081	7	16	of	of	ADP
ajlsi-3081	7	17	testicular	testicular	ADJ
ajlsi-3081	7	18	cancer	cancer	NOUN
ajlsi-3081	7	19	.	.	PUNCT
ajlsi-3081	8	1	the	the	DET
ajlsi-3081	8	2	primary	primary	ADJ
ajlsi-3081	8	3	differences	difference	NOUN
ajlsi-3081	8	4	between	between	ADP
ajlsi-3081	8	5	the	the	DET
ajlsi-3081	8	6	progression	progression	NOUN
ajlsi-3081	8	7	of	of	ADP
ajlsi-3081	8	8	seminomas	seminoma	NOUN
ajlsi-3081	8	9	and	and	CCONJ
ajlsi-3081	8	10	nonseminomas	nonseminoma	NOUN
ajlsi-3081	8	11	are	be	AUX
ajlsi-3081	8	12	explored	explore	VERB
ajlsi-3081	8	13	,	,	PUNCT
ajlsi-3081	8	14	with	with	ADP
ajlsi-3081	8	15	the	the	DET
ajlsi-3081	8	16	latter	latter	ADJ
ajlsi-3081	8	17	comprising	comprising	NOUN
ajlsi-3081	8	18	diverse	diverse	ADJ
ajlsi-3081	8	19	subtypes	subtype	NOUN
ajlsi-3081	8	20	such	such	ADJ
ajlsi-3081	8	21	as	as	ADP
ajlsi-3081	8	22	yolk	yolk	NOUN
ajlsi-3081	8	23	sac	sac	NOUN
ajlsi-3081	8	24	tumors	tumor	NOUN
ajlsi-3081	8	25	,	,	PUNCT
ajlsi-3081	8	26	teratomas	teratoma	NOUN
ajlsi-3081	8	27	,	,	PUNCT
ajlsi-3081	8	28	embryonal	embryonal	ADJ
ajlsi-3081	8	29	carcinomas	carcinoma	NOUN
ajlsi-3081	8	30	,	,	PUNCT
ajlsi-3081	8	31	and	and	CCONJ
ajlsi-3081	8	32	choriocarcinomas	choriocarcinoma	NOUN
ajlsi-3081	8	33	.	.	PUNCT
ajlsi-3081	9	1	this	this	DET
ajlsi-3081	9	2	research	research	NOUN
ajlsi-3081	9	3	studied	study	VERB
ajlsi-3081	9	4	patient	patient	ADJ
ajlsi-3081	9	5	demographics	demographic	NOUN
ajlsi-3081	9	6	,	,	PUNCT
ajlsi-3081	9	7	clinical	clinical	ADJ
ajlsi-3081	9	8	presentations	presentation	NOUN
ajlsi-3081	9	9	,	,	PUNCT
ajlsi-3081	9	10	histopathological	histopathological	ADJ
ajlsi-3081	9	11	patterns	pattern	NOUN
ajlsi-3081	9	12	,	,	PUNCT
ajlsi-3081	9	13	treatment	treatment	NOUN
ajlsi-3081	9	14	modalities	modality	NOUN
ajlsi-3081	9	15	,	,	PUNCT
ajlsi-3081	9	16	and	and	CCONJ
ajlsi-3081	9	17	associated	associated	ADJ
ajlsi-3081	9	18	complications	complication	NOUN
ajlsi-3081	9	19	.	.	PUNCT
ajlsi-3081	10	1	apart	apart	ADV
ajlsi-3081	10	2	from	from	ADP
ajlsi-3081	10	3	stage	stage	NOUN
ajlsi-3081	10	4	3	3	NUM
ajlsi-3081	10	5	cases	case	NOUN
ajlsi-3081	10	6	,	,	PUNCT
ajlsi-3081	10	7	the	the	DET
ajlsi-3081	10	8	present	present	ADJ
ajlsi-3081	10	9	research	research	NOUN
ajlsi-3081	10	10	found	find	VERB
ajlsi-3081	10	11	consistency	consistency	NOUN
ajlsi-3081	10	12	in	in	ADP
ajlsi-3081	10	13	survival	survival	NOUN
ajlsi-3081	10	14	outcomes	outcome	NOUN
ajlsi-3081	10	15	,	,	PUNCT
ajlsi-3081	10	16	recurrence	recurrence	NOUN
ajlsi-3081	10	17	rates	rate	NOUN
ajlsi-3081	10	18	,	,	PUNCT
ajlsi-3081	10	19	and	and	CCONJ
ajlsi-3081	10	20	risk	risk	NOUN
ajlsi-3081	10	21	variables	variable	NOUN
ajlsi-3081	10	22	across	across	ADP
ajlsi-3081	10	23	locations	location	NOUN
ajlsi-3081	10	24	.	.	PUNCT
ajlsi-3081	11	1	this	this	DET
ajlsi-3081	11	2	retrospective	retrospective	ADJ
ajlsi-3081	11	3	cohort	cohort	NOUN
ajlsi-3081	11	4	study	study	NOUN
ajlsi-3081	11	5	challenges	challenge	VERB
ajlsi-3081	11	6	long	long	ADV
ajlsi-3081	11	7	-	-	PUNCT
ajlsi-3081	11	8	held	hold	VERB
ajlsi-3081	11	9	beliefs	belief	NOUN
ajlsi-3081	11	10	and	and	CCONJ
ajlsi-3081	11	11	offers	offer	VERB
ajlsi-3081	11	12	new	new	ADJ
ajlsi-3081	11	13	insight	insight	NOUN
ajlsi-3081	11	14	into	into	ADP
ajlsi-3081	11	15	the	the	DET
ajlsi-3081	11	16	treatment	treatment	NOUN
ajlsi-3081	11	17	and	and	CCONJ
ajlsi-3081	11	18	prognosis	prognosis	NOUN
ajlsi-3081	11	19	of	of	ADP
ajlsi-3081	11	20	patients	patient	NOUN
ajlsi-3081	11	21	with	with	ADP
ajlsi-3081	11	22	testicular	testicular	ADJ
ajlsi-3081	11	23	cancer	cancer	NOUN
ajlsi-3081	11	24	at	at	ADP
ajlsi-3081	11	25	the	the	DET
ajlsi-3081	11	26	kfshrc	kfshrc	NOUN
ajlsi-3081	11	27	.	.	PUNCT
ajlsi-3081	12	1	this	this	DET
ajlsi-3081	12	2	study	study	NOUN
ajlsi-3081	12	3	is	be	AUX
ajlsi-3081	12	4	significant	significant	ADJ
ajlsi-3081	12	5	because	because	SCONJ
ajlsi-3081	12	6	it	it	PRON
ajlsi-3081	12	7	has	have	VERB
ajlsi-3081	12	8	the	the	DET
ajlsi-3081	12	9	potential	potential	NOUN
ajlsi-3081	12	10	to	to	PART
ajlsi-3081	12	11	influence	influence	VERB
ajlsi-3081	12	12	future	future	ADJ
ajlsi-3081	12	13	methods	method	NOUN
ajlsi-3081	12	14	of	of	ADP
ajlsi-3081	12	15	treating	treat	VERB
ajlsi-3081	12	16	testicular	testicular	ADJ
ajlsi-3081	12	17	cancer	cancer	NOUN
ajlsi-3081	12	18	and	and	CCONJ
ajlsi-3081	12	19	advance	advance	NOUN
ajlsi-3081	12	20	knowledge	knowledge	NOUN
ajlsi-3081	12	21	of	of	ADP
ajlsi-3081	12	22	the	the	DET
ajlsi-3081	12	23	subtleties	subtlety	NOUN
ajlsi-3081	12	24	and	and	CCONJ
ajlsi-3081	12	25	regional	regional	ADJ
ajlsi-3081	12	26	variations	variation	NOUN
ajlsi-3081	12	27	of	of	ADP
ajlsi-3081	12	28	the	the	DET
ajlsi-3081	12	29	illness	illness	NOUN
ajlsi-3081	12	30	,	,	PUNCT
ajlsi-3081	12	31	which	which	PRON
ajlsi-3081	12	32	is	be	AUX
ajlsi-3081	12	33	beneficial	beneficial	ADJ
ajlsi-3081	12	34	for	for	ADP
ajlsi-3081	12	35	both	both	DET
ajlsi-3081	12	36	patients	patient	NOUN
ajlsi-3081	12	37	and	and	CCONJ
ajlsi-3081	12	38	healthcare	healthcare	NOUN
ajlsi-3081	12	39	professionals	professional	NOUN
ajlsi-3081	12	40	.	.	PUNCT
ajlsi-3081	13	1	keywords	keyword	VERB
ajlsi-3081	13	2	demographic	demographic	ADJ
ajlsi-3081	13	3	analysis	analysis	NOUN
ajlsi-3081	13	4	,	,	PUNCT
ajlsi-3081	13	5	imaging	imaging	NOUN
ajlsi-3081	13	6	,	,	PUNCT
ajlsi-3081	13	7	orchiectomy	orchiectomy	NOUN
ajlsi-3081	13	8	,	,	PUNCT
ajlsi-3081	13	9	pathology	pathology	NOUN
ajlsi-3081	13	10	,	,	PUNCT
ajlsi-3081	13	11	testicular	testicular	ADJ
ajlsi-3081	13	12	cancer	cancer	NOUN
ajlsi-3081	13	13	,	,	PUNCT
ajlsi-3081	13	14	testicular	testicular	ADJ
ajlsi-3081	13	15	tumor	tumor	NOUN
ajlsi-3081	13	16	,	,	PUNCT
ajlsi-3081	13	17	undescended	undescended	ADJ
ajlsi-3081	13	18	testicles	testicle	NOUN
ajlsi-3081	13	19	1	1	NUM
ajlsi-3081	13	20	department	department	NOUN
ajlsi-3081	13	21	of	of	ADP
ajlsi-3081	13	22	urology	urology	NOUN
ajlsi-3081	13	23	,	,	PUNCT
ajlsi-3081	13	24	king	king	NOUN
ajlsi-3081	13	25	faisal	faisal	PROPN
ajlsi-3081	13	26	specialist	specialist	PROPN
ajlsi-3081	13	27	hospital	hospital	PROPN
ajlsi-3081	13	28	and	and	CCONJ
ajlsi-3081	13	29	research	research	NOUN
ajlsi-3081	13	30	centre	centre	NOUN
ajlsi-3081	13	31	and	and	CCONJ
ajlsi-3081	13	32	college	college	NOUN
ajlsi-3081	13	33	of	of	ADP
ajlsi-3081	13	34	medicine	medicine	NOUN
ajlsi-3081	13	35	,	,	PUNCT
ajlsi-3081	13	36	alfaisal	alfaisal	NOUN
ajlsi-3081	13	37	university	university	NOUN
ajlsi-3081	13	38	,	,	PUNCT
ajlsi-3081	13	39	riyadh	riyadh	PROPN
ajlsi-3081	13	40	,	,	PUNCT
ajlsi-3081	13	41	saudi	saudi	PROPN
ajlsi-3081	13	42	arabia	arabia	PROPN
ajlsi-3081	13	43	*	*	PUNCT
ajlsi-3081	13	44	corresponding	correspond	VERB
ajlsi-3081	13	45	author	author	NOUN
ajlsi-3081	13	46	’s	’s	PART
ajlsi-3081	13	47	e	e	NOUN
ajlsi-3081	13	48	-	-	NOUN
ajlsi-3081	13	49	mail	mail	NOUN
ajlsi-3081	13	50	:	:	PUNCT
ajlsi-3081	13	51	alkhateeb656@outlook.com	alkhateeb656@outlook.com	X
ajlsi-3081	14	1	introduction	introduction	NOUN
ajlsi-3081	14	2	testicular	testicular	NOUN
ajlsi-3081	14	3	germ	germ	NOUN
ajlsi-3081	14	4	cell	cell	NOUN
ajlsi-3081	14	5	tumors	tumor	NOUN
ajlsi-3081	14	6	are	be	AUX
ajlsi-3081	14	7	the	the	DET
ajlsi-3081	14	8	most	most	ADV
ajlsi-3081	14	9	common	common	ADJ
ajlsi-3081	14	10	types	type	NOUN
ajlsi-3081	14	11	of	of	ADP
ajlsi-3081	14	12	testicular	testicular	ADJ
ajlsi-3081	14	13	cancers	cancer	NOUN
ajlsi-3081	14	14	and	and	CCONJ
ajlsi-3081	14	15	contribute	contribute	VERB
ajlsi-3081	14	16	to	to	ADP
ajlsi-3081	14	17	a	a	DET
ajlsi-3081	14	18	total	total	NOUN
ajlsi-3081	14	19	of	of	ADP
ajlsi-3081	14	20	90	90	NUM
ajlsi-3081	14	21	%	%	NOUN
ajlsi-3081	14	22	of	of	ADP
ajlsi-3081	14	23	testes	testis	NOUN
ajlsi-3081	14	24	cancer	cancer	NOUN
ajlsi-3081	14	25	(	(	PUNCT
ajlsi-3081	14	26	bahrami	bahrami	NOUN
ajlsi-3081	14	27	et	et	PROPN
ajlsi-3081	14	28	al	al	PROPN
ajlsi-3081	14	29	.	.	PROPN
ajlsi-3081	14	30	,	,	PUNCT
ajlsi-3081	14	31	2007	2007	NUM
ajlsi-3081	14	32	)	)	PUNCT
ajlsi-3081	14	33	.	.	PUNCT
ajlsi-3081	15	1	testicular	testicular	ADJ
ajlsi-3081	15	2	tumors	tumor	NOUN
ajlsi-3081	15	3	account	account	VERB
ajlsi-3081	15	4	for	for	ADP
ajlsi-3081	15	5	only	only	ADV
ajlsi-3081	15	6	1	1	NUM
ajlsi-3081	15	7	%	%	NOUN
ajlsi-3081	15	8	of	of	ADP
ajlsi-3081	15	9	all	all	DET
ajlsi-3081	15	10	cancers	cancer	NOUN
ajlsi-3081	15	11	in	in	ADP
ajlsi-3081	15	12	men	man	NOUN
ajlsi-3081	15	13	and	and	CCONJ
ajlsi-3081	15	14	around	around	ADV
ajlsi-3081	15	15	5	5	NUM
ajlsi-3081	15	16	%	%	NOUN
ajlsi-3081	15	17	of	of	ADP
ajlsi-3081	15	18	all	all	DET
ajlsi-3081	15	19	urological	urological	ADJ
ajlsi-3081	15	20	cancers	cancer	NOUN
ajlsi-3081	15	21	(	(	PUNCT
ajlsi-3081	15	22	siegel	siegel	PROPN
ajlsi-3081	15	23	et	et	PROPN
ajlsi-3081	15	24	al	al	PROPN
ajlsi-3081	15	25	.	.	PROPN
ajlsi-3081	15	26	,	,	PUNCT
ajlsi-3081	15	27	2018	2018	NUM
ajlsi-3081	15	28	)	)	PUNCT
ajlsi-3081	15	29	.	.	PUNCT
ajlsi-3081	16	1	testicular	testicular	ADJ
ajlsi-3081	16	2	cancers	cancer	NOUN
ajlsi-3081	16	3	normally	normally	ADV
ajlsi-3081	16	4	occur	occur	VERB
ajlsi-3081	16	5	in	in	ADP
ajlsi-3081	16	6	patients	patient	NOUN
ajlsi-3081	16	7	with	with	ADP
ajlsi-3081	16	8	ages	age	NOUN
ajlsi-3081	16	9	ranging	range	VERB
ajlsi-3081	16	10	from	from	ADP
ajlsi-3081	16	11	15	15	NUM
ajlsi-3081	16	12	years	year	NOUN
ajlsi-3081	16	13	to	to	ADP
ajlsi-3081	16	14	35	35	NUM
ajlsi-3081	16	15	years	year	NOUN
ajlsi-3081	16	16	.	.	PUNCT
ajlsi-3081	17	1	the	the	DET
ajlsi-3081	17	2	incidence	incidence	NOUN
ajlsi-3081	17	3	and	and	CCONJ
ajlsi-3081	17	4	epidemiological	epidemiological	ADJ
ajlsi-3081	17	5	patterns	pattern	NOUN
ajlsi-3081	17	6	of	of	ADP
ajlsi-3081	17	7	testicular	testicular	ADJ
ajlsi-3081	17	8	cancer	cancer	NOUN
ajlsi-3081	17	9	vary	vary	VERB
ajlsi-3081	17	10	across	across	ADP
ajlsi-3081	17	11	different	different	ADJ
ajlsi-3081	17	12	geographic	geographic	ADJ
ajlsi-3081	17	13	regions	region	NOUN
ajlsi-3081	17	14	.	.	PUNCT
ajlsi-3081	18	1	american	american	ADJ
ajlsi-3081	18	2	cancer	cancer	PROPN
ajlsi-3081	18	3	society	society	PROPN
ajlsi-3081	18	4	(	(	PUNCT
ajlsi-3081	18	5	acs	acs	PROPN
ajlsi-3081	18	6	)	)	PUNCT
ajlsi-3081	18	7	has	have	AUX
ajlsi-3081	18	8	reported	report	VERB
ajlsi-3081	18	9	that	that	SCONJ
ajlsi-3081	18	10	9910	9910	NUM
ajlsi-3081	18	11	newly	newly	ADV
ajlsi-3081	18	12	diagnosed	diagnose	VERB
ajlsi-3081	18	13	patients	patient	NOUN
ajlsi-3081	18	14	of	of	ADP
ajlsi-3081	18	15	testicular	testicular	ADJ
ajlsi-3081	18	16	tumors	tumor	NOUN
ajlsi-3081	18	17	in	in	ADP
ajlsi-3081	18	18	the	the	DET
ajlsi-3081	18	19	year	year	NOUN
ajlsi-3081	18	20	2022	2022	NUM
ajlsi-3081	18	21	,	,	PUNCT
ajlsi-3081	18	22	out	out	ADP
ajlsi-3081	18	23	of	of	ADP
ajlsi-3081	18	24	which	which	PRON
ajlsi-3081	18	25	460	460	NUM
ajlsi-3081	18	26	are	be	AUX
ajlsi-3081	18	27	residents	resident	NOUN
ajlsi-3081	18	28	of	of	ADP
ajlsi-3081	18	29	the	the	DET
ajlsi-3081	18	30	usa	usa	PROPN
ajlsi-3081	18	31	(	(	PUNCT
ajlsi-3081	18	32	alghamdi	alghamdi	NOUN
ajlsi-3081	18	33	,	,	PUNCT
ajlsi-3081	18	34	2023	2023	NUM
ajlsi-3081	18	35	)	)	PUNCT
ajlsi-3081	18	36	.	.	PUNCT
ajlsi-3081	19	1	the	the	DET
ajlsi-3081	19	2	international	international	ADJ
ajlsi-3081	19	3	agency	agency	NOUN
ajlsi-3081	19	4	for	for	ADP
ajlsi-3081	19	5	research	research	NOUN
ajlsi-3081	19	6	on	on	ADP
ajlsi-3081	19	7	cancer	cancer	NOUN
ajlsi-3081	19	8	(	(	PUNCT
ajlsi-3081	19	9	iarc	iarc	NOUN
ajlsi-3081	19	10	)	)	PUNCT
ajlsi-3081	19	11	has	have	AUX
ajlsi-3081	19	12	reported	report	VERB
ajlsi-3081	19	13	s	s	VERB
ajlsi-3081	19	14	that	that	SCONJ
ajlsi-3081	19	15	the	the	DET
ajlsi-3081	19	16	age	age	NOUN
ajlsi-3081	19	17	-	-	PUNCT
ajlsi-3081	19	18	standardized	standardize	VERB
ajlsi-3081	19	19	incident	incident	NOUN
ajlsi-3081	19	20	rate	rate	NOUN
ajlsi-3081	19	21	for	for	ADP
ajlsi-3081	19	22	testicular	testicular	ADJ
ajlsi-3081	19	23	cancer	cancer	NOUN
ajlsi-3081	19	24	in	in	ADP
ajlsi-3081	19	25	men	man	NOUN
ajlsi-3081	19	26	in	in	ADP
ajlsi-3081	19	27	saudi	saudi	PROPN
ajlsi-3081	19	28	arabia	arabia	PROPN
ajlsi-3081	19	29	is	be	AUX
ajlsi-3081	19	30	around	around	ADV
ajlsi-3081	19	31	0.8	0.8	NUM
ajlsi-3081	19	32	cases	case	NOUN
ajlsi-3081	19	33	per	per	ADP
ajlsi-3081	19	34	100,000	100,000	NUM
ajlsi-3081	19	35	people	people	NOUN
ajlsi-3081	19	36	(	(	PUNCT
ajlsi-3081	19	37	s	s	PROPN
ajlsi-3081	19	38	,	,	PUNCT
ajlsi-3081	19	39	2007	2007	NUM
ajlsi-3081	19	40	)	)	PUNCT
ajlsi-3081	19	41	.	.	PUNCT
ajlsi-3081	20	1	nearly	nearly	ADV
ajlsi-3081	20	2	440	440	NUM
ajlsi-3081	20	3	deaths	death	NOUN
ajlsi-3081	20	4	were	be	AUX
ajlsi-3081	20	5	predicted	predict	VERB
ajlsi-3081	20	6	to	to	PART
ajlsi-3081	20	7	occur	occur	VERB
ajlsi-3081	20	8	due	due	ADP
ajlsi-3081	20	9	to	to	ADP
ajlsi-3081	20	10	testicular	testicular	ADJ
ajlsi-3081	20	11	cancer	cancer	NOUN
ajlsi-3081	20	12	in	in	ADP
ajlsi-3081	20	13	the	the	DET
ajlsi-3081	20	14	usa	usa	PROPN
ajlsi-3081	20	15	,	,	PUNCT
ajlsi-3081	20	16	with	with	ADP
ajlsi-3081	20	17	a	a	DET
ajlsi-3081	20	18	survival	survival	NOUN
ajlsi-3081	20	19	rate	rate	NOUN
ajlsi-3081	20	20	as	as	ADV
ajlsi-3081	20	21	high	high	ADJ
ajlsi-3081	20	22	as	as	ADP
ajlsi-3081	20	23	95	95	NUM
ajlsi-3081	20	24	%	%	NOUN
ajlsi-3081	20	25	and	and	CCONJ
ajlsi-3081	20	26	five	five	NUM
ajlsi-3081	20	27	years	year	NOUN
ajlsi-3081	20	28	of	of	ADP
ajlsi-3081	20	29	lifespan	lifespan	NOUN
ajlsi-3081	20	30	in	in	ADP
ajlsi-3081	20	31	the	the	DET
ajlsi-3081	20	32	year	year	NOUN
ajlsi-3081	20	33	2017	2017	NUM
ajlsi-3081	20	34	(	(	PUNCT
ajlsi-3081	20	35	gilligan	gilligan	NOUN
ajlsi-3081	20	36	et	et	PROPN
ajlsi-3081	20	37	al	al	PROPN
ajlsi-3081	20	38	.	.	PROPN
ajlsi-3081	20	39	,	,	PUNCT
ajlsi-3081	20	40	2019	2019	NUM
ajlsi-3081	20	41	)	)	PUNCT
ajlsi-3081	20	42	.	.	PUNCT
ajlsi-3081	21	1	the	the	DET
ajlsi-3081	21	2	frequency	frequency	NOUN
ajlsi-3081	21	3	of	of	ADP
ajlsi-3081	21	4	prevalence	prevalence	NOUN
ajlsi-3081	21	5	of	of	ADP
ajlsi-3081	21	6	testicular	testicular	ADJ
ajlsi-3081	21	7	cancer	cancer	NOUN
ajlsi-3081	21	8	is	be	AUX
ajlsi-3081	21	9	highly	highly	ADV
ajlsi-3081	21	10	dependent	dependent	ADJ
ajlsi-3081	21	11	on	on	ADP
ajlsi-3081	21	12	the	the	DET
ajlsi-3081	21	13	geographic	geographic	ADJ
ajlsi-3081	21	14	locations	location	NOUN
ajlsi-3081	21	15	of	of	ADP
ajlsi-3081	21	16	susceptible	susceptible	ADJ
ajlsi-3081	21	17	cases	case	NOUN
ajlsi-3081	21	18	(	(	PUNCT
ajlsi-3081	21	19	huyghe	huyghe	PROPN
ajlsi-3081	21	20	et	et	PROPN
ajlsi-3081	21	21	al	al	PROPN
ajlsi-3081	21	22	.	.	PROPN
ajlsi-3081	21	23	,	,	PUNCT
ajlsi-3081	21	24	2003	2003	NUM
ajlsi-3081	21	25	)	)	PUNCT
ajlsi-3081	21	26	.	.	PUNCT
ajlsi-3081	22	1	european	european	ADJ
ajlsi-3081	22	2	countries	country	NOUN
ajlsi-3081	22	3	have	have	AUX
ajlsi-3081	22	4	shown	show	VERB
ajlsi-3081	22	5	the	the	DET
ajlsi-3081	22	6	highest	high	ADJ
ajlsi-3081	22	7	age	age	NOUN
ajlsi-3081	22	8	-	-	PUNCT
ajlsi-3081	22	9	standardized	standardize	VERB
ajlsi-3081	22	10	incident	incident	NOUN
ajlsi-3081	22	11	rates	rate	NOUN
ajlsi-3081	22	12	,	,	PUNCT
ajlsi-3081	22	13	up	up	ADP
ajlsi-3081	22	14	to	to	PART
ajlsi-3081	22	15	6.3	6.3	NUM
ajlsi-3081	22	16	%	%	NOUN
ajlsi-3081	22	17	(	(	PUNCT
ajlsi-3081	22	18	shanmugalingam	shanmugalingam	NOUN
ajlsi-3081	22	19	et	et	PROPN
ajlsi-3081	22	20	al	al	PROPN
ajlsi-3081	22	21	.	.	PROPN
ajlsi-3081	22	22	,	,	PUNCT
ajlsi-3081	22	23	2013	2013	NUM
ajlsi-3081	22	24	)	)	PUNCT
ajlsi-3081	22	25	.	.	PUNCT
ajlsi-3081	23	1	notably	notably	ADV
ajlsi-3081	23	2	,	,	PUNCT
ajlsi-3081	23	3	regions	region	NOUN
ajlsi-3081	23	4	of	of	ADP
ajlsi-3081	23	5	the	the	DET
ajlsi-3081	23	6	usa	usa	PROPN
ajlsi-3081	23	7	,	,	PUNCT
ajlsi-3081	23	8	such	such	ADJ
ajlsi-3081	23	9	as	as	ADP
ajlsi-3081	23	10	north	north	ADJ
ajlsi-3081	23	11	american	american	ADJ
ajlsi-3081	23	12	countries	country	NOUN
ajlsi-3081	23	13	,	,	PUNCT
ajlsi-3081	23	14	have	have	AUX
ajlsi-3081	23	15	also	also	ADV
ajlsi-3081	23	16	given	give	VERB
ajlsi-3081	23	17	significant	significant	ADJ
ajlsi-3081	23	18	age	age	NOUN
ajlsi-3081	23	19	-	-	PUNCT
ajlsi-3081	23	20	standardized	standardize	VERB
ajlsi-3081	23	21	incident	incident	NOUN
ajlsi-3081	23	22	rates	rate	NOUN
ajlsi-3081	23	23	of	of	ADP
ajlsi-3081	23	24	about	about	ADV
ajlsi-3081	23	25	5.1	5.1	NUM
ajlsi-3081	23	26	%	%	NOUN
ajlsi-3081	23	27	,	,	PUNCT
ajlsi-3081	23	28	and	and	CCONJ
ajlsi-3081	23	29	latin	latin	PROPN
ajlsi-3081	23	30	america	america	PROPN
ajlsi-3081	23	31	and	and	CCONJ
ajlsi-3081	23	32	the	the	DET
ajlsi-3081	23	33	caribbean	caribbean	PROPN
ajlsi-3081	23	34	have	have	VERB
ajlsi-3081	23	35	incident	incident	NOUN
ajlsi-3081	23	36	rates	rate	NOUN
ajlsi-3081	23	37	of	of	ADP
ajlsi-3081	23	38	4.4	4.4	NUM
ajlsi-3081	23	39	%	%	NOUN
ajlsi-3081	23	40	(	(	PUNCT
ajlsi-3081	23	41	nigam	nigam	PROPN
ajlsi-3081	23	42	et	et	PROPN
ajlsi-3081	23	43	al	al	PROPN
ajlsi-3081	23	44	.	.	PROPN
ajlsi-3081	23	45	,	,	PUNCT
ajlsi-3081	23	46	2015	2015	NUM
ajlsi-3081	23	47	)	)	PUNCT
ajlsi-3081	23	48	.	.	PUNCT
ajlsi-3081	24	1	in	in	ADP
ajlsi-3081	24	2	comparison	comparison	NOUN
ajlsi-3081	24	3	,	,	PUNCT
ajlsi-3081	24	4	asian	asian	ADJ
ajlsi-3081	24	5	and	and	CCONJ
ajlsi-3081	24	6	african	african	ADJ
ajlsi-3081	24	7	countries	country	NOUN
ajlsi-3081	24	8	have	have	VERB
ajlsi-3081	24	9	the	the	DET
ajlsi-3081	24	10	lowest	low	ADJ
ajlsi-3081	24	11	age	age	NOUN
ajlsi-3081	24	12	-	-	PUNCT
ajlsi-3081	24	13	standardized	standardize	VERB
ajlsi-3081	24	14	incident	incident	NOUN
ajlsi-3081	24	15	rates	rate	NOUN
ajlsi-3081	24	16	of	of	ADP
ajlsi-3081	24	17	0.77	0.77	NUM
ajlsi-3081	24	18	%	%	NOUN
ajlsi-3081	24	19	and	and	CCONJ
ajlsi-3081	24	20	0.34	0.34	NUM
ajlsi-3081	24	21	%	%	NOUN
ajlsi-3081	24	22	(	(	PUNCT
ajlsi-3081	24	23	wang	wang	PROPN
ajlsi-3081	24	24	et	et	PROPN
ajlsi-3081	24	25	al	al	PROPN
ajlsi-3081	24	26	.	.	PROPN
ajlsi-3081	24	27	,	,	PUNCT
ajlsi-3081	24	28	2021	2021	NUM
ajlsi-3081	24	29	)	)	PUNCT
ajlsi-3081	24	30	.	.	PUNCT
ajlsi-3081	25	1	the	the	DET
ajlsi-3081	25	2	incidence	incidence	NOUN
ajlsi-3081	25	3	of	of	ADP
ajlsi-3081	25	4	germ	germ	NOUN
ajlsi-3081	25	5	cell	cell	NOUN
ajlsi-3081	25	6	tumors	tumor	NOUN
ajlsi-3081	25	7	appears	appear	VERB
ajlsi-3081	25	8	to	to	PART
ajlsi-3081	25	9	be	be	AUX
ajlsi-3081	25	10	increasing	increase	VERB
ajlsi-3081	25	11	worldwide	worldwide	ADV
ajlsi-3081	25	12	.	.	PUNCT
ajlsi-3081	26	1	in	in	ADP
ajlsi-3081	26	2	the	the	DET
ajlsi-3081	26	3	united	united	PROPN
ajlsi-3081	26	4	states	states	PROPN
ajlsi-3081	26	5	,	,	PUNCT
ajlsi-3081	26	6	the	the	DET
ajlsi-3081	26	7	agedependent	agedependent	PROPN
ajlsi-3081	26	8	prevalence	prevalence	NOUN
ajlsi-3081	26	9	frequency	frequency	NOUN
ajlsi-3081	26	10	for	for	ADP
ajlsi-3081	26	11	puberty	puberty	NOUN
ajlsi-3081	26	12	hitting	hit	VERB
ajlsi-3081	26	13	boys	boy	NOUN
ajlsi-3081	26	14	and	and	CCONJ
ajlsi-3081	26	15	men	man	NOUN
ajlsi-3081	26	16	15	15	NUM
ajlsi-3081	26	17	to	to	PART
ajlsi-3081	26	18	49	49	NUM
ajlsi-3081	26	19	years	year	NOUN
ajlsi-3081	26	20	old	old	ADJ
ajlsi-3081	26	21	accelerated	accelerate	VERB
ajlsi-3081	26	22	from	from	ADP
ajlsi-3081	26	23	2.5	2.5	NUM
ajlsi-3081	26	24	to	to	ADP
ajlsi-3081	26	25	5.1	5.1	NUM
ajlsi-3081	26	26	per	per	ADP
ajlsi-3081	26	27	100000	100000	NUM
ajlsi-3081	26	28	people	people	NOUN
ajlsi-3081	26	29	in	in	ADP
ajlsi-3081	26	30	the	the	DET
ajlsi-3081	26	31	year	year	NOUN
ajlsi-3081	26	32	2004	2004	NUM
ajlsi-3081	26	33	(	(	PUNCT
ajlsi-3081	26	34	bleyer	bleyer	NOUN
ajlsi-3081	26	35	,	,	PUNCT
ajlsi-3081	26	36	2007	2007	NUM
ajlsi-3081	26	37	)	)	PUNCT
ajlsi-3081	26	38	.	.	PUNCT
ajlsi-3081	27	1	meanwhile	meanwhile	ADV
ajlsi-3081	27	2	,	,	PUNCT
ajlsi-3081	27	3	the	the	DET
ajlsi-3081	27	4	growth	growth	NOUN
ajlsi-3081	27	5	rate	rate	NOUN
ajlsi-3081	27	6	of	of	ADP
ajlsi-3081	27	7	seminomas	seminoma	NOUN
ajlsi-3081	27	8	was	be	AUX
ajlsi-3081	27	9	exponential	exponential	ADJ
ajlsi-3081	27	10	concerning	concern	VERB
ajlsi-3081	27	11	seminomas	seminoma	NOUN
ajlsi-3081	27	12	germ	germ	NOUN
ajlsi-3081	27	13	cell	cell	NOUN
ajlsi-3081	27	14	tumors	tumor	NOUN
ajlsi-3081	27	15	.	.	PUNCT
ajlsi-3081	28	1	the	the	DET
ajlsi-3081	28	2	focused	focused	ADJ
ajlsi-3081	28	3	study	study	NOUN
ajlsi-3081	28	4	aims	aim	VERB
ajlsi-3081	28	5	to	to	PART
ajlsi-3081	28	6	fulfill	fulfill	VERB
ajlsi-3081	28	7	the	the	DET
ajlsi-3081	28	8	research	research	NOUN
ajlsi-3081	28	9	gap	gap	NOUN
ajlsi-3081	28	10	that	that	PRON
ajlsi-3081	28	11	proves	prove	VERB
ajlsi-3081	28	12	that	that	SCONJ
ajlsi-3081	28	13	there	there	PRON
ajlsi-3081	28	14	is	be	VERB
ajlsi-3081	28	15	comparatively	comparatively	ADV
ajlsi-3081	28	16	limited	limited	ADJ
ajlsi-3081	28	17	data	datum	NOUN
ajlsi-3081	28	18	available	available	ADJ
ajlsi-3081	28	19	on	on	ADP
ajlsi-3081	28	20	the	the	DET
ajlsi-3081	28	21	prevalence	prevalence	NOUN
ajlsi-3081	28	22	of	of	ADP
ajlsi-3081	28	23	testicular	testicular	ADJ
ajlsi-3081	28	24	cancer	cancer	NOUN
ajlsi-3081	28	25	in	in	ADP
ajlsi-3081	28	26	saudi	saudi	PROPN
ajlsi-3081	28	27	arabia	arabia	PROPN
ajlsi-3081	28	28	.	.	PUNCT
ajlsi-3081	29	1	the	the	DET
ajlsi-3081	29	2	present	present	ADJ
ajlsi-3081	29	3	retrospective	retrospective	ADJ
ajlsi-3081	29	4	cohort	cohort	NOUN
ajlsi-3081	29	5	study	study	NOUN
ajlsi-3081	29	6	aimed	aim	VERB
ajlsi-3081	29	7	to	to	PART
ajlsi-3081	29	8	perform	perform	VERB
ajlsi-3081	29	9	an	an	DET
ajlsi-3081	29	10	extensive	extensive	ADJ
ajlsi-3081	29	11	analysis	analysis	NOUN
ajlsi-3081	29	12	of	of	ADP
ajlsi-3081	29	13	testicular	testicular	ADJ
ajlsi-3081	29	14	tumors	tumor	NOUN
ajlsi-3081	29	15	in	in	ADP
ajlsi-3081	29	16	residents	resident	NOUN
ajlsi-3081	29	17	of	of	ADP
ajlsi-3081	29	18	saudi	saudi	PROPN
ajlsi-3081	29	19	arabia	arabia	PROPN
ajlsi-3081	29	20	whom	whom	PRON
ajlsi-3081	29	21	king	king	PROPN
ajlsi-3081	29	22	faisal	faisal	PROPN
ajlsi-3081	29	23	specialist	specialist	PROPN
ajlsi-3081	29	24	hospital	hospital	PROPN
ajlsi-3081	29	25	and	and	CCONJ
ajlsi-3081	29	26	research	research	NOUN
ajlsi-3081	29	27	centre	centre	NOUN
ajlsi-3081	29	28	have	have	AUX
ajlsi-3081	29	29	treated	treat	VERB
ajlsi-3081	29	30	.	.	PUNCT
ajlsi-3081	30	1	the	the	DET
ajlsi-3081	30	2	present	present	ADJ
ajlsi-3081	30	3	research	research	NOUN
ajlsi-3081	30	4	examined	examine	VERB
ajlsi-3081	30	5	incidence	incidence	NOUN
ajlsi-3081	30	6	rate	rate	NOUN
ajlsi-3081	30	7	,	,	PUNCT
ajlsi-3081	30	8	prevalence	prevalence	NOUN
ajlsi-3081	30	9	trends	trend	NOUN
ajlsi-3081	30	10	,	,	PUNCT
ajlsi-3081	30	11	patient	patient	ADJ
ajlsi-3081	30	12	management	management	NOUN
ajlsi-3081	30	13	and	and	CCONJ
ajlsi-3081	30	14	its	its	PRON
ajlsi-3081	30	15	outcomes	outcome	NOUN
ajlsi-3081	30	16	,	,	PUNCT
ajlsi-3081	30	17	and	and	CCONJ
ajlsi-3081	30	18	the	the	DET
ajlsi-3081	30	19	progression	progression	NOUN
ajlsi-3081	30	20	-	-	PUNCT
ajlsi-3081	30	21	free	free	ADJ
ajlsi-3081	30	22	survival	survival	NOUN
ajlsi-3081	30	23	of	of	ADP
ajlsi-3081	30	24	patients	patient	NOUN
ajlsi-3081	30	25	.	.	PUNCT
ajlsi-3081	31	1	materials	material	NOUN
ajlsi-3081	31	2	and	and	CCONJ
ajlsi-3081	31	3	methods	method	NOUN
ajlsi-3081	31	4	study	study	NOUN
ajlsi-3081	31	5	design	design	NOUN
ajlsi-3081	31	6	and	and	CCONJ
ajlsi-3081	31	7	setting	set	VERB
ajlsi-3081	31	8	the	the	DET
ajlsi-3081	31	9	study	study	NOUN
ajlsi-3081	31	10	is	be	AUX
ajlsi-3081	31	11	a	a	DET
ajlsi-3081	31	12	retrospective	retrospective	ADJ
ajlsi-3081	31	13	cohort	cohort	NOUN
ajlsi-3081	31	14	study	study	NOUN
ajlsi-3081	31	15	of	of	ADP
ajlsi-3081	31	16	pre	pre	ADJ
ajlsi-3081	31	17	-	-	ADJ
ajlsi-3081	31	18	existing	existing	ADJ
ajlsi-3081	31	19	data	datum	NOUN
ajlsi-3081	31	20	.	.	PUNCT
ajlsi-3081	32	1	all	all	DET
ajlsi-3081	32	2	participants	participant	NOUN
ajlsi-3081	32	3	of	of	ADP
ajlsi-3081	32	4	this	this	DET
ajlsi-3081	32	5	study	study	NOUN
ajlsi-3081	32	6	are	be	AUX
ajlsi-3081	32	7	patients	patient	NOUN
ajlsi-3081	32	8	who	who	PRON
ajlsi-3081	32	9	were	be	AUX
ajlsi-3081	32	10	diagnosed	diagnose	VERB
ajlsi-3081	32	11	or	or	CCONJ
ajlsi-3081	32	12	had	have	AUX
ajlsi-3081	32	13	received	receive	VERB
ajlsi-3081	32	14	treatment	treatment	NOUN
ajlsi-3081	32	15	for	for	ADP
ajlsi-3081	32	16	a	a	DET
ajlsi-3081	32	17	testicular	testicular	ADJ
ajlsi-3081	32	18	tumor	tumor	NOUN
ajlsi-3081	32	19	in	in	ADP
ajlsi-3081	32	20	the	the	DET
ajlsi-3081	32	21	king	king	NOUN
ajlsi-3081	32	22	faisal	faisal	PROPN
ajlsi-3081	32	23	specialist	specialist	PROPN
ajlsi-3081	32	24	hospital	hospital	PROPN
ajlsi-3081	32	25	&	&	CCONJ
ajlsi-3081	32	26	research	research	PROPN
ajlsi-3081	32	27	pa	pa	PROPN
ajlsi-3081	32	28	ge	ge	PROPN
ajlsi-3081	32	29	58	58	NUM
ajlsi-3081	32	30	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-3081	32	31	am	am	NOUN
ajlsi-3081	32	32	.	.	PUNCT
ajlsi-3081	33	1	j.	j.	PROPN
ajlsi-3081	33	2	life	life	PROPN
ajlsi-3081	33	3	sci	sci	PROPN
ajlsi-3081	33	4	.	.	PUNCT
ajlsi-3081	33	5	innov	innov	PROPN
ajlsi-3081	33	6	.	.	PUNCT
ajlsi-3081	34	1	3(2	3(2	NUM
ajlsi-3081	34	2	)	)	PUNCT
ajlsi-3081	34	3	57	57	NUM
ajlsi-3081	34	4	-	-	SYM
ajlsi-3081	34	5	63	63	NUM
ajlsi-3081	34	6	,	,	PUNCT
ajlsi-3081	34	7	2024	2024	NUM
ajlsi-3081	34	8	center	center	NOUN
ajlsi-3081	34	9	(	(	PUNCT
ajlsi-3081	34	10	kfshrc	kfshrc	PROPN
ajlsi-3081	34	11	)	)	PUNCT
ajlsi-3081	34	12	.	.	PUNCT
ajlsi-3081	35	1	the	the	DET
ajlsi-3081	35	2	retrospective	retrospective	ADJ
ajlsi-3081	35	3	cohort	cohort	NOUN
ajlsi-3081	35	4	study	study	NOUN
ajlsi-3081	35	5	covers	cover	VERB
ajlsi-3081	35	6	multiple	multiple	ADJ
ajlsi-3081	35	7	clinical	clinical	ADJ
ajlsi-3081	35	8	aspects	aspect	NOUN
ajlsi-3081	35	9	,	,	PUNCT
ajlsi-3081	35	10	including	include	VERB
ajlsi-3081	35	11	histological	histological	ADJ
ajlsi-3081	35	12	types	type	NOUN
ajlsi-3081	35	13	of	of	ADP
ajlsi-3081	35	14	the	the	DET
ajlsi-3081	35	15	tumor	tumor	NOUN
ajlsi-3081	35	16	,	,	PUNCT
ajlsi-3081	35	17	the	the	DET
ajlsi-3081	35	18	staging	staging	NOUN
ajlsi-3081	35	19	of	of	ADP
ajlsi-3081	35	20	the	the	DET
ajlsi-3081	35	21	cancer	cancer	NOUN
ajlsi-3081	35	22	,	,	PUNCT
ajlsi-3081	35	23	and	and	CCONJ
ajlsi-3081	35	24	the	the	DET
ajlsi-3081	35	25	mode	mode	NOUN
ajlsi-3081	35	26	of	of	ADP
ajlsi-3081	35	27	treatments	treatment	NOUN
ajlsi-3081	35	28	employed	employ	VERB
ajlsi-3081	35	29	for	for	ADP
ajlsi-3081	35	30	those	those	DET
ajlsi-3081	35	31	cases	case	NOUN
ajlsi-3081	35	32	that	that	PRON
ajlsi-3081	35	33	were	be	AUX
ajlsi-3081	35	34	treated	treat	VERB
ajlsi-3081	35	35	.	.	PUNCT
ajlsi-3081	36	1	the	the	DET
ajlsi-3081	36	2	current	current	ADJ
ajlsi-3081	36	3	study	study	NOUN
ajlsi-3081	36	4	has	have	AUX
ajlsi-3081	36	5	also	also	ADV
ajlsi-3081	36	6	included	include	VERB
ajlsi-3081	36	7	radiographic	radiographic	ADJ
ajlsi-3081	36	8	imaging	imaging	NOUN
ajlsi-3081	36	9	of	of	ADP
ajlsi-3081	36	10	the	the	DET
ajlsi-3081	36	11	tumor	tumor	NOUN
ajlsi-3081	36	12	and	and	CCONJ
ajlsi-3081	36	13	tumor	tumor	NOUN
ajlsi-3081	36	14	markers	marker	NOUN
ajlsi-3081	36	15	.	.	PUNCT
ajlsi-3081	37	1	case	case	NOUN
ajlsi-3081	37	2	records	record	NOUN
ajlsi-3081	37	3	that	that	PRON
ajlsi-3081	37	4	were	be	AUX
ajlsi-3081	37	5	incomplete	incomplete	ADJ
ajlsi-3081	37	6	or	or	CCONJ
ajlsi-3081	37	7	lacked	lack	VERB
ajlsi-3081	37	8	essential	essential	ADJ
ajlsi-3081	37	9	data	datum	NOUN
ajlsi-3081	37	10	were	be	AUX
ajlsi-3081	37	11	excluded	exclude	VERB
ajlsi-3081	37	12	.	.	PUNCT
ajlsi-3081	38	1	only	only	ADV
ajlsi-3081	38	2	those	those	DET
ajlsi-3081	38	3	patients	patient	NOUN
ajlsi-3081	38	4	who	who	PRON
ajlsi-3081	38	5	were	be	AUX
ajlsi-3081	38	6	residents	resident	NOUN
ajlsi-3081	38	7	of	of	ADP
ajlsi-3081	38	8	saudi	saudi	PROPN
ajlsi-3081	38	9	arabia	arabia	PROPN
ajlsi-3081	38	10	and	and	CCONJ
ajlsi-3081	38	11	were	be	AUX
ajlsi-3081	38	12	diagnosed	diagnose	VERB
ajlsi-3081	38	13	and	and	CCONJ
ajlsi-3081	38	14	treated	treat	VERB
ajlsi-3081	38	15	at	at	ADP
ajlsi-3081	38	16	king	king	PROPN
ajlsi-3081	38	17	faisal	faisal	PROPN
ajlsi-3081	38	18	specialist	specialist	PROPN
ajlsi-3081	38	19	hospital	hospital	PROPN
ajlsi-3081	38	20	&	&	CCONJ
ajlsi-3081	38	21	research	research	PROPN
ajlsi-3081	38	22	center	center	PROPN
ajlsi-3081	38	23	(	(	PUNCT
ajlsi-3081	38	24	kfshrc	kfshrc	PROPN
ajlsi-3081	38	25	)	)	PUNCT
ajlsi-3081	38	26	were	be	AUX
ajlsi-3081	38	27	included	include	VERB
ajlsi-3081	38	28	in	in	ADP
ajlsi-3081	38	29	the	the	DET
ajlsi-3081	38	30	study	study	NOUN
ajlsi-3081	38	31	.	.	PUNCT
ajlsi-3081	39	1	participants	participant	NOUN
ajlsi-3081	39	2	the	the	DET
ajlsi-3081	39	3	study	study	NOUN
ajlsi-3081	39	4	included	include	VERB
ajlsi-3081	39	5	a	a	DET
ajlsi-3081	39	6	total	total	NOUN
ajlsi-3081	39	7	of	of	ADP
ajlsi-3081	39	8	125	125	NUM
ajlsi-3081	39	9	patients	patient	NOUN
ajlsi-3081	39	10	;	;	PUNCT
ajlsi-3081	39	11	all	all	DET
ajlsi-3081	39	12	the	the	DET
ajlsi-3081	39	13	patients	patient	NOUN
ajlsi-3081	39	14	underwent	undergo	VERB
ajlsi-3081	39	15	orchiectomy	orchiectomy	ADJ
ajlsi-3081	39	16	surgery	surgery	NOUN
ajlsi-3081	39	17	as	as	ADP
ajlsi-3081	39	18	a	a	DET
ajlsi-3081	39	19	treatment	treatment	NOUN
ajlsi-3081	39	20	.	.	PUNCT
ajlsi-3081	40	1	the	the	DET
ajlsi-3081	40	2	participants	participant	NOUN
ajlsi-3081	40	3	were	be	AUX
ajlsi-3081	40	4	categorized	categorize	VERB
ajlsi-3081	40	5	as	as	ADP
ajlsi-3081	40	6	one	one	NUM
ajlsi-3081	40	7	main	main	ADJ
ajlsi-3081	40	8	group	group	NOUN
ajlsi-3081	40	9	and	and	CCONJ
ajlsi-3081	40	10	had	have	VERB
ajlsi-3081	40	11	four	four	NUM
ajlsi-3081	40	12	sub	sub	NOUN
ajlsi-3081	40	13	-	-	NOUN
ajlsi-3081	40	14	groups	group	NOUN
ajlsi-3081	40	15	.	.	PUNCT
ajlsi-3081	41	1	the	the	DET
ajlsi-3081	41	2	main	main	ADJ
ajlsi-3081	41	3	group	group	NOUN
ajlsi-3081	41	4	comprises	comprise	VERB
ajlsi-3081	41	5	residents	resident	NOUN
ajlsi-3081	41	6	of	of	ADP
ajlsi-3081	41	7	riyadh	riyadh	PROPN
ajlsi-3081	41	8	and	and	CCONJ
ajlsi-3081	41	9	those	those	PRON
ajlsi-3081	41	10	living	live	VERB
ajlsi-3081	41	11	outside	outside	ADP
ajlsi-3081	41	12	riyadh	riyadh	NOUN
ajlsi-3081	41	13	.	.	PUNCT
ajlsi-3081	42	1	our	our	PRON
ajlsi-3081	42	2	study	study	NOUN
ajlsi-3081	42	3	included	include	VERB
ajlsi-3081	42	4	1	1	NUM
ajlsi-3081	42	5	main	main	ADJ
ajlsi-3081	42	6	group	group	NOUN
ajlsi-3081	42	7	and	and	CCONJ
ajlsi-3081	42	8	4	4	NUM
ajlsi-3081	42	9	subgroups	subgroup	NOUN
ajlsi-3081	42	10	.	.	PUNCT
ajlsi-3081	43	1	the	the	DET
ajlsi-3081	43	2	main	main	ADJ
ajlsi-3081	43	3	group	group	NOUN
ajlsi-3081	43	4	compared	compare	VERB
ajlsi-3081	43	5	patients	patient	NOUN
ajlsi-3081	43	6	living	live	VERB
ajlsi-3081	43	7	in	in	ADP
ajlsi-3081	43	8	riyadh	riyadh	NOUN
ajlsi-3081	43	9	with	with	ADP
ajlsi-3081	43	10	those	those	PRON
ajlsi-3081	43	11	residing	reside	VERB
ajlsi-3081	43	12	outside	outside	ADP
ajlsi-3081	43	13	riyadh	riyadh	NOUN
ajlsi-3081	43	14	.	.	PUNCT
ajlsi-3081	44	1	the	the	DET
ajlsi-3081	44	2	sub	sub	NOUN
ajlsi-3081	44	3	-	-	NOUN
ajlsi-3081	44	4	groups	group	NOUN
ajlsi-3081	44	5	are	be	AUX
ajlsi-3081	44	6	formed	form	VERB
ajlsi-3081	44	7	based	base	VERB
ajlsi-3081	44	8	on	on	ADP
ajlsi-3081	44	9	the	the	DET
ajlsi-3081	44	10	recurrence	recurrence	NOUN
ajlsi-3081	44	11	of	of	ADP
ajlsi-3081	44	12	cancer	cancer	NOUN
ajlsi-3081	44	13	,	,	PUNCT
ajlsi-3081	44	14	the	the	DET
ajlsi-3081	44	15	pathology	pathology	NOUN
ajlsi-3081	44	16	type	type	NOUN
ajlsi-3081	44	17	of	of	ADP
ajlsi-3081	44	18	cancer	cancer	NOUN
ajlsi-3081	44	19	,	,	PUNCT
ajlsi-3081	44	20	the	the	DET
ajlsi-3081	44	21	progression	progression	NOUN
ajlsi-3081	44	22	or	or	CCONJ
ajlsi-3081	44	23	the	the	DET
ajlsi-3081	44	24	risk	risk	NOUN
ajlsi-3081	44	25	factor	factor	NOUN
ajlsi-3081	44	26	of	of	ADP
ajlsi-3081	44	27	the	the	DET
ajlsi-3081	44	28	tumors	tumor	NOUN
ajlsi-3081	44	29	,	,	PUNCT
ajlsi-3081	44	30	and	and	CCONJ
ajlsi-3081	44	31	the	the	DET
ajlsi-3081	44	32	stage	stage	NOUN
ajlsi-3081	44	33	of	of	ADP
ajlsi-3081	44	34	the	the	DET
ajlsi-3081	44	35	tumors	tumor	NOUN
ajlsi-3081	44	36	.	.	PUNCT
ajlsi-3081	45	1	data	datum	NOUN
ajlsi-3081	45	2	source	source	NOUN
ajlsi-3081	45	3	and	and	CCONJ
ajlsi-3081	45	4	variables	variable	NOUN
ajlsi-3081	45	5	the	the	DET
ajlsi-3081	45	6	medical	medical	ADJ
ajlsi-3081	45	7	records	record	NOUN
ajlsi-3081	45	8	of	of	ADP
ajlsi-3081	45	9	patients	patient	NOUN
ajlsi-3081	45	10	,	,	PUNCT
ajlsi-3081	45	11	including	include	VERB
ajlsi-3081	45	12	the	the	DET
ajlsi-3081	45	13	demographic	demographic	ADJ
ajlsi-3081	45	14	data	datum	NOUN
ajlsi-3081	45	15	and	and	CCONJ
ajlsi-3081	45	16	all	all	DET
ajlsi-3081	45	17	the	the	DET
ajlsi-3081	45	18	data	datum	NOUN
ajlsi-3081	45	19	regarding	regard	VERB
ajlsi-3081	45	20	the	the	DET
ajlsi-3081	45	21	pathological	pathological	ADJ
ajlsi-3081	45	22	type	type	NOUN
ajlsi-3081	45	23	of	of	ADP
ajlsi-3081	45	24	tumors	tumor	NOUN
ajlsi-3081	45	25	,	,	PUNCT
ajlsi-3081	45	26	the	the	DET
ajlsi-3081	45	27	rate	rate	NOUN
ajlsi-3081	45	28	of	of	ADP
ajlsi-3081	45	29	recurrence	recurrence	NOUN
ajlsi-3081	45	30	of	of	ADP
ajlsi-3081	45	31	the	the	DET
ajlsi-3081	45	32	tumors	tumor	NOUN
ajlsi-3081	45	33	,	,	PUNCT
ajlsi-3081	45	34	and	and	CCONJ
ajlsi-3081	45	35	the	the	DET
ajlsi-3081	45	36	progression	progression	NOUN
ajlsi-3081	45	37	of	of	ADP
ajlsi-3081	45	38	the	the	DET
ajlsi-3081	45	39	disease	disease	NOUN
ajlsi-3081	45	40	,	,	PUNCT
ajlsi-3081	45	41	were	be	AUX
ajlsi-3081	45	42	retrieved	retrieve	VERB
ajlsi-3081	45	43	from	from	ADP
ajlsi-3081	45	44	the	the	DET
ajlsi-3081	45	45	reported	report	VERB
ajlsi-3081	45	46	data	datum	NOUN
ajlsi-3081	45	47	of	of	ADP
ajlsi-3081	45	48	the	the	DET
ajlsi-3081	45	49	research	research	NOUN
ajlsi-3081	45	50	centre	centre	NOUN
ajlsi-3081	45	51	.	.	PUNCT
ajlsi-3081	46	1	the	the	DET
ajlsi-3081	46	2	symptoms	symptom	NOUN
ajlsi-3081	46	3	and	and	CCONJ
ajlsi-3081	46	4	their	their	PRON
ajlsi-3081	46	5	appearances	appearance	NOUN
ajlsi-3081	46	6	,	,	PUNCT
ajlsi-3081	46	7	the	the	DET
ajlsi-3081	46	8	treatment	treatment	NOUN
ajlsi-3081	46	9	procedure	procedure	NOUN
ajlsi-3081	46	10	and	and	CCONJ
ajlsi-3081	46	11	their	their	PRON
ajlsi-3081	46	12	impacts	impact	NOUN
ajlsi-3081	46	13	,	,	PUNCT
ajlsi-3081	46	14	and	and	CCONJ
ajlsi-3081	46	15	the	the	DET
ajlsi-3081	46	16	progression	progression	NOUN
ajlsi-3081	46	17	-	-	PUNCT
ajlsi-3081	46	18	free	free	ADJ
ajlsi-3081	46	19	survival	survival	NOUN
ajlsi-3081	46	20	rate	rate	NOUN
ajlsi-3081	46	21	were	be	AUX
ajlsi-3081	46	22	directly	directly	ADV
ajlsi-3081	46	23	obtained	obtain	VERB
ajlsi-3081	46	24	from	from	ADP
ajlsi-3081	46	25	the	the	DET
ajlsi-3081	46	26	clinical	clinical	ADJ
ajlsi-3081	46	27	data	datum	NOUN
ajlsi-3081	46	28	present	present	ADJ
ajlsi-3081	46	29	in	in	ADP
ajlsi-3081	46	30	the	the	DET
ajlsi-3081	46	31	repository	repository	NOUN
ajlsi-3081	46	32	of	of	ADP
ajlsi-3081	46	33	the	the	DET
ajlsi-3081	46	34	research	research	NOUN
ajlsi-3081	46	35	center	center	NOUN
ajlsi-3081	46	36	.	.	PUNCT
ajlsi-3081	47	1	the	the	DET
ajlsi-3081	47	2	factors	factor	NOUN
ajlsi-3081	47	3	used	use	VERB
ajlsi-3081	47	4	to	to	PART
ajlsi-3081	47	5	narrow	narrow	VERB
ajlsi-3081	47	6	down	down	ADP
ajlsi-3081	47	7	the	the	DET
ajlsi-3081	47	8	data	datum	NOUN
ajlsi-3081	47	9	included	include	VERB
ajlsi-3081	47	10	the	the	DET
ajlsi-3081	47	11	age	age	NOUN
ajlsi-3081	47	12	of	of	ADP
ajlsi-3081	47	13	patients	patient	NOUN
ajlsi-3081	47	14	,	,	PUNCT
ajlsi-3081	47	15	who	who	PRON
ajlsi-3081	47	16	were	be	AUX
ajlsi-3081	47	17	classified	classify	VERB
ajlsi-3081	47	18	into	into	ADP
ajlsi-3081	47	19	sub	sub	NOUN
ajlsi-3081	47	20	-	-	NOUN
ajlsi-3081	47	21	groups	group	NOUN
ajlsi-3081	47	22	;	;	PUNCT
ajlsi-3081	47	23	patients	patient	NOUN
ajlsi-3081	47	24	aged	age	VERB
ajlsi-3081	47	25	25	25	NUM
ajlsi-3081	47	26	-	-	SYM
ajlsi-3081	47	27	65	65	NUM
ajlsi-3081	47	28	were	be	AUX
ajlsi-3081	47	29	included	include	VERB
ajlsi-3081	47	30	.	.	PUNCT
ajlsi-3081	48	1	the	the	DET
ajlsi-3081	48	2	demographic	demographic	ADJ
ajlsi-3081	48	3	data	datum	NOUN
ajlsi-3081	48	4	was	be	AUX
ajlsi-3081	48	5	also	also	ADV
ajlsi-3081	48	6	categorized	categorize	VERB
ajlsi-3081	48	7	into	into	ADP
ajlsi-3081	48	8	subgroups	subgroup	NOUN
ajlsi-3081	48	9	of	of	ADP
ajlsi-3081	48	10	patients	patient	NOUN
ajlsi-3081	48	11	living	live	VERB
ajlsi-3081	48	12	in	in	ADP
ajlsi-3081	48	13	riyadh	riyadh	PROPN
ajlsi-3081	48	14	and	and	CCONJ
ajlsi-3081	48	15	outside	outside	ADJ
ajlsi-3081	48	16	riyadh	riyadh	NOUN
ajlsi-3081	48	17	.	.	PUNCT
ajlsi-3081	49	1	data	datum	NOUN
ajlsi-3081	49	2	from	from	ADP
ajlsi-3081	49	3	patients	patient	NOUN
ajlsi-3081	49	4	across	across	ADP
ajlsi-3081	49	5	different	different	ADJ
ajlsi-3081	49	6	kingdom	kingdom	NOUN
ajlsi-3081	49	7	regions	region	NOUN
ajlsi-3081	49	8	with	with	ADP
ajlsi-3081	49	9	testicular	testicular	ADJ
ajlsi-3081	49	10	cancer	cancer	NOUN
ajlsi-3081	49	11	treated	treat	VERB
ajlsi-3081	49	12	at	at	ADP
ajlsi-3081	49	13	king	king	PROPN
ajlsi-3081	49	14	faisal	faisal	PROPN
ajlsi-3081	49	15	specialist	specialist	PROPN
ajlsi-3081	49	16	hospital	hospital	PROPN
ajlsi-3081	49	17	&	&	CCONJ
ajlsi-3081	49	18	research	research	PROPN
ajlsi-3081	49	19	center	center	PROPN
ajlsi-3081	49	20	(	(	PUNCT
ajlsi-3081	49	21	kfshrc	kfshrc	PROPN
ajlsi-3081	49	22	)	)	PUNCT
ajlsi-3081	49	23	were	be	AUX
ajlsi-3081	49	24	analyzed	analyze	VERB
ajlsi-3081	49	25	to	to	PART
ajlsi-3081	49	26	study	study	VERB
ajlsi-3081	49	27	the	the	DET
ajlsi-3081	49	28	pattern	pattern	NOUN
ajlsi-3081	49	29	of	of	ADP
ajlsi-3081	49	30	testicular	testicular	ADJ
ajlsi-3081	49	31	tumors	tumor	NOUN
ajlsi-3081	49	32	and	and	CCONJ
ajlsi-3081	49	33	management	management	NOUN
ajlsi-3081	49	34	outcomes	outcome	NOUN
ajlsi-3081	49	35	in	in	ADP
ajlsi-3081	49	36	tertiary	tertiary	ADJ
ajlsi-3081	49	37	care	care	NOUN
ajlsi-3081	49	38	hospitals	hospital	NOUN
ajlsi-3081	49	39	in	in	ADP
ajlsi-3081	49	40	many	many	ADJ
ajlsi-3081	49	41	regions	region	NOUN
ajlsi-3081	49	42	of	of	ADP
ajlsi-3081	49	43	saudi	saudi	PROPN
ajlsi-3081	49	44	arabia	arabia	PROPN
ajlsi-3081	49	45	.	.	PUNCT
ajlsi-3081	50	1	data	datum	NOUN
ajlsi-3081	50	2	analysis	analysis	NOUN
ajlsi-3081	50	3	the	the	DET
ajlsi-3081	50	4	kaplan	kaplan	PROPN
ajlsi-3081	50	5	-	-	PUNCT
ajlsi-3081	50	6	meier	meier	PROPN
ajlsi-3081	50	7	method	method	NOUN
ajlsi-3081	50	8	was	be	AUX
ajlsi-3081	50	9	applied	apply	VERB
ajlsi-3081	50	10	to	to	PART
ajlsi-3081	50	11	calculate	calculate	VERB
ajlsi-3081	50	12	survival	survival	NOUN
ajlsi-3081	50	13	curves	curve	NOUN
ajlsi-3081	50	14	,	,	PUNCT
ajlsi-3081	50	15	and	and	CCONJ
ajlsi-3081	50	16	the	the	DET
ajlsi-3081	50	17	log	log	NOUN
ajlsi-3081	50	18	-	-	PUNCT
ajlsi-3081	50	19	rank	rank	NOUN
ajlsi-3081	50	20	test	test	NOUN
ajlsi-3081	50	21	was	be	AUX
ajlsi-3081	50	22	used	use	VERB
ajlsi-3081	50	23	to	to	PART
ajlsi-3081	50	24	compare	compare	VERB
ajlsi-3081	50	25	them	they	PRON
ajlsi-3081	50	26	.	.	PUNCT
ajlsi-3081	51	1	all	all	DET
ajlsi-3081	51	2	the	the	DET
ajlsi-3081	51	3	statistical	statistical	ADJ
ajlsi-3081	51	4	data	datum	NOUN
ajlsi-3081	51	5	were	be	AUX
ajlsi-3081	51	6	studied	study	VERB
ajlsi-3081	51	7	using	use	VERB
ajlsi-3081	51	8	spss	spss	PROPN
ajlsi-3081	51	9	version	version	NOUN
ajlsi-3081	51	10	13.0	13.0	NUM
ajlsi-3081	51	11	(	(	PUNCT
ajlsi-3081	51	12	spss	spss	PROPN
ajlsi-3081	51	13	inc.chicago	inc.chicago	PROPN
ajlsi-3081	51	14	,	,	PUNCT
ajlsi-3081	51	15	il	il	PROPN
ajlsi-3081	51	16	,	,	PUNCT
ajlsi-3081	51	17	us	we	PRON
ajlsi-3081	51	18	)	)	PUNCT
ajlsi-3081	51	19	,	,	PUNCT
ajlsi-3081	51	20	and	and	CCONJ
ajlsi-3081	51	21	the	the	DET
ajlsi-3081	51	22	standard	standard	ADJ
ajlsi-3081	51	23	deviation	deviation	NOUN
ajlsi-3081	51	24	were	be	AUX
ajlsi-3081	51	25	calculated	calculate	VERB
ajlsi-3081	51	26	for	for	ADP
ajlsi-3081	51	27	the	the	DET
ajlsi-3081	51	28	demographic	demographic	ADJ
ajlsi-3081	51	29	characters	character	NOUN
ajlsi-3081	51	30	of	of	ADP
ajlsi-3081	51	31	the	the	DET
ajlsi-3081	51	32	population	population	NOUN
ajlsi-3081	51	33	.	.	PUNCT
ajlsi-3081	52	1	the	the	DET
ajlsi-3081	52	2	two	two	NUM
ajlsi-3081	52	3	-	-	PUNCT
ajlsi-3081	52	4	tailed	tail	VERB
ajlsi-3081	52	5	unpaired	unpaired	ADJ
ajlsi-3081	52	6	or	or	CCONJ
ajlsi-3081	52	7	paired	pair	VERB
ajlsi-3081	52	8	student	student	NOUN
ajlsi-3081	52	9	’s	’s	PART
ajlsi-3081	52	10	t	t	PROPN
ajlsi-3081	52	11	-	-	PUNCT
ajlsi-3081	52	12	test	test	NOUN
ajlsi-3081	52	13	was	be	AUX
ajlsi-3081	52	14	used	use	VERB
ajlsi-3081	52	15	to	to	PART
ajlsi-3081	52	16	determine	determine	VERB
ajlsi-3081	52	17	the	the	DET
ajlsi-3081	52	18	statistical	statistical	ADJ
ajlsi-3081	52	19	variation	variation	NOUN
ajlsi-3081	52	20	between	between	ADP
ajlsi-3081	52	21	the	the	DET
ajlsi-3081	52	22	sub	sub	NOUN
ajlsi-3081	52	23	-	-	NOUN
ajlsi-3081	52	24	groups	group	NOUN
ajlsi-3081	52	25	.	.	PUNCT
ajlsi-3081	53	1	statistical	statistical	ADJ
ajlsi-3081	53	2	considerations	consideration	NOUN
ajlsi-3081	53	3	the	the	DET
ajlsi-3081	53	4	study	study	NOUN
ajlsi-3081	53	5	’s	’s	PART
ajlsi-3081	53	6	main	main	ADJ
ajlsi-3081	53	7	goal	goal	NOUN
ajlsi-3081	53	8	was	be	AUX
ajlsi-3081	53	9	the	the	DET
ajlsi-3081	53	10	rate	rate	NOUN
ajlsi-3081	53	11	of	of	ADP
ajlsi-3081	53	12	cancer	cancer	NOUN
ajlsi-3081	53	13	-	-	PUNCT
ajlsi-3081	53	14	specific	specific	ADJ
ajlsi-3081	53	15	survival	survival	NOUN
ajlsi-3081	53	16	(	(	PUNCT
ajlsi-3081	53	17	css	css	PROPN
ajlsi-3081	53	18	)	)	PUNCT
ajlsi-3081	53	19	,	,	PUNCT
ajlsi-3081	53	20	calculated	calculate	VERB
ajlsi-3081	53	21	by	by	ADP
ajlsi-3081	53	22	the	the	DET
ajlsi-3081	53	23	interval	interval	NOUN
ajlsi-3081	53	24	between	between	ADP
ajlsi-3081	53	25	the	the	DET
ajlsi-3081	53	26	moment	moment	NOUN
ajlsi-3081	53	27	surgery	surgery	NOUN
ajlsi-3081	53	28	is	be	AUX
ajlsi-3081	53	29	completed	complete	VERB
ajlsi-3081	53	30	and	and	CCONJ
ajlsi-3081	53	31	the	the	DET
ajlsi-3081	53	32	time	time	NOUN
ajlsi-3081	53	33	of	of	ADP
ajlsi-3081	53	34	death	death	NOUN
ajlsi-3081	53	35	or	or	CCONJ
ajlsi-3081	53	36	last	last	ADJ
ajlsi-3081	53	37	follow	follow	NOUN
ajlsi-3081	53	38	-	-	PUNCT
ajlsi-3081	53	39	up	up	NOUN
ajlsi-3081	53	40	.	.	PUNCT
ajlsi-3081	54	1	another	another	DET
ajlsi-3081	54	2	critical	critical	ADJ
ajlsi-3081	54	3	parameter	parameter	NOUN
ajlsi-3081	54	4	of	of	ADP
ajlsi-3081	54	5	the	the	DET
ajlsi-3081	54	6	research	research	NOUN
ajlsi-3081	54	7	was	be	AUX
ajlsi-3081	54	8	recurrence	recurrence	NOUN
ajlsi-3081	54	9	-	-	PUNCT
ajlsi-3081	54	10	free	free	ADJ
ajlsi-3081	54	11	survival	survival	NOUN
ajlsi-3081	54	12	(	(	PUNCT
ajlsi-3081	54	13	rfs	rfs	PROPN
ajlsi-3081	54	14	)	)	PUNCT
ajlsi-3081	54	15	,	,	PUNCT
ajlsi-3081	54	16	calculated	calculate	VERB
ajlsi-3081	54	17	by	by	ADP
ajlsi-3081	54	18	studying	study	VERB
ajlsi-3081	54	19	the	the	DET
ajlsi-3081	54	20	interval	interval	NOUN
ajlsi-3081	54	21	between	between	ADP
ajlsi-3081	54	22	the	the	DET
ajlsi-3081	54	23	surgery	surgery	NOUN
ajlsi-3081	54	24	date	date	NOUN
ajlsi-3081	54	25	and	and	CCONJ
ajlsi-3081	54	26	tumor	tumor	NOUN
ajlsi-3081	54	27	recurrence	recurrence	NOUN
ajlsi-3081	54	28	.	.	PUNCT
ajlsi-3081	55	1	the	the	DET
ajlsi-3081	55	2	third	third	ADJ
ajlsi-3081	55	3	main	main	ADJ
ajlsi-3081	55	4	parameter	parameter	NOUN
ajlsi-3081	55	5	of	of	ADP
ajlsi-3081	55	6	the	the	DET
ajlsi-3081	55	7	study	study	NOUN
ajlsi-3081	55	8	,	,	PUNCT
ajlsi-3081	55	9	called	call	VERB
ajlsi-3081	55	10	overall	overall	ADJ
ajlsi-3081	55	11	survival	survival	NOUN
ajlsi-3081	55	12	(	(	PUNCT
ajlsi-3081	55	13	os	os	NOUN
ajlsi-3081	55	14	)	)	PUNCT
ajlsi-3081	55	15	,	,	PUNCT
ajlsi-3081	55	16	was	be	AUX
ajlsi-3081	55	17	calculated	calculate	VERB
ajlsi-3081	55	18	from	from	ADP
ajlsi-3081	55	19	the	the	DET
ajlsi-3081	55	20	period	period	NOUN
ajlsi-3081	55	21	of	of	ADP
ajlsi-3081	55	22	surgery	surgery	NOUN
ajlsi-3081	55	23	to	to	ADP
ajlsi-3081	55	24	the	the	DET
ajlsi-3081	55	25	time	time	NOUN
ajlsi-3081	55	26	of	of	ADP
ajlsi-3081	55	27	mortality	mortality	NOUN
ajlsi-3081	55	28	.	.	PUNCT
ajlsi-3081	56	1	the	the	DET
ajlsi-3081	56	2	fourth	fourth	ADJ
ajlsi-3081	56	3	parameter	parameter	NOUN
ajlsi-3081	56	4	analyzed	analyze	VERB
ajlsi-3081	56	5	was	be	AUX
ajlsi-3081	56	6	the	the	DET
ajlsi-3081	56	7	thirty	thirty	NUM
ajlsi-3081	56	8	-	-	PUNCT
ajlsi-3081	56	9	day	day	NOUN
ajlsi-3081	56	10	mortality	mortality	NOUN
ajlsi-3081	56	11	.	.	PUNCT
ajlsi-3081	57	1	it	it	PRON
ajlsi-3081	57	2	represents	represent	VERB
ajlsi-3081	57	3	any	any	DET
ajlsi-3081	57	4	death	death	NOUN
ajlsi-3081	57	5	that	that	PRON
ajlsi-3081	57	6	happened	happen	VERB
ajlsi-3081	57	7	within	within	ADP
ajlsi-3081	57	8	30	30	NUM
ajlsi-3081	57	9	days	day	NOUN
ajlsi-3081	57	10	after	after	ADP
ajlsi-3081	57	11	radical	radical	ADJ
ajlsi-3081	57	12	orchiectomy	orchiectomy	NOUN
ajlsi-3081	57	13	.	.	PUNCT
ajlsi-3081	58	1	the	the	DET
ajlsi-3081	58	2	p	p	PROPN
ajlsi-3081	58	3	values	value	NOUN
ajlsi-3081	58	4	p	p	X
ajlsi-3081	58	5	<	<	X
ajlsi-3081	58	6	0.05	0.05	NUM
ajlsi-3081	58	7	for	for	ADP
ajlsi-3081	58	8	all	all	DET
ajlsi-3081	58	9	tests	test	NOUN
ajlsi-3081	58	10	were	be	AUX
ajlsi-3081	58	11	considered	consider	VERB
ajlsi-3081	58	12	significant	significant	ADJ
ajlsi-3081	58	13	.	.	PUNCT
ajlsi-3081	59	1	ethical	ethical	ADJ
ajlsi-3081	59	2	considerations	consideration	NOUN
ajlsi-3081	59	3	ethical	ethical	ADJ
ajlsi-3081	59	4	approval	approval	NOUN
ajlsi-3081	59	5	was	be	AUX
ajlsi-3081	59	6	taken	take	VERB
ajlsi-3081	59	7	from	from	ADP
ajlsi-3081	59	8	the	the	DET
ajlsi-3081	59	9	hospital	hospital	NOUN
ajlsi-3081	59	10	’s	’s	PART
ajlsi-3081	59	11	institutional	institutional	PROPN
ajlsi-3081	59	12	review	review	PROPN
ajlsi-3081	59	13	board	board	NOUN
ajlsi-3081	59	14	(	(	PUNCT
ajlsi-3081	59	15	irb	irb	PROPN
ajlsi-3081	59	16	)	)	PUNCT
ajlsi-3081	59	17	.	.	PUNCT
ajlsi-3081	60	1	ensuring	ensure	VERB
ajlsi-3081	60	2	anonymity	anonymity	NOUN
ajlsi-3081	60	3	and	and	CCONJ
ajlsi-3081	60	4	secrecy	secrecy	NOUN
ajlsi-3081	60	5	is	be	AUX
ajlsi-3081	60	6	the	the	DET
ajlsi-3081	60	7	top	top	ADJ
ajlsi-3081	60	8	concern	concern	NOUN
ajlsi-3081	60	9	when	when	SCONJ
ajlsi-3081	60	10	discussing	discuss	VERB
ajlsi-3081	60	11	and	and	CCONJ
ajlsi-3081	60	12	publishing	publish	VERB
ajlsi-3081	60	13	our	our	PRON
ajlsi-3081	60	14	results	result	NOUN
ajlsi-3081	60	15	.	.	PUNCT
ajlsi-3081	61	1	participants	participant	NOUN
ajlsi-3081	61	2	’	'	PUNCT
ajlsi-3081	61	3	private	private	ADJ
ajlsi-3081	61	4	information	information	NOUN
ajlsi-3081	61	5	is	be	AUX
ajlsi-3081	61	6	kept	keep	VERB
ajlsi-3081	61	7	private	private	ADJ
ajlsi-3081	61	8	,	,	PUNCT
ajlsi-3081	61	9	protecting	protect	VERB
ajlsi-3081	61	10	their	their	PRON
ajlsi-3081	61	11	right	right	NOUN
ajlsi-3081	61	12	to	to	ADP
ajlsi-3081	61	13	privacy	privacy	NOUN
ajlsi-3081	61	14	and	and	CCONJ
ajlsi-3081	61	15	following	follow	VERB
ajlsi-3081	61	16	the	the	DET
ajlsi-3081	61	17	protocol	protocol	NOUN
ajlsi-3081	61	18	according	accord	VERB
ajlsi-3081	61	19	to	to	ADP
ajlsi-3081	61	20	ethical	ethical	ADJ
ajlsi-3081	61	21	guidelines	guideline	NOUN
ajlsi-3081	61	22	.	.	PUNCT
ajlsi-3081	62	1	results	result	NOUN
ajlsi-3081	62	2	and	and	CCONJ
ajlsi-3081	62	3	discussions	discussion	NOUN
ajlsi-3081	62	4	analysis	analysis	NOUN
ajlsi-3081	62	5	of	of	ADP
ajlsi-3081	62	6	survival	survival	NOUN
ajlsi-3081	62	7	curve	curve	NOUN
ajlsi-3081	62	8	analysis	analysis	NOUN
ajlsi-3081	62	9	the	the	DET
ajlsi-3081	62	10	study	study	NOUN
ajlsi-3081	62	11	used	use	VERB
ajlsi-3081	62	12	a	a	DET
ajlsi-3081	62	13	chi	chi	ADJ
ajlsi-3081	62	14	-	-	PUNCT
ajlsi-3081	62	15	square	square	ADJ
ajlsi-3081	62	16	homogeneity	homogeneity	NOUN
ajlsi-3081	62	17	test	test	NOUN
ajlsi-3081	62	18	to	to	PART
ajlsi-3081	62	19	find	find	VERB
ajlsi-3081	62	20	the	the	DET
ajlsi-3081	62	21	difference	difference	NOUN
ajlsi-3081	62	22	between	between	ADP
ajlsi-3081	62	23	the	the	DET
ajlsi-3081	62	24	survival	survival	NOUN
ajlsi-3081	62	25	rate	rate	NOUN
ajlsi-3081	62	26	of	of	ADP
ajlsi-3081	62	27	patients	patient	NOUN
ajlsi-3081	62	28	living	live	VERB
ajlsi-3081	62	29	in	in	ADP
ajlsi-3081	62	30	riyadh	riyadh	PROPN
ajlsi-3081	62	31	and	and	CCONJ
ajlsi-3081	62	32	those	those	PRON
ajlsi-3081	62	33	residing	reside	VERB
ajlsi-3081	62	34	outside	outside	ADP
ajlsi-3081	62	35	riyadh	riyadh	NOUN
ajlsi-3081	62	36	.	.	PUNCT
ajlsi-3081	63	1	the	the	DET
ajlsi-3081	63	2	relation	relation	NOUN
ajlsi-3081	63	3	between	between	ADP
ajlsi-3081	63	4	these	these	DET
ajlsi-3081	63	5	variables	variable	NOUN
ajlsi-3081	63	6	was	be	AUX
ajlsi-3081	63	7	non	non	ADJ
ajlsi-3081	63	8	-	-	ADJ
ajlsi-3081	63	9	significant	significant	ADJ
ajlsi-3081	63	10	1	1	NUM
ajlsi-3081	63	11	,	,	PUNCT
ajlsi-3081	63	12	x2	x2	PROPN
ajlsi-3081	63	13	(	(	PUNCT
ajlsi-3081	63	14	1	1	NUM
ajlsi-3081	63	15	,	,	PUNCT
ajlsi-3081	63	16	n	n	NOUN
ajlsi-3081	63	17	=	=	SYM
ajlsi-3081	63	18	125	125	NUM
ajlsi-3081	63	19	)	)	PUNCT
ajlsi-3081	63	20	=	=	NOUN
ajlsi-3081	63	21	0.97	0.97	NUM
ajlsi-3081	63	22	,	,	PUNCT
ajlsi-3081	63	23	p=0.32	p=0.32	NOUN
ajlsi-3081	63	24	,	,	PUNCT
ajlsi-3081	63	25	and	and	CCONJ
ajlsi-3081	63	26	the	the	DET
ajlsi-3081	63	27	survival	survival	NOUN
ajlsi-3081	63	28	curve	curve	NOUN
ajlsi-3081	63	29	showed	show	VERB
ajlsi-3081	63	30	no	no	DET
ajlsi-3081	63	31	difference	difference	NOUN
ajlsi-3081	63	32	in	in	ADP
ajlsi-3081	63	33	overall	overall	ADJ
ajlsi-3081	63	34	survival	survival	NOUN
ajlsi-3081	63	35	.	.	PUNCT
ajlsi-3081	64	1	nonetheless	nonetheless	ADV
ajlsi-3081	64	2	,	,	PUNCT
ajlsi-3081	64	3	there	there	PRON
ajlsi-3081	64	4	was	be	VERB
ajlsi-3081	64	5	a	a	DET
ajlsi-3081	64	6	difference	difference	NOUN
ajlsi-3081	64	7	in	in	ADP
ajlsi-3081	64	8	survival	survival	NOUN
ajlsi-3081	64	9	between	between	ADP
ajlsi-3081	64	10	seminoma	seminoma	NOUN
ajlsi-3081	64	11	and	and	CCONJ
ajlsi-3081	64	12	nsgt	nsgt	NOUN
ajlsi-3081	64	13	;	;	PUNCT
ajlsi-3081	64	14	the	the	DET
ajlsi-3081	64	15	test	test	NOUN
ajlsi-3081	64	16	was	be	AUX
ajlsi-3081	64	17	marginally	marginally	ADV
ajlsi-3081	64	18	significant	significant	ADJ
ajlsi-3081	64	19	at	at	ADP
ajlsi-3081	64	20	x2	x2	PROPN
ajlsi-3081	64	21	(	(	PUNCT
ajlsi-3081	64	22	1	1	NUM
ajlsi-3081	64	23	,	,	PUNCT
ajlsi-3081	64	24	n	n	NOUN
ajlsi-3081	64	25	=	=	SYM
ajlsi-3081	64	26	125	125	NUM
ajlsi-3081	64	27	)	)	PUNCT
ajlsi-3081	64	28	=	=	SYM
ajlsi-3081	64	29	3.14	3.14	NUM
ajlsi-3081	64	30	,	,	PUNCT
ajlsi-3081	64	31	p=0.07	p=0.07	X
ajlsi-3081	64	32	.	.	PUNCT
ajlsi-3081	65	1	moreover	moreover	ADV
ajlsi-3081	65	2	,	,	PUNCT
ajlsi-3081	65	3	the	the	DET
ajlsi-3081	65	4	overall	overall	ADJ
ajlsi-3081	65	5	survival	survival	NOUN
ajlsi-3081	65	6	between	between	ADP
ajlsi-3081	65	7	patients	patient	NOUN
ajlsi-3081	65	8	with	with	ADP
ajlsi-3081	65	9	undescended	undescended	ADJ
ajlsi-3081	65	10	and	and	CCONJ
ajlsi-3081	65	11	normal	normal	ADJ
ajlsi-3081	65	12	testis	testis	NOUN
ajlsi-3081	65	13	showed	show	VERB
ajlsi-3081	65	14	no	no	DET
ajlsi-3081	65	15	difference	difference	NOUN
ajlsi-3081	65	16	,	,	PUNCT
ajlsi-3081	65	17	and	and	CCONJ
ajlsi-3081	65	18	the	the	DET
ajlsi-3081	65	19	test	test	NOUN
ajlsi-3081	65	20	was	be	AUX
ajlsi-3081	65	21	not	not	PART
ajlsi-3081	65	22	significant	significant	ADJ
ajlsi-3081	66	1	x2	x2	NOUN
ajlsi-3081	66	2	(	(	PUNCT
ajlsi-3081	66	3	1	1	NUM
ajlsi-3081	66	4	,	,	PUNCT
ajlsi-3081	66	5	n	n	NOUN
ajlsi-3081	66	6	=	=	SYM
ajlsi-3081	66	7	125	125	NUM
ajlsi-3081	66	8	)	)	PUNCT
ajlsi-3081	66	9	=	=	SYM
ajlsi-3081	66	10	0.25	0.25	NUM
ajlsi-3081	66	11	,	,	PUNCT
ajlsi-3081	66	12	p=0.6	p=0.6	NOUN
ajlsi-3081	66	13	.	.	PUNCT
ajlsi-3081	67	1	finally	finally	ADV
ajlsi-3081	67	2	,	,	PUNCT
ajlsi-3081	67	3	survival	survival	NOUN
ajlsi-3081	67	4	rate	rate	NOUN
ajlsi-3081	67	5	by	by	ADP
ajlsi-3081	67	6	stage	stage	NOUN
ajlsi-3081	67	7	presentation	presentation	NOUN
ajlsi-3081	67	8	showed	show	VERB
ajlsi-3081	67	9	no	no	DET
ajlsi-3081	67	10	difference	difference	NOUN
ajlsi-3081	67	11	in	in	ADP
ajlsi-3081	67	12	the	the	DET
ajlsi-3081	67	13	overall	overall	ADJ
ajlsi-3081	67	14	testicular	testicular	ADJ
ajlsi-3081	67	15	cancer	cancer	NOUN
ajlsi-3081	67	16	stage	stage	NOUN
ajlsi-3081	67	17	groups	group	NOUN
ajlsi-3081	67	18	1a-2c	1a-2c	NUM
ajlsi-3081	67	19	presentation	presentation	NOUN
ajlsi-3081	67	20	except	except	SCONJ
ajlsi-3081	67	21	for	for	ADP
ajlsi-3081	67	22	group	group	NOUN
ajlsi-3081	67	23	3	3	NUM
ajlsi-3081	67	24	,	,	PUNCT
ajlsi-3081	67	25	which	which	PRON
ajlsi-3081	67	26	had	have	VERB
ajlsi-3081	67	27	the	the	DET
ajlsi-3081	67	28	worst	bad	ADJ
ajlsi-3081	67	29	prognosis	prognosis	NOUN
ajlsi-3081	67	30	,	,	PUNCT
ajlsi-3081	67	31	and	and	CCONJ
ajlsi-3081	67	32	the	the	DET
ajlsi-3081	67	33	test	test	NOUN
ajlsi-3081	67	34	was	be	AUX
ajlsi-3081	67	35	marginally	marginally	ADV
ajlsi-3081	67	36	significant	significant	ADJ
ajlsi-3081	68	1	x2	x2	NOUN
ajlsi-3081	68	2	(	(	PUNCT
ajlsi-3081	68	3	6	6	NUM
ajlsi-3081	68	4	,	,	PUNCT
ajlsi-3081	68	5	n	n	NOUN
ajlsi-3081	68	6	=	=	SYM
ajlsi-3081	68	7	125	125	NUM
ajlsi-3081	68	8	)	)	PUNCT
ajlsi-3081	68	9	=	=	NOUN
ajlsi-3081	68	10	11.68	11.68	NUM
ajlsi-3081	68	11	,	,	PUNCT
ajlsi-3081	68	12	p=0.06	p=0.06	NOUN
ajlsi-3081	68	13	.	.	PUNCT
ajlsi-3081	69	1	patients	patient	NOUN
ajlsi-3081	69	2	characteristics	characteristic	VERB
ajlsi-3081	69	3	the	the	DET
ajlsi-3081	69	4	present	present	ADJ
ajlsi-3081	69	5	research	research	NOUN
ajlsi-3081	69	6	included	include	VERB
ajlsi-3081	69	7	a	a	DET
ajlsi-3081	69	8	total	total	NOUN
ajlsi-3081	69	9	of	of	ADP
ajlsi-3081	69	10	125	125	NUM
ajlsi-3081	69	11	patients	patient	NOUN
ajlsi-3081	69	12	who	who	PRON
ajlsi-3081	69	13	were	be	AUX
ajlsi-3081	69	14	diagnosed	diagnose	VERB
ajlsi-3081	69	15	and	and	CCONJ
ajlsi-3081	69	16	treated	treat	VERB
ajlsi-3081	69	17	at	at	ADP
ajlsi-3081	69	18	king	king	PROPN
ajlsi-3081	69	19	faisal	faisal	PROPN
ajlsi-3081	69	20	specialist	specialist	PROPN
ajlsi-3081	69	21	hospital	hospital	PROPN
ajlsi-3081	69	22	&	&	CCONJ
ajlsi-3081	69	23	research	research	PROPN
ajlsi-3081	69	24	center	center	PROPN
ajlsi-3081	69	25	(	(	PUNCT
ajlsi-3081	69	26	kfshrc	kfshrc	PROPN
ajlsi-3081	69	27	)	)	PUNCT
ajlsi-3081	69	28	between	between	ADP
ajlsi-3081	69	29	20102017	20102017	NUM
ajlsi-3081	69	30	.	.	PUNCT
ajlsi-3081	70	1	all	all	DET
ajlsi-3081	70	2	these	these	DET
ajlsi-3081	70	3	patients	patient	NOUN
ajlsi-3081	70	4	suffered	suffer	VERB
ajlsi-3081	70	5	from	from	ADP
ajlsi-3081	70	6	two	two	NUM
ajlsi-3081	70	7	different	different	ADJ
ajlsi-3081	70	8	pathologies	pathology	NOUN
ajlsi-3081	70	9	,	,	PUNCT
ajlsi-3081	70	10	including	include	VERB
ajlsi-3081	70	11	non	non	ADJ
ajlsi-3081	70	12	-	-	ADJ
ajlsi-3081	70	13	seminomatous	seminomatous	ADJ
ajlsi-3081	70	14	germ	germ	NOUN
ajlsi-3081	70	15	cell	cell	NOUN
ajlsi-3081	70	16	tumors	tumor	NOUN
ajlsi-3081	70	17	(	(	PUNCT
ajlsi-3081	70	18	nsgct	nsgct	PROPN
ajlsi-3081	70	19	)	)	PUNCT
ajlsi-3081	70	20	and	and	CCONJ
ajlsi-3081	70	21	seminomatous	seminomatous	ADJ
ajlsi-3081	70	22	germ	germ	NOUN
ajlsi-3081	70	23	cell	cell	NOUN
ajlsi-3081	70	24	tumors	tumor	NOUN
ajlsi-3081	70	25	.	.	PUNCT
ajlsi-3081	71	1	patient	patient	ADJ
ajlsi-3081	71	2	characteristics	characteristic	NOUN
ajlsi-3081	71	3	are	be	AUX
ajlsi-3081	71	4	shown	show	VERB
ajlsi-3081	71	5	in	in	ADP
ajlsi-3081	71	6	the	the	DET
ajlsi-3081	71	7	figures	figure	NOUN
ajlsi-3081	71	8	below	below	ADV
ajlsi-3081	71	9	.	.	PUNCT
ajlsi-3081	72	1	the	the	DET
ajlsi-3081	72	2	median	median	ADJ
ajlsi-3081	72	3	age	age	NOUN
ajlsi-3081	72	4	was	be	AUX
ajlsi-3081	72	5	33	33	NUM
ajlsi-3081	72	6	(	(	PUNCT
ajlsi-3081	72	7	range	range	NOUN
ajlsi-3081	72	8	:	:	PUNCT
ajlsi-3081	72	9	28–40	28–40	NUM
ajlsi-3081	72	10	yr	yr	NOUN
ajlsi-3081	72	11	)	)	PUNCT
ajlsi-3081	72	12	.	.	PUNCT
ajlsi-3081	73	1	figure	figure	NOUN
ajlsi-3081	73	2	1	1	NUM
ajlsi-3081	73	3	shows	show	VERB
ajlsi-3081	73	4	that	that	SCONJ
ajlsi-3081	73	5	the	the	DET
ajlsi-3081	73	6	highest	high	ADJ
ajlsi-3081	73	7	ratio	ratio	NOUN
ajlsi-3081	73	8	of	of	ADP
ajlsi-3081	73	9	patients	patient	NOUN
ajlsi-3081	73	10	affected	affect	VERB
ajlsi-3081	73	11	by	by	ADP
ajlsi-3081	73	12	testicular	testicular	ADJ
ajlsi-3081	73	13	cancer	cancer	NOUN
ajlsi-3081	73	14	lies	lie	VERB
ajlsi-3081	73	15	in	in	ADP
ajlsi-3081	73	16	the	the	DET
ajlsi-3081	73	17	age	age	NOUN
ajlsi-3081	73	18	bracket	bracket	NOUN
ajlsi-3081	73	19	of	of	ADP
ajlsi-3081	73	20	26	26	NUM
ajlsi-3081	73	21	-	-	SYM
ajlsi-3081	73	22	35	35	NUM
ajlsi-3081	73	23	years	year	NOUN
ajlsi-3081	73	24	.	.	PUNCT
ajlsi-3081	74	1	one	one	NUM
ajlsi-3081	74	2	reason	reason	NOUN
ajlsi-3081	74	3	behind	behind	ADP
ajlsi-3081	74	4	this	this	PRON
ajlsi-3081	74	5	could	could	AUX
ajlsi-3081	74	6	be	be	AUX
ajlsi-3081	74	7	the	the	DET
ajlsi-3081	74	8	presence	presence	NOUN
ajlsi-3081	74	9	of	of	ADP
ajlsi-3081	74	10	seminomatous	seminomatous	ADJ
ajlsi-3081	74	11	germ	germ	NOUN
ajlsi-3081	74	12	cell	cell	NOUN
ajlsi-3081	74	13	tumors	tumor	NOUN
ajlsi-3081	74	14	,	,	PUNCT
ajlsi-3081	74	15	which	which	PRON
ajlsi-3081	74	16	commonly	commonly	ADV
ajlsi-3081	74	17	affect	affect	VERB
ajlsi-3081	74	18	men	man	NOUN
ajlsi-3081	74	19	in	in	ADP
ajlsi-3081	74	20	their	their	PRON
ajlsi-3081	74	21	thirties	thirty	NOUN
ajlsi-3081	74	22	and	and	CCONJ
ajlsi-3081	74	23	above	above	ADV
ajlsi-3081	74	24	.	.	PUNCT
ajlsi-3081	75	1	the	the	DET
ajlsi-3081	75	2	second	second	ADJ
ajlsi-3081	75	3	highest	high	ADJ
ajlsi-3081	75	4	number	number	NOUN
ajlsi-3081	75	5	of	of	ADP
ajlsi-3081	75	6	patients	patient	NOUN
ajlsi-3081	75	7	noted	note	VERB
ajlsi-3081	75	8	was	be	AUX
ajlsi-3081	75	9	0	0	NUM
ajlsi-3081	75	10	-	-	SYM
ajlsi-3081	75	11	25	25	NUM
ajlsi-3081	75	12	years	year	NOUN
ajlsi-3081	75	13	old	old	ADJ
ajlsi-3081	75	14	;	;	PUNCT
ajlsi-3081	75	15	these	these	DET
ajlsi-3081	75	16	patients	patient	NOUN
ajlsi-3081	75	17	are	be	AUX
ajlsi-3081	75	18	more	more	ADV
ajlsi-3081	75	19	likely	likely	ADJ
ajlsi-3081	75	20	to	to	PART
ajlsi-3081	75	21	be	be	AUX
ajlsi-3081	75	22	affected	affect	VERB
ajlsi-3081	75	23	by	by	ADP
ajlsi-3081	75	24	non	non	ADJ
ajlsi-3081	75	25	-	-	ADJ
ajlsi-3081	75	26	seminomatous	seminomatous	ADJ
ajlsi-3081	75	27	germ	germ	NOUN
ajlsi-3081	75	28	cell	cell	NOUN
ajlsi-3081	75	29	tumors	tumor	NOUN
ajlsi-3081	75	30	.	.	PUNCT
ajlsi-3081	76	1	9.60	9.60	NUM
ajlsi-3081	76	2	%	%	NOUN
ajlsi-3081	76	3	of	of	ADP
ajlsi-3081	76	4	patients	patient	NOUN
ajlsi-3081	76	5	were	be	AUX
ajlsi-3081	76	6	46	46	NUM
ajlsi-3081	76	7	-	-	SYM
ajlsi-3081	76	8	55	55	NUM
ajlsi-3081	76	9	,	,	PUNCT
ajlsi-3081	76	10	while	while	SCONJ
ajlsi-3081	76	11	patients	patient	NOUN
ajlsi-3081	76	12	in	in	ADP
ajlsi-3081	76	13	their	their	PRON
ajlsi-3081	76	14	late	late	ADJ
ajlsi-3081	76	15	fifties	fifty	NOUN
ajlsi-3081	76	16	and	and	CCONJ
ajlsi-3081	76	17	early	early	ADJ
ajlsi-3081	76	18	sixties	sixty	NOUN
ajlsi-3081	76	19	constituted	constitute	VERB
ajlsi-3081	76	20	only	only	ADV
ajlsi-3081	76	21	4	4	NUM
ajlsi-3081	76	22	%	%	NOUN
ajlsi-3081	76	23	.	.	PUNCT
ajlsi-3081	77	1	patients	patient	NOUN
ajlsi-3081	77	2	in	in	ADP
ajlsi-3081	77	3	their	their	PRON
ajlsi-3081	77	4	late	late	ADJ
ajlsi-3081	77	5	sixties	sixty	NOUN
ajlsi-3081	77	6	were	be	AUX
ajlsi-3081	77	7	countable	countable	ADJ
ajlsi-3081	77	8	as	as	SCONJ
ajlsi-3081	77	9	they	they	PRON
ajlsi-3081	77	10	accounted	account	VERB
ajlsi-3081	77	11	for	for	ADP
ajlsi-3081	77	12	less	less	ADJ
ajlsi-3081	77	13	than	than	ADP
ajlsi-3081	77	14	1	1	NUM
ajlsi-3081	77	15	%	%	NOUN
ajlsi-3081	77	16	of	of	ADP
ajlsi-3081	77	17	the	the	DET
ajlsi-3081	77	18	whole	whole	ADJ
ajlsi-3081	77	19	selected	select	VERB
ajlsi-3081	77	20	population	population	NOUN
ajlsi-3081	77	21	.	.	PUNCT
ajlsi-3081	78	1	pa	pa	PROPN
ajlsi-3081	78	2	ge	ge	PROPN
ajlsi-3081	78	3	59	59	NUM
ajlsi-3081	78	4	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-3081	78	5	am	am	NOUN
ajlsi-3081	78	6	.	.	PUNCT
ajlsi-3081	79	1	j.	j.	PROPN
ajlsi-3081	79	2	life	life	PROPN
ajlsi-3081	79	3	sci	sci	PROPN
ajlsi-3081	79	4	.	.	PUNCT
ajlsi-3081	79	5	innov	innov	PROPN
ajlsi-3081	79	6	.	.	PUNCT
ajlsi-3081	80	1	3(2	3(2	NUM
ajlsi-3081	80	2	)	)	PUNCT
ajlsi-3081	80	3	57	57	NUM
ajlsi-3081	80	4	-	-	SYM
ajlsi-3081	80	5	63	63	NUM
ajlsi-3081	80	6	,	,	PUNCT
ajlsi-3081	80	7	2024	2024	NUM
ajlsi-3081	80	8	figure	figure	NOUN
ajlsi-3081	80	9	1	1	NUM
ajlsi-3081	80	10	:	:	PUNCT
ajlsi-3081	80	11	age	age	NOUN
ajlsi-3081	80	12	ratio	ratio	NOUN
ajlsi-3081	80	13	of	of	ADP
ajlsi-3081	80	14	patients	patient	NOUN
ajlsi-3081	80	15	affected	affect	VERB
ajlsi-3081	80	16	by	by	ADP
ajlsi-3081	80	17	testicular	testicular	ADJ
ajlsi-3081	80	18	cancer	cancer	NOUN
ajlsi-3081	80	19	.	.	PUNCT
ajlsi-3081	81	1	types	type	NOUN
ajlsi-3081	81	2	of	of	ADP
ajlsi-3081	81	3	pathologies	pathology	NOUN
ajlsi-3081	81	4	seventy	seventy	NUM
ajlsi-3081	81	5	-	-	PUNCT
ajlsi-3081	81	6	three	three	NUM
ajlsi-3081	81	7	out	out	ADP
ajlsi-3081	81	8	of	of	ADP
ajlsi-3081	81	9	a	a	DET
ajlsi-3081	81	10	total	total	NOUN
ajlsi-3081	81	11	of	of	ADP
ajlsi-3081	81	12	125	125	NUM
ajlsi-3081	81	13	patients	patient	NOUN
ajlsi-3081	81	14	were	be	AUX
ajlsi-3081	81	15	affected	affect	VERB
ajlsi-3081	81	16	by	by	ADP
ajlsi-3081	81	17	non	non	ADJ
ajlsi-3081	81	18	-	-	ADJ
ajlsi-3081	81	19	seminomatous	seminomatous	ADJ
ajlsi-3081	81	20	germ	germ	NOUN
ajlsi-3081	81	21	cell	cell	NOUN
ajlsi-3081	81	22	tumors	tumor	NOUN
ajlsi-3081	81	23	(	(	PUNCT
ajlsi-3081	81	24	nsgct	nsgct	PROPN
ajlsi-3081	81	25	)	)	PUNCT
ajlsi-3081	81	26	.	.	PUNCT
ajlsi-3081	82	1	of	of	ADP
ajlsi-3081	82	2	those	those	DET
ajlsi-3081	82	3	73	73	NUM
ajlsi-3081	82	4	patients	patient	NOUN
ajlsi-3081	82	5	,	,	PUNCT
ajlsi-3081	82	6	nearly	nearly	ADV
ajlsi-3081	82	7	54	54	NUM
ajlsi-3081	82	8	were	be	AUX
ajlsi-3081	82	9	affected	affect	VERB
ajlsi-3081	82	10	by	by	ADP
ajlsi-3081	82	11	mixed	mixed	ADJ
ajlsi-3081	82	12	germ	germ	NOUN
ajlsi-3081	82	13	cell	cell	NOUN
ajlsi-3081	82	14	tumors	tumor	NOUN
ajlsi-3081	82	15	.	.	PUNCT
ajlsi-3081	83	1	it	it	PRON
ajlsi-3081	83	2	was	be	AUX
ajlsi-3081	83	3	also	also	ADV
ajlsi-3081	83	4	seen	see	VERB
ajlsi-3081	83	5	that	that	SCONJ
ajlsi-3081	83	6	almost	almost	ADV
ajlsi-3081	83	7	52	52	NUM
ajlsi-3081	83	8	recorded	recorded	ADJ
ajlsi-3081	83	9	cases	case	NOUN
ajlsi-3081	83	10	were	be	AUX
ajlsi-3081	83	11	affected	affect	VERB
ajlsi-3081	83	12	by	by	ADP
ajlsi-3081	83	13	seminomas	seminoma	NOUN
ajlsi-3081	83	14	.	.	PUNCT
ajlsi-3081	84	1	the	the	DET
ajlsi-3081	84	2	line	line	NOUN
ajlsi-3081	84	3	graph	graph	NOUN
ajlsi-3081	84	4	in	in	ADP
ajlsi-3081	84	5	figure	figure	NOUN
ajlsi-3081	84	6	3	3	NUM
ajlsi-3081	84	7	shows	show	VERB
ajlsi-3081	84	8	the	the	DET
ajlsi-3081	84	9	survival	survival	NOUN
ajlsi-3081	84	10	probability	probability	NOUN
ajlsi-3081	84	11	of	of	ADP
ajlsi-3081	84	12	patients	patient	NOUN
ajlsi-3081	84	13	affected	affect	VERB
ajlsi-3081	84	14	by	by	ADP
ajlsi-3081	84	15	the	the	DET
ajlsi-3081	84	16	non	non	ADJ
ajlsi-3081	84	17	-	-	ADJ
ajlsi-3081	84	18	seminomatous	seminomatous	ADJ
ajlsi-3081	84	19	germ	germ	NOUN
ajlsi-3081	84	20	cell	cell	NOUN
ajlsi-3081	84	21	tumor	tumor	NOUN
ajlsi-3081	84	22	(	(	PUNCT
ajlsi-3081	84	23	nsgct	nsgct	PROPN
ajlsi-3081	84	24	)	)	PUNCT
ajlsi-3081	84	25	and	and	CCONJ
ajlsi-3081	84	26	seminomatous	seminomatous	ADJ
ajlsi-3081	84	27	germ	germ	NOUN
ajlsi-3081	84	28	cell	cell	NOUN
ajlsi-3081	84	29	tumor	tumor	NOUN
ajlsi-3081	84	30	.	.	PUNCT
ajlsi-3081	85	1	seminoma	seminoma	NOUN
ajlsi-3081	85	2	survival	survival	NOUN
ajlsi-3081	85	3	rates	rate	NOUN
ajlsi-3081	85	4	are	be	AUX
ajlsi-3081	85	5	higher	high	ADJ
ajlsi-3081	85	6	than	than	ADP
ajlsi-3081	85	7	other	other	ADJ
ajlsi-3081	85	8	testicular	testicular	ADJ
ajlsi-3081	85	9	germ	germ	NOUN
ajlsi-3081	85	10	cell	cell	NOUN
ajlsi-3081	85	11	tumor	tumor	NOUN
ajlsi-3081	85	12	forms	form	NOUN
ajlsi-3081	85	13	,	,	PUNCT
ajlsi-3081	85	14	as	as	SCONJ
ajlsi-3081	85	15	indicated	indicate	VERB
ajlsi-3081	85	16	by	by	ADP
ajlsi-3081	85	17	the	the	DET
ajlsi-3081	85	18	curve	curve	NOUN
ajlsi-3081	85	19	representing	represent	VERB
ajlsi-3081	85	20	this	this	DET
ajlsi-3081	85	21	tumor	tumor	NOUN
ajlsi-3081	85	22	type	type	NOUN
ajlsi-3081	85	23	.	.	PUNCT
ajlsi-3081	86	1	the	the	DET
ajlsi-3081	86	2	high	high	ADJ
ajlsi-3081	86	3	survival	survival	NOUN
ajlsi-3081	86	4	rate	rate	NOUN
ajlsi-3081	86	5	for	for	ADP
ajlsi-3081	86	6	seminomas	seminoma	NOUN
ajlsi-3081	86	7	is	be	AUX
ajlsi-3081	86	8	because	because	SCONJ
ajlsi-3081	86	9	,	,	PUNCT
ajlsi-3081	86	10	compared	compare	VERB
ajlsi-3081	86	11	to	to	ADP
ajlsi-3081	86	12	other	other	ADJ
ajlsi-3081	86	13	forms	form	NOUN
ajlsi-3081	86	14	of	of	ADP
ajlsi-3081	86	15	testicular	testicular	ADJ
ajlsi-3081	86	16	germ	germ	NOUN
ajlsi-3081	86	17	cell	cell	NOUN
ajlsi-3081	86	18	tumors	tumor	NOUN
ajlsi-3081	86	19	,	,	PUNCT
ajlsi-3081	86	20	seminomas	seminoma	NOUN
ajlsi-3081	86	21	usually	usually	ADV
ajlsi-3081	86	22	show	show	VERB
ajlsi-3081	86	23	less	less	ADV
ajlsi-3081	86	24	aggressive	aggressive	ADJ
ajlsi-3081	86	25	behavior	behavior	NOUN
ajlsi-3081	86	26	.	.	PUNCT
ajlsi-3081	87	1	the	the	DET
ajlsi-3081	87	2	survival	survival	NOUN
ajlsi-3081	87	3	probability	probability	NOUN
ajlsi-3081	87	4	declines	decline	VERB
ajlsi-3081	87	5	with	with	ADP
ajlsi-3081	87	6	time	time	NOUN
ajlsi-3081	87	7	,	,	PUNCT
ajlsi-3081	87	8	as	as	SCONJ
ajlsi-3081	87	9	seen	see	VERB
ajlsi-3081	87	10	by	by	ADP
ajlsi-3081	87	11	the	the	DET
ajlsi-3081	87	12	curves	curve	NOUN
ajlsi-3081	87	13	for	for	ADP
ajlsi-3081	87	14	each	each	PRON
ajlsi-3081	87	15	of	of	ADP
ajlsi-3081	87	16	the	the	DET
ajlsi-3081	87	17	three	three	NUM
ajlsi-3081	87	18	groups	group	NOUN
ajlsi-3081	87	19	.	.	PUNCT
ajlsi-3081	88	1	the	the	DET
ajlsi-3081	88	2	decline	decline	NOUN
ajlsi-3081	88	3	in	in	ADP
ajlsi-3081	88	4	survival	survival	NOUN
ajlsi-3081	88	5	probability	probability	NOUN
ajlsi-3081	88	6	is	be	AUX
ajlsi-3081	88	7	because	because	SCONJ
ajlsi-3081	88	8	some	some	DET
ajlsi-3081	88	9	cancer	cancer	NOUN
ajlsi-3081	88	10	patients	patient	NOUN
ajlsi-3081	88	11	still	still	ADV
ajlsi-3081	88	12	pass	pass	VERB
ajlsi-3081	88	13	away	away	ADV
ajlsi-3081	88	14	after	after	ADP
ajlsi-3081	88	15	receiving	receive	VERB
ajlsi-3081	88	16	treatment	treatment	NOUN
ajlsi-3081	88	17	.	.	PUNCT
ajlsi-3081	89	1	the	the	DET
ajlsi-3081	89	2	degree	degree	NOUN
ajlsi-3081	89	3	of	of	ADP
ajlsi-3081	89	4	overall	overall	ADJ
ajlsi-3081	89	5	survival	survival	NOUN
ajlsi-3081	89	6	decreases	decrease	VERB
ajlsi-3081	89	7	over	over	ADP
ajlsi-3081	89	8	time	time	NOUN
ajlsi-3081	89	9	.	.	PUNCT
ajlsi-3081	90	1	figure	figure	NOUN
ajlsi-3081	90	2	2	2	NUM
ajlsi-3081	90	3	shows	show	VERB
ajlsi-3081	90	4	an	an	DET
ajlsi-3081	90	5	examination	examination	NOUN
ajlsi-3081	90	6	of	of	ADP
ajlsi-3081	90	7	survival	survival	NOUN
ajlsi-3081	90	8	curves	curve	NOUN
ajlsi-3081	90	9	reveals	reveal	VERB
ajlsi-3081	90	10	a	a	DET
ajlsi-3081	90	11	noteworthy	noteworthy	ADJ
ajlsi-3081	90	12	distinction	distinction	NOUN
ajlsi-3081	90	13	in	in	ADP
ajlsi-3081	90	14	overall	overall	ADJ
ajlsi-3081	90	15	survival	survival	NOUN
ajlsi-3081	90	16	between	between	ADP
ajlsi-3081	90	17	seminoma	seminoma	NOUN
ajlsi-3081	90	18	and	and	CCONJ
ajlsi-3081	90	19	other	other	ADJ
ajlsi-3081	90	20	germ	germ	NOUN
ajlsi-3081	90	21	cell	cell	NOUN
ajlsi-3081	90	22	cancers	cancer	NOUN
ajlsi-3081	90	23	.	.	PUNCT
ajlsi-3081	91	1	demographic	demographic	ADJ
ajlsi-3081	91	2	characteristics	characteristic	NOUN
ajlsi-3081	91	3	figure	figure	NOUN
ajlsi-3081	91	4	2	2	NUM
ajlsi-3081	91	5	:	:	PUNCT
ajlsi-3081	91	6	survival	survival	NOUN
ajlsi-3081	91	7	curves	curve	NOUN
ajlsi-3081	91	8	between	between	ADP
ajlsi-3081	91	9	seminoma	seminoma	NOUN
ajlsi-3081	91	10	and	and	CCONJ
ajlsi-3081	91	11	other	other	ADJ
ajlsi-3081	91	12	germ	germ	NOUN
ajlsi-3081	91	13	cell	cell	NOUN
ajlsi-3081	91	14	cancers	cancer	NOUN
ajlsi-3081	91	15	.	.	PUNCT
ajlsi-3081	92	1	analysis	analysis	NOUN
ajlsi-3081	92	2	of	of	ADP
ajlsi-3081	92	3	patients	patient	NOUN
ajlsi-3081	92	4	’	'	PUNCT
ajlsi-3081	92	5	demographic	demographic	ADJ
ajlsi-3081	92	6	data	datum	NOUN
ajlsi-3081	92	7	showed	show	VERB
ajlsi-3081	92	8	that	that	SCONJ
ajlsi-3081	92	9	nearly	nearly	ADV
ajlsi-3081	92	10	50	50	NUM
ajlsi-3081	92	11	%	%	NOUN
ajlsi-3081	92	12	of	of	ADP
ajlsi-3081	92	13	included	include	VERB
ajlsi-3081	92	14	patients	patient	NOUN
ajlsi-3081	92	15	were	be	AUX
ajlsi-3081	92	16	residents	resident	NOUN
ajlsi-3081	92	17	of	of	ADP
ajlsi-3081	92	18	riyadh	riyadh	PROPN
ajlsi-3081	92	19	.	.	PUNCT
ajlsi-3081	93	1	almost	almost	ADV
ajlsi-3081	93	2	12	12	NUM
ajlsi-3081	93	3	%	%	NOUN
ajlsi-3081	93	4	belonged	belong	VERB
ajlsi-3081	93	5	to	to	ADP
ajlsi-3081	93	6	the	the	DET
ajlsi-3081	93	7	northern	northern	ADJ
ajlsi-3081	93	8	province	province	NOUN
ajlsi-3081	93	9	,	,	PUNCT
ajlsi-3081	93	10	while	while	SCONJ
ajlsi-3081	93	11	nearly	nearly	ADV
ajlsi-3081	93	12	10	10	NUM
ajlsi-3081	93	13	%	%	NOUN
ajlsi-3081	93	14	of	of	ADP
ajlsi-3081	93	15	the	the	DET
ajlsi-3081	93	16	cases	case	NOUN
ajlsi-3081	93	17	were	be	AUX
ajlsi-3081	93	18	reported	report	VERB
ajlsi-3081	93	19	from	from	ADP
ajlsi-3081	93	20	the	the	DET
ajlsi-3081	93	21	eastern	eastern	ADJ
ajlsi-3081	93	22	province	province	NOUN
ajlsi-3081	93	23	.	.	PUNCT
ajlsi-3081	94	1	jawf	jawf	NOUN
ajlsi-3081	94	2	and	and	CCONJ
ajlsi-3081	94	3	tabuk	tabuk	PROPN
ajlsi-3081	94	4	showed	show	VERB
ajlsi-3081	94	5	the	the	DET
ajlsi-3081	94	6	lowest	low	ADJ
ajlsi-3081	94	7	cases	case	NOUN
ajlsi-3081	94	8	,	,	PUNCT
ajlsi-3081	94	9	i.e.	i.e.	X
ajlsi-3081	94	10	,	,	PUNCT
ajlsi-3081	94	11	only	only	ADV
ajlsi-3081	94	12	0.8	0.8	NUM
ajlsi-3081	94	13	%	%	NOUN
ajlsi-3081	94	14	.	.	PUNCT
ajlsi-3081	95	1	figure	figure	VERB
ajlsi-3081	95	2	4	4	NUM
ajlsi-3081	95	3	depicts	depict	VERB
ajlsi-3081	95	4	a	a	DET
ajlsi-3081	95	5	difference	difference	NOUN
ajlsi-3081	95	6	in	in	ADP
ajlsi-3081	95	7	survival	survival	NOUN
ajlsi-3081	95	8	between	between	ADP
ajlsi-3081	95	9	the	the	DET
ajlsi-3081	95	10	two	two	NUM
ajlsi-3081	95	11	groups	group	NOUN
ajlsi-3081	95	12	:	:	PUNCT
ajlsi-3081	95	13	the	the	DET
ajlsi-3081	95	14	group	group	NOUN
ajlsi-3081	95	15	living	live	VERB
ajlsi-3081	95	16	in	in	ADP
ajlsi-3081	95	17	riyadh	riyadh	PROPN
ajlsi-3081	95	18	has	have	VERB
ajlsi-3081	95	19	a	a	DET
ajlsi-3081	95	20	higher	high	ADJ
ajlsi-3081	95	21	probability	probability	NOUN
ajlsi-3081	95	22	of	of	ADP
ajlsi-3081	95	23	survival	survival	NOUN
ajlsi-3081	95	24	than	than	ADP
ajlsi-3081	95	25	those	those	PRON
ajlsi-3081	95	26	living	live	VERB
ajlsi-3081	95	27	in	in	ADP
ajlsi-3081	95	28	other	other	ADJ
ajlsi-3081	95	29	regions	region	NOUN
ajlsi-3081	95	30	.	.	PUNCT
ajlsi-3081	96	1	this	this	DET
ajlsi-3081	96	2	high	high	ADJ
ajlsi-3081	96	3	survival	survival	NOUN
ajlsi-3081	96	4	probability	probability	NOUN
ajlsi-3081	96	5	could	could	AUX
ajlsi-3081	96	6	be	be	AUX
ajlsi-3081	96	7	due	due	ADJ
ajlsi-3081	96	8	to	to	ADP
ajlsi-3081	96	9	several	several	ADJ
ajlsi-3081	96	10	factors	factor	NOUN
ajlsi-3081	96	11	,	,	PUNCT
ajlsi-3081	96	12	such	such	ADJ
ajlsi-3081	96	13	as	as	ADP
ajlsi-3081	96	14	healthcare	healthcare	NOUN
ajlsi-3081	96	15	access	access	NOUN
ajlsi-3081	96	16	or	or	CCONJ
ajlsi-3081	96	17	lifestyle	lifestyle	NOUN
ajlsi-3081	96	18	differences	difference	NOUN
ajlsi-3081	96	19	.	.	PUNCT
ajlsi-3081	97	1	the	the	DET
ajlsi-3081	97	2	likelihood	likelihood	NOUN
ajlsi-3081	97	3	of	of	ADP
ajlsi-3081	97	4	survival	survival	NOUN
ajlsi-3081	97	5	is	be	AUX
ajlsi-3081	97	6	high	high	ADJ
ajlsi-3081	97	7	in	in	ADP
ajlsi-3081	97	8	the	the	DET
ajlsi-3081	97	9	first	first	ADJ
ajlsi-3081	97	10	few	few	ADJ
ajlsi-3081	97	11	years	year	NOUN
ajlsi-3081	97	12	following	follow	VERB
ajlsi-3081	97	13	surgery	surgery	NOUN
ajlsi-3081	97	14	,	,	PUNCT
ajlsi-3081	97	15	but	but	CCONJ
ajlsi-3081	97	16	it	it	PRON
ajlsi-3081	97	17	then	then	ADV
ajlsi-3081	97	18	starts	start	VERB
ajlsi-3081	97	19	to	to	PART
ajlsi-3081	97	20	decline	decline	VERB
ajlsi-3081	97	21	.	.	PUNCT
ajlsi-3081	98	1	according	accord	VERB
ajlsi-3081	98	2	to	to	ADP
ajlsi-3081	98	3	the	the	DET
ajlsi-3081	98	4	survival	survival	NOUN
ajlsi-3081	98	5	curve	curve	PROPN
ajlsi-3081	98	6	study	study	PROPN
ajlsi-3081	98	7	,	,	PUNCT
ajlsi-3081	98	8	figure	figure	VERB
ajlsi-3081	98	9	3	3	NUM
ajlsi-3081	98	10	shows	show	VERB
ajlsi-3081	98	11	no	no	DET
ajlsi-3081	98	12	overall	overall	ADJ
ajlsi-3081	98	13	survival	survival	NOUN
ajlsi-3081	98	14	difference	difference	NOUN
ajlsi-3081	98	15	between	between	ADP
ajlsi-3081	98	16	riyadh	riyadh	PROPN
ajlsi-3081	98	17	and	and	CCONJ
ajlsi-3081	98	18	other	other	ADJ
ajlsi-3081	98	19	places	place	NOUN
ajlsi-3081	98	20	.	.	PUNCT
ajlsi-3081	99	1	most	most	ADJ
ajlsi-3081	99	2	patients	patient	NOUN
ajlsi-3081	99	3	,	,	PUNCT
ajlsi-3081	99	4	i.e.	i.e.	X
ajlsi-3081	99	5	,	,	PUNCT
ajlsi-3081	99	6	29.6	29.6	NUM
ajlsi-3081	99	7	%	%	NOUN
ajlsi-3081	99	8	included	include	VERB
ajlsi-3081	99	9	patients	patient	NOUN
ajlsi-3081	99	10	,	,	PUNCT
ajlsi-3081	99	11	were	be	AUX
ajlsi-3081	99	12	diagnosed	diagnose	VERB
ajlsi-3081	99	13	and	and	CCONJ
ajlsi-3081	99	14	treated	treat	VERB
ajlsi-3081	99	15	at	at	ADP
ajlsi-3081	99	16	stage	stage	NOUN
ajlsi-3081	99	17	1a	1a	NOUN
ajlsi-3081	99	18	,	,	PUNCT
ajlsi-3081	99	19	and	and	CCONJ
ajlsi-3081	99	20	8.8	8.8	NUM
ajlsi-3081	99	21	%	%	NOUN
ajlsi-3081	99	22	were	be	AUX
ajlsi-3081	99	23	diagnosed	diagnose	VERB
ajlsi-3081	99	24	at	at	ADP
ajlsi-3081	99	25	stage	stage	NOUN
ajlsi-3081	99	26	.	.	PUNCT
ajlsi-3081	100	1	at	at	ADP
ajlsi-3081	100	2	stage	stage	NOUN
ajlsi-3081	100	3	3	3	NUM
ajlsi-3081	100	4	,	,	PUNCT
ajlsi-3081	100	5	the	the	DET
ajlsi-3081	100	6	worst	bad	ADJ
ajlsi-3081	100	7	progression	progression	NOUN
ajlsi-3081	100	8	was	be	AUX
ajlsi-3081	100	9	seen	see	VERB
ajlsi-3081	100	10	,	,	PUNCT
ajlsi-3081	100	11	and	and	CCONJ
ajlsi-3081	100	12	nearly	nearly	ADV
ajlsi-3081	100	13	25.6	25.6	NUM
ajlsi-3081	100	14	%	%	NOUN
ajlsi-3081	100	15	patients	patient	NOUN
ajlsi-3081	100	16	of	of	ADP
ajlsi-3081	100	17	total	total	ADJ
ajlsi-3081	100	18	patients	patient	NOUN
ajlsi-3081	100	19	suffered	suffer	VERB
ajlsi-3081	100	20	through	through	ADP
ajlsi-3081	100	21	it	it	PRON
ajlsi-3081	100	22	.	.	PUNCT
ajlsi-3081	101	1	this	this	DET
ajlsi-3081	101	2	worst	bad	ADJ
ajlsi-3081	101	3	progression	progression	NOUN
ajlsi-3081	101	4	can	can	AUX
ajlsi-3081	101	5	be	be	AUX
ajlsi-3081	101	6	due	due	ADJ
ajlsi-3081	101	7	to	to	ADP
ajlsi-3081	101	8	the	the	DET
ajlsi-3081	101	9	aggressive	aggressive	ADJ
ajlsi-3081	101	10	nature	nature	NOUN
ajlsi-3081	101	11	of	of	ADP
ajlsi-3081	101	12	non	non	ADJ
ajlsi-3081	101	13	-	-	ADJ
ajlsi-3081	101	14	seminomatous	seminomatous	ADJ
ajlsi-3081	101	15	germ	germ	NOUN
ajlsi-3081	101	16	cell	cell	NOUN
ajlsi-3081	101	17	tumors	tumor	NOUN
ajlsi-3081	101	18	(	(	PUNCT
ajlsi-3081	101	19	nsgct	nsgct	PROPN
ajlsi-3081	101	20	)	)	PUNCT
ajlsi-3081	101	21	.	.	PUNCT
ajlsi-3081	102	1	at	at	ADP
ajlsi-3081	102	2	the	the	DET
ajlsi-3081	102	3	end	end	NOUN
ajlsi-3081	102	4	of	of	ADP
ajlsi-3081	102	5	the	the	DET
ajlsi-3081	102	6	study	study	NOUN
ajlsi-3081	102	7	,	,	PUNCT
ajlsi-3081	102	8	6(4.8	6(4.8	NUM
ajlsi-3081	102	9	%	%	NOUN
ajlsi-3081	102	10	)	)	PUNCT
ajlsi-3081	102	11	patients	patient	NOUN
ajlsi-3081	102	12	had	have	VERB
ajlsi-3081	102	13	recurrence	recurrence	NOUN
ajlsi-3081	102	14	,	,	PUNCT
ajlsi-3081	102	15	4(3.2	4(3.2	NUM
ajlsi-3081	102	16	%	%	NOUN
ajlsi-3081	102	17	)	)	PUNCT
ajlsi-3081	102	18	passed	pass	VERB
ajlsi-3081	102	19	away	away	ADP
ajlsi-3081	102	20	due	due	ADP
ajlsi-3081	102	21	to	to	ADP
ajlsi-3081	102	22	disease	disease	NOUN
ajlsi-3081	102	23	,	,	PUNCT
ajlsi-3081	102	24	and	and	CCONJ
ajlsi-3081	102	25	115(92	115(92	NUM
ajlsi-3081	102	26	%	%	NOUN
ajlsi-3081	102	27	)	)	PUNCT
ajlsi-3081	102	28	were	be	AUX
ajlsi-3081	102	29	in	in	ADP
ajlsi-3081	102	30	remission	remission	NOUN
ajlsi-3081	102	31	.	.	PUNCT
ajlsi-3081	103	1	risk	risk	NOUN
ajlsi-3081	103	2	factorcryptorchidism	factorcryptorchidism	NOUN
ajlsi-3081	103	3	in	in	ADP
ajlsi-3081	103	4	the	the	DET
ajlsi-3081	103	5	case	case	NOUN
ajlsi-3081	103	6	of	of	ADP
ajlsi-3081	103	7	patients	patient	NOUN
ajlsi-3081	103	8	with	with	ADP
ajlsi-3081	103	9	testicular	testicular	ADJ
ajlsi-3081	103	10	cancer	cancer	NOUN
ajlsi-3081	103	11	,	,	PUNCT
ajlsi-3081	103	12	undescended	undescende	VERB
ajlsi-3081	103	13	testis	testi	NOUN
ajlsi-3081	103	14	appeared	appear	VERB
ajlsi-3081	103	15	to	to	PART
ajlsi-3081	103	16	be	be	AUX
ajlsi-3081	103	17	a	a	DET
ajlsi-3081	103	18	prominent	prominent	ADJ
ajlsi-3081	103	19	risk	risk	NOUN
ajlsi-3081	103	20	factor	factor	NOUN
ajlsi-3081	103	21	.	.	PUNCT
ajlsi-3081	104	1	the	the	DET
ajlsi-3081	104	2	graph	graph	NOUN
ajlsi-3081	104	3	in	in	ADP
ajlsi-3081	104	4	figure	figure	NOUN
ajlsi-3081	104	5	5	5	NUM
ajlsi-3081	104	6	shows	show	VERB
ajlsi-3081	104	7	that	that	SCONJ
ajlsi-3081	104	8	the	the	DET
ajlsi-3081	104	9	probability	probability	NOUN
ajlsi-3081	104	10	of	of	ADP
ajlsi-3081	104	11	survival	survival	NOUN
ajlsi-3081	104	12	is	be	AUX
ajlsi-3081	104	13	lower	low	ADJ
ajlsi-3081	104	14	for	for	ADP
ajlsi-3081	104	15	people	people	NOUN
ajlsi-3081	104	16	who	who	PRON
ajlsi-3081	104	17	have	have	AUX
ajlsi-3081	104	18	been	be	AUX
ajlsi-3081	104	19	affected	affect	VERB
ajlsi-3081	104	20	by	by	ADP
ajlsi-3081	104	21	an	an	DET
ajlsi-3081	104	22	undescended	undescended	ADJ
ajlsi-3081	104	23	testis	testis	NOUN
ajlsi-3081	104	24	condition	condition	NOUN
ajlsi-3081	104	25	than	than	ADP
ajlsi-3081	104	26	for	for	ADP
ajlsi-3081	104	27	people	people	NOUN
ajlsi-3081	104	28	who	who	PRON
ajlsi-3081	104	29	have	have	AUX
ajlsi-3081	104	30	not	not	PART
ajlsi-3081	104	31	been	be	AUX
ajlsi-3081	104	32	exposed	expose	VERB
ajlsi-3081	104	33	to	to	ADP
ajlsi-3081	104	34	any	any	DET
ajlsi-3081	104	35	such	such	ADJ
ajlsi-3081	104	36	risk	risk	NOUN
ajlsi-3081	104	37	factor	factor	NOUN
ajlsi-3081	104	38	.	.	PUNCT
ajlsi-3081	105	1	patients	patient	NOUN
ajlsi-3081	105	2	with	with	ADP
ajlsi-3081	105	3	any	any	DET
ajlsi-3081	105	4	history	history	NOUN
ajlsi-3081	105	5	of	of	ADP
ajlsi-3081	105	6	undescended	undescended	ADJ
ajlsi-3081	105	7	testis	testis	NOUN
ajlsi-3081	105	8	are	be	AUX
ajlsi-3081	105	9	likely	likely	ADJ
ajlsi-3081	105	10	to	to	PART
ajlsi-3081	105	11	develop	develop	VERB
ajlsi-3081	105	12	testicular	testicular	ADJ
ajlsi-3081	105	13	cancer	cancer	NOUN
ajlsi-3081	105	14	.	.	PUNCT
ajlsi-3081	106	1	figure	figure	NOUN
ajlsi-3081	106	2	5	5	NUM
ajlsi-3081	106	3	shows	show	VERB
ajlsi-3081	106	4	no	no	DET
ajlsi-3081	106	5	discernible	discernible	ADJ
ajlsi-3081	106	6	difference	difference	NOUN
ajlsi-3081	106	7	in	in	ADP
ajlsi-3081	106	8	overall	overall	ADJ
ajlsi-3081	106	9	pa	pa	PROPN
ajlsi-3081	106	10	ge	ge	PROPN
ajlsi-3081	106	11	60	60	NUM
ajlsi-3081	106	12	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-3081	106	13	am	am	NOUN
ajlsi-3081	106	14	.	.	PUNCT
ajlsi-3081	107	1	j.	j.	PROPN
ajlsi-3081	107	2	life	life	PROPN
ajlsi-3081	107	3	sci	sci	PROPN
ajlsi-3081	107	4	.	.	PUNCT
ajlsi-3081	107	5	innov	innov	PROPN
ajlsi-3081	107	6	.	.	PUNCT
ajlsi-3081	108	1	3(2	3(2	NUM
ajlsi-3081	108	2	)	)	PUNCT
ajlsi-3081	108	3	57	57	NUM
ajlsi-3081	108	4	-	-	SYM
ajlsi-3081	108	5	63	63	NUM
ajlsi-3081	108	6	,	,	PUNCT
ajlsi-3081	108	7	2024	2024	NUM
ajlsi-3081	108	8	figure	figure	NOUN
ajlsi-3081	108	9	3	3	NUM
ajlsi-3081	108	10	:	:	PUNCT
ajlsi-3081	108	11	survival	survival	NOUN
ajlsi-3081	108	12	difference	difference	NOUN
ajlsi-3081	108	13	between	between	ADP
ajlsi-3081	108	14	riyadh	riyadh	PROPN
ajlsi-3081	108	15	and	and	CCONJ
ajlsi-3081	108	16	other	other	ADJ
ajlsi-3081	108	17	places	place	NOUN
ajlsi-3081	108	18	figure	figure	VERB
ajlsi-3081	108	19	4	4	NUM
ajlsi-3081	108	20	:	:	PUNCT
ajlsi-3081	108	21	stage	stage	NOUN
ajlsi-3081	108	22	presentation	presentation	NOUN
ajlsi-3081	108	23	of	of	ADP
ajlsi-3081	108	24	tumor	tumor	NOUN
ajlsi-3081	108	25	figure	figure	NOUN
ajlsi-3081	108	26	5	5	NUM
ajlsi-3081	108	27	:	:	PUNCT
ajlsi-3081	108	28	survival	survival	NOUN
ajlsi-3081	108	29	curve	curve	NOUN
ajlsi-3081	108	30	analysis	analysis	NOUN
ajlsi-3081	108	31	shows	show	VERB
ajlsi-3081	108	32	no	no	DET
ajlsi-3081	108	33	significant	significant	ADJ
ajlsi-3081	108	34	difference	difference	NOUN
ajlsi-3081	108	35	in	in	ADP
ajlsi-3081	108	36	overall	overall	ADJ
ajlsi-3081	108	37	survival	survival	NOUN
ajlsi-3081	108	38	between	between	ADP
ajlsi-3081	108	39	patients	patient	NOUN
ajlsi-3081	108	40	with	with	ADP
ajlsi-3081	108	41	descending	descend	VERB
ajlsi-3081	108	42	testicles	testicle	NOUN
ajlsi-3081	108	43	and	and	CCONJ
ajlsi-3081	108	44	those	those	PRON
ajlsi-3081	108	45	without	without	ADP
ajlsi-3081	108	46	.	.	PUNCT
ajlsi-3081	109	1	survival	survival	NOUN
ajlsi-3081	109	2	between	between	ADP
ajlsi-3081	109	3	patients	patient	NOUN
ajlsi-3081	109	4	with	with	ADP
ajlsi-3081	109	5	descending	descend	VERB
ajlsi-3081	109	6	testicles	testicle	NOUN
ajlsi-3081	109	7	and	and	CCONJ
ajlsi-3081	109	8	those	those	PRON
ajlsi-3081	109	9	without	without	ADP
ajlsi-3081	109	10	,	,	PUNCT
ajlsi-3081	109	11	according	accord	VERB
ajlsi-3081	109	12	to	to	ADP
ajlsi-3081	109	13	survival	survival	NOUN
ajlsi-3081	109	14	curve	curve	NOUN
ajlsi-3081	109	15	analysis	analysis	NOUN
ajlsi-3081	109	16	.	.	PUNCT
ajlsi-3081	110	1	discussion	discussion	NOUN
ajlsi-3081	110	2	testicular	testicular	NOUN
ajlsi-3081	110	3	cancer	cancer	NOUN
ajlsi-3081	110	4	is	be	AUX
ajlsi-3081	110	5	a	a	DET
ajlsi-3081	110	6	malignant	malignant	ADJ
ajlsi-3081	110	7	tumor	tumor	NOUN
ajlsi-3081	110	8	associated	associate	VERB
ajlsi-3081	110	9	with	with	ADP
ajlsi-3081	110	10	the	the	DET
ajlsi-3081	110	11	testicles	testicle	NOUN
ajlsi-3081	110	12	,	,	PUNCT
ajlsi-3081	110	13	which	which	PRON
ajlsi-3081	110	14	are	be	AUX
ajlsi-3081	110	15	the	the	DET
ajlsi-3081	110	16	primary	primary	ADJ
ajlsi-3081	110	17	components	component	NOUN
ajlsi-3081	110	18	of	of	ADP
ajlsi-3081	110	19	the	the	DET
ajlsi-3081	110	20	male	male	ADJ
ajlsi-3081	110	21	genitals	genital	NOUN
ajlsi-3081	110	22	.	.	PUNCT
ajlsi-3081	111	1	testicles	testicle	NOUN
ajlsi-3081	111	2	are	be	AUX
ajlsi-3081	111	3	primarily	primarily	ADV
ajlsi-3081	111	4	responsible	responsible	ADJ
ajlsi-3081	111	5	for	for	ADP
ajlsi-3081	111	6	the	the	DET
ajlsi-3081	111	7	production	production	NOUN
ajlsi-3081	111	8	of	of	ADP
ajlsi-3081	111	9	sperm	sperm	NOUN
ajlsi-3081	111	10	;	;	PUNCT
ajlsi-3081	111	11	they	they	PRON
ajlsi-3081	111	12	also	also	ADV
ajlsi-3081	111	13	regulate	regulate	VERB
ajlsi-3081	111	14	hormonal	hormonal	ADJ
ajlsi-3081	111	15	balance	balance	NOUN
ajlsi-3081	111	16	as	as	SCONJ
ajlsi-3081	111	17	they	they	PRON
ajlsi-3081	111	18	are	be	AUX
ajlsi-3081	111	19	responsible	responsible	ADJ
ajlsi-3081	111	20	for	for	ADP
ajlsi-3081	111	21	the	the	DET
ajlsi-3081	111	22	release	release	NOUN
ajlsi-3081	111	23	of	of	ADP
ajlsi-3081	111	24	testosterone	testosterone	NOUN
ajlsi-3081	111	25	.	.	PUNCT
ajlsi-3081	112	1	testicular	testicular	ADJ
ajlsi-3081	112	2	cancer	cancer	NOUN
ajlsi-3081	112	3	usually	usually	ADV
ajlsi-3081	112	4	occurs	occur	VERB
ajlsi-3081	112	5	between	between	ADP
ajlsi-3081	112	6	the	the	DET
ajlsi-3081	112	7	ages	age	NOUN
ajlsi-3081	112	8	of	of	ADP
ajlsi-3081	112	9	15	15	NUM
ajlsi-3081	112	10	and	and	CCONJ
ajlsi-3081	112	11	35	35	NUM
ajlsi-3081	112	12	.	.	PUNCT
ajlsi-3081	112	13	testicular	testicular	ADJ
ajlsi-3081	112	14	cancer	cancer	NOUN
ajlsi-3081	112	15	is	be	AUX
ajlsi-3081	112	16	common	common	ADJ
ajlsi-3081	112	17	in	in	ADP
ajlsi-3081	112	18	young	young	ADJ
ajlsi-3081	112	19	men	man	NOUN
ajlsi-3081	112	20	,	,	PUNCT
ajlsi-3081	112	21	and	and	CCONJ
ajlsi-3081	112	22	it	it	PRON
ajlsi-3081	112	23	can	can	AUX
ajlsi-3081	112	24	be	be	AUX
ajlsi-3081	112	25	easily	easily	ADV
ajlsi-3081	112	26	diagnosed	diagnose	VERB
ajlsi-3081	112	27	by	by	ADP
ajlsi-3081	112	28	self	self	NOUN
ajlsi-3081	112	29	-	-	PUNCT
ajlsi-3081	112	30	examination	examination	NOUN
ajlsi-3081	112	31	of	of	ADP
ajlsi-3081	112	32	the	the	DET
ajlsi-3081	112	33	testicles	testicle	NOUN
ajlsi-3081	112	34	and	and	CCONJ
ajlsi-3081	112	35	the	the	DET
ajlsi-3081	112	36	tumor	tumor	NOUN
ajlsi-3081	112	37	can	can	AUX
ajlsi-3081	112	38	be	be	AUX
ajlsi-3081	112	39	cured	cure	VERB
ajlsi-3081	112	40	by	by	ADP
ajlsi-3081	112	41	surgery	surgery	NOUN
ajlsi-3081	112	42	if	if	SCONJ
ajlsi-3081	112	43	diagnosed	diagnose	VERB
ajlsi-3081	112	44	early	early	ADV
ajlsi-3081	112	45	(	(	PUNCT
ajlsi-3081	112	46	altunkurek	altunkurek	NOUN
ajlsi-3081	112	47	,	,	PUNCT
ajlsi-3081	112	48	2020	2020	NUM
ajlsi-3081	112	49	)	)	PUNCT
ajlsi-3081	112	50	.	.	PUNCT
ajlsi-3081	113	1	the	the	DET
ajlsi-3081	113	2	degree	degree	NOUN
ajlsi-3081	113	3	of	of	ADP
ajlsi-3081	113	4	incidence	incidence	NOUN
ajlsi-3081	113	5	of	of	ADP
ajlsi-3081	113	6	testicular	testicular	ADJ
ajlsi-3081	113	7	cancer	cancer	NOUN
ajlsi-3081	113	8	highly	highly	ADV
ajlsi-3081	113	9	depends	depend	VERB
ajlsi-3081	113	10	upon	upon	SCONJ
ajlsi-3081	113	11	factors	factor	NOUN
ajlsi-3081	113	12	such	such	ADJ
ajlsi-3081	113	13	as	as	ADP
ajlsi-3081	113	14	demographic	demographic	ADJ
ajlsi-3081	113	15	locations	location	NOUN
ajlsi-3081	113	16	,	,	PUNCT
ajlsi-3081	113	17	age	age	NOUN
ajlsi-3081	113	18	,	,	PUNCT
ajlsi-3081	113	19	multiple	multiple	ADJ
ajlsi-3081	113	20	types	type	NOUN
ajlsi-3081	113	21	of	of	ADP
ajlsi-3081	113	22	pathology	pathology	NOUN
ajlsi-3081	113	23	,	,	PUNCT
ajlsi-3081	113	24	and	and	CCONJ
ajlsi-3081	113	25	congenital	congenital	ADJ
ajlsi-3081	113	26	disabilities	disability	NOUN
ajlsi-3081	113	27	such	such	ADJ
ajlsi-3081	113	28	as	as	ADP
ajlsi-3081	113	29	cryptorchidism	cryptorchidism	NOUN
ajlsi-3081	113	30	,	,	PUNCT
ajlsi-3081	113	31	which	which	PRON
ajlsi-3081	113	32	act	act	VERB
ajlsi-3081	113	33	as	as	ADP
ajlsi-3081	113	34	major	major	ADJ
ajlsi-3081	113	35	risk	risk	NOUN
ajlsi-3081	113	36	factors	factor	NOUN
ajlsi-3081	113	37	(	(	PUNCT
ajlsi-3081	113	38	yazici	yazici	NOUN
ajlsi-3081	113	39	et	et	PROPN
ajlsi-3081	113	40	al	al	PROPN
ajlsi-3081	113	41	.	.	PROPN
ajlsi-3081	113	42	,	,	PUNCT
ajlsi-3081	113	43	2023	2023	NUM
ajlsi-3081	113	44	)	)	PUNCT
ajlsi-3081	113	45	.	.	PUNCT
ajlsi-3081	114	1	the	the	DET
ajlsi-3081	114	2	reported	report	VERB
ajlsi-3081	114	3	cases	case	NOUN
ajlsi-3081	114	4	of	of	ADP
ajlsi-3081	114	5	testicular	testicular	ADJ
ajlsi-3081	114	6	cancers	cancer	NOUN
ajlsi-3081	114	7	globally	globally	ADV
ajlsi-3081	114	8	are	be	AUX
ajlsi-3081	114	9	approximately	approximately	ADV
ajlsi-3081	114	10	78400	78400	NUM
ajlsi-3081	114	11	,	,	PUNCT
ajlsi-3081	114	12	making	make	VERB
ajlsi-3081	114	13	it	it	PRON
ajlsi-3081	114	14	the	the	DET
ajlsi-3081	114	15	20th	20th	ADJ
ajlsi-3081	114	16	most	most	ADV
ajlsi-3081	114	17	prevalent	prevalent	ADJ
ajlsi-3081	114	18	cancer	cancer	NOUN
ajlsi-3081	114	19	(	(	PUNCT
ajlsi-3081	114	20	safiri	safiri	PROPN
ajlsi-3081	114	21	et	et	PROPN
ajlsi-3081	114	22	al	al	PROPN
ajlsi-3081	114	23	.	.	PROPN
ajlsi-3081	114	24	,	,	PUNCT
ajlsi-3081	114	25	2023	2023	NUM
ajlsi-3081	114	26	)	)	PUNCT
ajlsi-3081	114	27	.	.	PUNCT
ajlsi-3081	115	1	testicular	testicular	ADJ
ajlsi-3081	115	2	cancer	cancer	NOUN
ajlsi-3081	115	3	showed	show	VERB
ajlsi-3081	115	4	an	an	DET
ajlsi-3081	115	5	interesting	interesting	ADJ
ajlsi-3081	115	6	trend	trend	NOUN
ajlsi-3081	115	7	in	in	ADP
ajlsi-3081	115	8	terms	term	NOUN
ajlsi-3081	115	9	of	of	ADP
ajlsi-3081	115	10	demographic	demographic	ADJ
ajlsi-3081	115	11	locations	location	NOUN
ajlsi-3081	115	12	;	;	PUNCT
ajlsi-3081	115	13	it	it	PRON
ajlsi-3081	115	14	was	be	AUX
ajlsi-3081	115	15	seen	see	VERB
ajlsi-3081	115	16	that	that	SCONJ
ajlsi-3081	115	17	more	more	ADJ
ajlsi-3081	115	18	than	than	ADP
ajlsi-3081	115	19	62	62	NUM
ajlsi-3081	115	20	nations	nation	NOUN
ajlsi-3081	115	21	worldwide	worldwide	ADV
ajlsi-3081	115	22	were	be	AUX
ajlsi-3081	115	23	affected	affect	VERB
ajlsi-3081	115	24	(	(	PUNCT
ajlsi-3081	115	25	bray	bray	PROPN
ajlsi-3081	115	26	et	et	PROPN
ajlsi-3081	115	27	al	al	PROPN
ajlsi-3081	115	28	.	.	PROPN
ajlsi-3081	115	29	,	,	PUNCT
ajlsi-3081	115	30	2013	2013	NUM
ajlsi-3081	115	31	)	)	PUNCT
ajlsi-3081	115	32	,	,	PUNCT
ajlsi-3081	115	33	with	with	ADP
ajlsi-3081	115	34	the	the	DET
ajlsi-3081	115	35	highest	high	ADJ
ajlsi-3081	115	36	rate	rate	NOUN
ajlsi-3081	115	37	in	in	ADP
ajlsi-3081	115	38	west	west	NOUN
ajlsi-3081	115	39	,	,	PUNCT
ajlsi-3081	115	40	north	north	NOUN
ajlsi-3081	115	41	,	,	PUNCT
ajlsi-3081	115	42	and	and	CCONJ
ajlsi-3081	115	43	south	south	PROPN
ajlsi-3081	115	44	europe	europe	PROPN
ajlsi-3081	115	45	,	,	PUNCT
ajlsi-3081	115	46	oceania	oceania	PROPN
ajlsi-3081	115	47	,	,	PUNCT
ajlsi-3081	115	48	and	and	CCONJ
ajlsi-3081	115	49	north	north	PROPN
ajlsi-3081	115	50	america	america	PROPN
ajlsi-3081	115	51	.	.	PUNCT
ajlsi-3081	116	1	the	the	DET
ajlsi-3081	116	2	continents	continent	NOUN
ajlsi-3081	116	3	that	that	PRON
ajlsi-3081	116	4	are	be	AUX
ajlsi-3081	116	5	less	less	ADV
ajlsi-3081	116	6	developed	develop	VERB
ajlsi-3081	116	7	,	,	PUNCT
ajlsi-3081	116	8	such	such	ADJ
ajlsi-3081	116	9	as	as	ADP
ajlsi-3081	116	10	asia	asia	PROPN
ajlsi-3081	116	11	and	and	CCONJ
ajlsi-3081	116	12	africa	africa	PROPN
ajlsi-3081	116	13	,	,	PUNCT
ajlsi-3081	116	14	showed	show	VERB
ajlsi-3081	116	15	the	the	DET
ajlsi-3081	116	16	lowest	low	ADJ
ajlsi-3081	116	17	rate	rate	NOUN
ajlsi-3081	116	18	(	(	PUNCT
ajlsi-3081	116	19	giona	giona	NOUN
ajlsi-3081	116	20	,	,	PUNCT
ajlsi-3081	116	21	2022	2022	NUM
ajlsi-3081	116	22	)	)	PUNCT
ajlsi-3081	116	23	.	.	PUNCT
ajlsi-3081	117	1	the	the	DET
ajlsi-3081	117	2	rate	rate	NOUN
ajlsi-3081	117	3	of	of	ADP
ajlsi-3081	117	4	incidence	incidence	NOUN
ajlsi-3081	117	5	of	of	ADP
ajlsi-3081	117	6	testicular	testicular	ADJ
ajlsi-3081	117	7	cancer	cancer	NOUN
ajlsi-3081	117	8	in	in	ADP
ajlsi-3081	117	9	saudi	saudi	PROPN
ajlsi-3081	117	10	arabia	arabia	PROPN
ajlsi-3081	117	11	has	have	AUX
ajlsi-3081	117	12	been	be	AUX
ajlsi-3081	117	13	accelerated	accelerate	VERB
ajlsi-3081	117	14	in	in	ADP
ajlsi-3081	117	15	the	the	DET
ajlsi-3081	117	16	last	last	ADJ
ajlsi-3081	117	17	decades	decade	NOUN
ajlsi-3081	117	18	(	(	PUNCT
ajlsi-3081	117	19	abomelha	abomelha	NOUN
ajlsi-3081	117	20	,	,	PUNCT
ajlsi-3081	117	21	2017	2017	NUM
ajlsi-3081	117	22	)	)	PUNCT
ajlsi-3081	117	23	.	.	PUNCT
ajlsi-3081	118	1	as	as	ADP
ajlsi-3081	118	2	per	per	ADP
ajlsi-3081	118	3	the	the	DET
ajlsi-3081	118	4	saudi	saudi	ADJ
ajlsi-3081	118	5	cancer	cancer	NOUN
ajlsi-3081	118	6	registry	registry	NOUN
ajlsi-3081	118	7	(	(	PUNCT
ajlsi-3081	118	8	scr	scr	NOUN
ajlsi-3081	118	9	)	)	PUNCT
ajlsi-3081	118	10	,	,	PUNCT
ajlsi-3081	118	11	in	in	ADP
ajlsi-3081	118	12	2017	2017	NUM
ajlsi-3081	118	13	,	,	PUNCT
ajlsi-3081	118	14	the	the	DET
ajlsi-3081	118	15	total	total	ADJ
ajlsi-3081	118	16	reported	report	VERB
ajlsi-3081	118	17	cases	case	NOUN
ajlsi-3081	118	18	reached	reach	VERB
ajlsi-3081	118	19	the	the	DET
ajlsi-3081	118	20	figure	figure	NOUN
ajlsi-3081	118	21	of	of	ADP
ajlsi-3081	118	22	8850	8850	NUM
ajlsi-3081	118	23	new	new	ADJ
ajlsi-3081	118	24	cases	case	NOUN
ajlsi-3081	118	25	,	,	PUNCT
ajlsi-3081	118	26	and	and	CCONJ
ajlsi-3081	118	27	the	the	DET
ajlsi-3081	118	28	death	death	NOUN
ajlsi-3081	118	29	toll	toll	NOUN
ajlsi-3081	118	30	reached	reach	VERB
ajlsi-3081	118	31	an	an	DET
ajlsi-3081	118	32	approximate	approximate	ADJ
ajlsi-3081	118	33	number	number	NOUN
ajlsi-3081	118	34	of	of	ADP
ajlsi-3081	118	35	410	410	NUM
ajlsi-3081	118	36	(	(	PUNCT
ajlsi-3081	118	37	baird	baird	PROPN
ajlsi-3081	118	38	et	et	PROPN
ajlsi-3081	118	39	al	al	PROPN
ajlsi-3081	118	40	.	.	PROPN
ajlsi-3081	118	41	,	,	PUNCT
ajlsi-3081	118	42	2018	2018	NUM
ajlsi-3081	118	43	)	)	PUNCT
ajlsi-3081	118	44	.	.	PUNCT
ajlsi-3081	119	1	in	in	ADP
ajlsi-3081	119	2	europe	europe	PROPN
ajlsi-3081	119	3	,	,	PUNCT
ajlsi-3081	119	4	the	the	DET
ajlsi-3081	119	5	survival	survival	NOUN
ajlsi-3081	119	6	rate	rate	NOUN
ajlsi-3081	119	7	shown	show	VERB
ajlsi-3081	119	8	by	by	ADP
ajlsi-3081	119	9	testicular	testicular	ADJ
ajlsi-3081	119	10	cancer	cancer	NOUN
ajlsi-3081	119	11	is	be	AUX
ajlsi-3081	119	12	95	95	NUM
ajlsi-3081	119	13	%	%	NOUN
ajlsi-3081	119	14	per	per	ADP
ajlsi-3081	119	15	person	person	NOUN
ajlsi-3081	119	16	,	,	PUNCT
ajlsi-3081	119	17	which	which	PRON
ajlsi-3081	119	18	to	to	ADP
ajlsi-3081	119	19	date	date	NOUN
ajlsi-3081	119	20	is	be	AUX
ajlsi-3081	119	21	the	the	DET
ajlsi-3081	119	22	highest	high	ADJ
ajlsi-3081	119	23	recorded	record	VERB
ajlsi-3081	119	24	survival	survival	NOUN
ajlsi-3081	119	25	rate	rate	NOUN
ajlsi-3081	119	26	for	for	ADP
ajlsi-3081	119	27	any	any	DET
ajlsi-3081	119	28	cancer	cancer	NOUN
ajlsi-3081	119	29	occurring	occur	VERB
ajlsi-3081	119	30	in	in	ADP
ajlsi-3081	119	31	men	man	NOUN
ajlsi-3081	119	32	(	(	PUNCT
ajlsi-3081	119	33	znaor	znaor	NOUN
ajlsi-3081	119	34	et	et	PROPN
ajlsi-3081	119	35	al	al	PROPN
ajlsi-3081	119	36	.	.	PROPN
ajlsi-3081	119	37	,	,	PUNCT
ajlsi-3081	119	38	2020	2020	NUM
ajlsi-3081	119	39	)	)	PUNCT
ajlsi-3081	119	40	.	.	PUNCT
ajlsi-3081	120	1	there	there	PRON
ajlsi-3081	120	2	are	be	VERB
ajlsi-3081	120	3	many	many	ADJ
ajlsi-3081	120	4	risk	risk	NOUN
ajlsi-3081	120	5	factors	factor	NOUN
ajlsi-3081	120	6	contributing	contribute	VERB
ajlsi-3081	120	7	to	to	ADP
ajlsi-3081	120	8	testicular	testicular	ADJ
ajlsi-3081	120	9	cancer	cancer	NOUN
ajlsi-3081	120	10	in	in	ADP
ajlsi-3081	120	11	men	man	NOUN
ajlsi-3081	120	12	,	,	PUNCT
ajlsi-3081	120	13	such	such	ADJ
ajlsi-3081	120	14	as	as	ADP
ajlsi-3081	120	15	smoking	smoking	NOUN
ajlsi-3081	120	16	,	,	PUNCT
ajlsi-3081	120	17	undescended	undescende	VERB
ajlsi-3081	120	18	testis	testis	NOUN
ajlsi-3081	120	19	,	,	PUNCT
ajlsi-3081	120	20	family	family	NOUN
ajlsi-3081	120	21	history	history	NOUN
ajlsi-3081	120	22	,	,	PUNCT
ajlsi-3081	120	23	and	and	CCONJ
ajlsi-3081	120	24	infertility	infertility	NOUN
ajlsi-3081	120	25	.	.	PUNCT
ajlsi-3081	121	1	the	the	DET
ajlsi-3081	121	2	major	major	ADJ
ajlsi-3081	121	3	risk	risk	NOUN
ajlsi-3081	121	4	posing	pose	VERB
ajlsi-3081	121	5	factor	factor	NOUN
ajlsi-3081	121	6	is	be	AUX
ajlsi-3081	121	7	cryptorchidism	cryptorchidism	NOUN
ajlsi-3081	121	8	,	,	PUNCT
ajlsi-3081	121	9	or	or	CCONJ
ajlsi-3081	121	10	the	the	DET
ajlsi-3081	121	11	condition	condition	NOUN
ajlsi-3081	121	12	of	of	ADP
ajlsi-3081	121	13	having	have	VERB
ajlsi-3081	121	14	an	an	DET
ajlsi-3081	121	15	undescended	undescended	ADJ
ajlsi-3081	121	16	testicle	testicle	NOUN
ajlsi-3081	121	17	.	.	PUNCT
ajlsi-3081	122	1	patients	patient	NOUN
ajlsi-3081	122	2	with	with	ADP
ajlsi-3081	122	3	this	this	DET
ajlsi-3081	122	4	condition	condition	NOUN
ajlsi-3081	122	5	are	be	AUX
ajlsi-3081	122	6	more	more	ADV
ajlsi-3081	122	7	likely	likely	ADJ
ajlsi-3081	122	8	to	to	PART
ajlsi-3081	122	9	get	get	VERB
ajlsi-3081	122	10	testicular	testicular	ADJ
ajlsi-3081	122	11	cancer	cancer	NOUN
ajlsi-3081	122	12	compared	compare	VERB
ajlsi-3081	122	13	to	to	ADP
ajlsi-3081	122	14	others	other	NOUN
ajlsi-3081	122	15	(	(	PUNCT
ajlsi-3081	122	16	ergül	ergül	NOUN
ajlsi-3081	122	17	et	et	PROPN
ajlsi-3081	122	18	al	al	PROPN
ajlsi-3081	122	19	.	.	PROPN
ajlsi-3081	122	20	,	,	PUNCT
ajlsi-3081	122	21	2024	2024	NUM
ajlsi-3081	122	22	)	)	PUNCT
ajlsi-3081	122	23	.	.	PUNCT
ajlsi-3081	123	1	patients	patient	NOUN
ajlsi-3081	123	2	having	have	VERB
ajlsi-3081	123	3	genetic	genetic	ADJ
ajlsi-3081	123	4	conditions	condition	NOUN
ajlsi-3081	123	5	such	such	ADJ
ajlsi-3081	123	6	as	as	ADP
ajlsi-3081	123	7	klinefelter	klinefelter	PROPN
ajlsi-3081	123	8	syndrome	syndrome	PROPN
ajlsi-3081	123	9	can	can	AUX
ajlsi-3081	123	10	raise	raise	VERB
ajlsi-3081	123	11	a	a	DET
ajlsi-3081	123	12	person	person	NOUN
ajlsi-3081	123	13	’s	’s	PART
ajlsi-3081	123	14	chance	chance	NOUN
ajlsi-3081	123	15	pa	pa	PROPN
ajlsi-3081	123	16	ge	ge	PROPN
ajlsi-3081	123	17	61	61	NUM
ajlsi-3081	123	18	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-3081	123	19	am	am	NOUN
ajlsi-3081	123	20	.	.	PUNCT
ajlsi-3081	124	1	j.	j.	PROPN
ajlsi-3081	124	2	life	life	PROPN
ajlsi-3081	124	3	sci	sci	PROPN
ajlsi-3081	124	4	.	.	PUNCT
ajlsi-3081	124	5	innov	innov	PROPN
ajlsi-3081	124	6	.	.	PUNCT
ajlsi-3081	125	1	3(2	3(2	NUM
ajlsi-3081	125	2	)	)	PUNCT
ajlsi-3081	125	3	57	57	NUM
ajlsi-3081	125	4	-	-	SYM
ajlsi-3081	125	5	63	63	NUM
ajlsi-3081	125	6	,	,	PUNCT
ajlsi-3081	125	7	2024	2024	NUM
ajlsi-3081	125	8	of	of	ADP
ajlsi-3081	125	9	acquiring	acquire	VERB
ajlsi-3081	125	10	testicular	testicular	ADJ
ajlsi-3081	125	11	cancer	cancer	NOUN
ajlsi-3081	125	12	(	(	PUNCT
ajlsi-3081	125	13	swerdlow	swerdlow	NOUN
ajlsi-3081	125	14	et	et	PROPN
ajlsi-3081	125	15	al	al	PROPN
ajlsi-3081	125	16	.	.	PROPN
ajlsi-3081	125	17	,	,	PUNCT
ajlsi-3081	125	18	2006	2006	NUM
ajlsi-3081	125	19	)	)	PUNCT
ajlsi-3081	125	20	.	.	PUNCT
ajlsi-3081	126	1	in	in	ADP
ajlsi-3081	126	2	case	case	NOUN
ajlsi-3081	126	3	of	of	ADP
ajlsi-3081	126	4	genetic	genetic	ADJ
ajlsi-3081	126	5	mutation	mutation	NOUN
ajlsi-3081	126	6	such	such	ADJ
ajlsi-3081	126	7	as	as	ADP
ajlsi-3081	126	8	those	those	PRON
ajlsi-3081	126	9	in	in	ADP
ajlsi-3081	126	10	the	the	DET
ajlsi-3081	126	11	kitlg	kitlg	PROPN
ajlsi-3081	126	12	gene	gene	NOUN
ajlsi-3081	126	13	also	also	ADV
ajlsi-3081	126	14	increases	increase	VERB
ajlsi-3081	126	15	the	the	DET
ajlsi-3081	126	16	risk	risk	NOUN
ajlsi-3081	126	17	of	of	ADP
ajlsi-3081	126	18	developing	develop	VERB
ajlsi-3081	126	19	testicular	testicular	ADJ
ajlsi-3081	126	20	cancer	cancer	NOUN
ajlsi-3081	126	21	(	(	PUNCT
ajlsi-3081	126	22	pyle	pyle	PROPN
ajlsi-3081	126	23	et	et	PROPN
ajlsi-3081	126	24	al	al	PROPN
ajlsi-3081	126	25	.	.	PROPN
ajlsi-3081	126	26	,	,	PUNCT
ajlsi-3081	126	27	2024	2024	NUM
ajlsi-3081	126	28	)	)	PUNCT
ajlsi-3081	126	29	.	.	PUNCT
ajlsi-3081	127	1	it	it	PRON
ajlsi-3081	127	2	can	can	AUX
ajlsi-3081	127	3	relapse	relapse	VERB
ajlsi-3081	127	4	in	in	ADP
ajlsi-3081	127	5	men	man	NOUN
ajlsi-3081	127	6	who	who	PRON
ajlsi-3081	127	7	have	have	AUX
ajlsi-3081	127	8	been	be	AUX
ajlsi-3081	127	9	affected	affect	VERB
ajlsi-3081	127	10	previously	previously	ADV
ajlsi-3081	127	11	by	by	ADP
ajlsi-3081	127	12	testicular	testicular	ADJ
ajlsi-3081	127	13	cancer	cancer	NOUN
ajlsi-3081	127	14	in	in	ADP
ajlsi-3081	127	15	either	either	DET
ajlsi-3081	127	16	testicle	testicle	NOUN
ajlsi-3081	127	17	.	.	PUNCT
ajlsi-3081	128	1	the	the	DET
ajlsi-3081	128	2	study	study	NOUN
ajlsi-3081	128	3	has	have	AUX
ajlsi-3081	128	4	shown	show	VERB
ajlsi-3081	128	5	that	that	SCONJ
ajlsi-3081	128	6	the	the	DET
ajlsi-3081	128	7	age	age	NOUN
ajlsi-3081	128	8	bracket	bracket	NOUN
ajlsi-3081	128	9	mostly	mostly	ADV
ajlsi-3081	128	10	affected	affect	VERB
ajlsi-3081	128	11	by	by	ADP
ajlsi-3081	128	12	testicular	testicular	ADJ
ajlsi-3081	128	13	cancer	cancer	NOUN
ajlsi-3081	128	14	ranges	range	VERB
ajlsi-3081	128	15	from	from	ADP
ajlsi-3081	128	16	15	15	NUM
ajlsi-3081	128	17	-	-	SYM
ajlsi-3081	128	18	35	35	NUM
ajlsi-3081	128	19	,	,	PUNCT
ajlsi-3081	128	20	so	so	SCONJ
ajlsi-3081	128	21	men	man	NOUN
ajlsi-3081	128	22	at	at	ADP
ajlsi-3081	128	23	this	this	DET
ajlsi-3081	128	24	age	age	NOUN
ajlsi-3081	128	25	are	be	AUX
ajlsi-3081	128	26	most	most	ADV
ajlsi-3081	128	27	prone	prone	ADJ
ajlsi-3081	128	28	(	(	PUNCT
ajlsi-3081	128	29	franco	franco	PROPN
ajlsi-3081	128	30	et	et	PROPN
ajlsi-3081	128	31	al	al	PROPN
ajlsi-3081	128	32	.	.	PROPN
ajlsi-3081	128	33	,	,	PUNCT
ajlsi-3081	128	34	2023	2023	NUM
ajlsi-3081	128	35	)	)	PUNCT
ajlsi-3081	128	36	.	.	PUNCT
ajlsi-3081	129	1	one	one	NUM
ajlsi-3081	129	2	of	of	ADP
ajlsi-3081	129	3	the	the	DET
ajlsi-3081	129	4	main	main	ADJ
ajlsi-3081	129	5	reasons	reason	NOUN
ajlsi-3081	129	6	why	why	SCONJ
ajlsi-3081	129	7	european	european	ADJ
ajlsi-3081	129	8	and	and	CCONJ
ajlsi-3081	129	9	american	american	ADJ
ajlsi-3081	129	10	nations	nation	NOUN
ajlsi-3081	129	11	have	have	AUX
ajlsi-3081	129	12	shown	show	VERB
ajlsi-3081	129	13	the	the	DET
ajlsi-3081	129	14	highest	high	ADJ
ajlsi-3081	129	15	rate	rate	NOUN
ajlsi-3081	129	16	of	of	ADP
ajlsi-3081	129	17	incidence	incidence	NOUN
ajlsi-3081	129	18	for	for	ADP
ajlsi-3081	129	19	testicular	testicular	ADJ
ajlsi-3081	129	20	cancer	cancer	NOUN
ajlsi-3081	129	21	is	be	AUX
ajlsi-3081	129	22	the	the	DET
ajlsi-3081	129	23	fact	fact	NOUN
ajlsi-3081	129	24	that	that	SCONJ
ajlsi-3081	129	25	white	white	ADJ
ajlsi-3081	129	26	men	man	NOUN
ajlsi-3081	129	27	are	be	AUX
ajlsi-3081	129	28	more	more	ADV
ajlsi-3081	129	29	prone	prone	ADJ
ajlsi-3081	129	30	to	to	ADP
ajlsi-3081	129	31	this	this	DET
ajlsi-3081	129	32	cancer	cancer	NOUN
ajlsi-3081	129	33	compared	compare	VERB
ajlsi-3081	129	34	to	to	ADP
ajlsi-3081	129	35	other	other	ADJ
ajlsi-3081	129	36	ethnicities	ethnicity	NOUN
ajlsi-3081	129	37	(	(	PUNCT
ajlsi-3081	129	38	ghazarian	ghazarian	INTJ
ajlsi-3081	129	39	et	et	PROPN
ajlsi-3081	129	40	al	al	PROPN
ajlsi-3081	129	41	.	.	PROPN
ajlsi-3081	129	42	,	,	PUNCT
ajlsi-3081	129	43	2015	2015	NUM
ajlsi-3081	129	44	)	)	PUNCT
ajlsi-3081	129	45	.	.	PUNCT
ajlsi-3081	130	1	environmental	environmental	ADJ
ajlsi-3081	130	2	factors	factor	NOUN
ajlsi-3081	130	3	also	also	ADV
ajlsi-3081	130	4	play	play	VERB
ajlsi-3081	130	5	a	a	DET
ajlsi-3081	130	6	role	role	NOUN
ajlsi-3081	130	7	in	in	ADP
ajlsi-3081	130	8	the	the	DET
ajlsi-3081	130	9	prevalence	prevalence	NOUN
ajlsi-3081	130	10	of	of	ADP
ajlsi-3081	130	11	testicular	testicular	ADJ
ajlsi-3081	130	12	cancer	cancer	NOUN
ajlsi-3081	130	13	.	.	PUNCT
ajlsi-3081	131	1	studies	study	NOUN
ajlsi-3081	131	2	have	have	AUX
ajlsi-3081	131	3	shown	show	VERB
ajlsi-3081	131	4	that	that	DET
ajlsi-3081	131	5	exposure	exposure	NOUN
ajlsi-3081	131	6	to	to	ADP
ajlsi-3081	131	7	toxins	toxin	NOUN
ajlsi-3081	131	8	such	such	ADJ
ajlsi-3081	131	9	as	as	ADP
ajlsi-3081	131	10	endocrine	endocrine	NOUN
ajlsi-3081	131	11	-	-	PUNCT
ajlsi-3081	131	12	disrupting	disrupt	VERB
ajlsi-3081	131	13	chemicals	chemical	NOUN
ajlsi-3081	131	14	(	(	PUNCT
ajlsi-3081	131	15	edcs	edc	NOUN
ajlsi-3081	131	16	)	)	PUNCT
ajlsi-3081	131	17	during	during	ADP
ajlsi-3081	131	18	pregnancy	pregnancy	NOUN
ajlsi-3081	131	19	and	and	CCONJ
ajlsi-3081	131	20	the	the	DET
ajlsi-3081	131	21	early	early	ADJ
ajlsi-3081	131	22	stages	stage	NOUN
ajlsi-3081	131	23	of	of	ADP
ajlsi-3081	131	24	life	life	NOUN
ajlsi-3081	131	25	increases	increase	VERB
ajlsi-3081	131	26	the	the	DET
ajlsi-3081	131	27	risk	risk	NOUN
ajlsi-3081	131	28	factor	factor	NOUN
ajlsi-3081	131	29	of	of	ADP
ajlsi-3081	131	30	acquiring	acquire	VERB
ajlsi-3081	131	31	testicular	testicular	ADJ
ajlsi-3081	131	32	cancer	cancer	NOUN
ajlsi-3081	131	33	(	(	PUNCT
ajlsi-3081	131	34	cannarella	cannarella	NOUN
ajlsi-3081	131	35	et	et	NOUN
ajlsi-3081	131	36	al	al	PROPN
ajlsi-3081	131	37	.	.	PROPN
ajlsi-3081	131	38	,	,	PUNCT
ajlsi-3081	131	39	2023	2023	NUM
ajlsi-3081	131	40	)	)	PUNCT
ajlsi-3081	131	41	.	.	PUNCT
ajlsi-3081	132	1	seminomas	seminoma	NOUN
ajlsi-3081	132	2	and	and	CCONJ
ajlsi-3081	132	3	nonseminomas	nonseminomas	PROPN
ajlsi-3081	132	4	(	(	PUNCT
ajlsi-3081	132	5	nsgcts	nsgct	NOUN
ajlsi-3081	132	6	)	)	PUNCT
ajlsi-3081	132	7	are	be	AUX
ajlsi-3081	132	8	the	the	DET
ajlsi-3081	132	9	primary	primary	ADJ
ajlsi-3081	132	10	germ	germ	NOUN
ajlsi-3081	132	11	cell	cell	NOUN
ajlsi-3081	132	12	tumors	tumor	NOUN
ajlsi-3081	132	13	,	,	PUNCT
ajlsi-3081	132	14	accounting	account	VERB
ajlsi-3081	132	15	for	for	ADP
ajlsi-3081	132	16	most	most	ADJ
ajlsi-3081	132	17	testicular	testicular	ADJ
ajlsi-3081	132	18	malignancies	malignancy	NOUN
ajlsi-3081	132	19	.	.	PUNCT
ajlsi-3081	133	1	because	because	SCONJ
ajlsi-3081	133	2	nsgcts	nsgct	NOUN
ajlsi-3081	133	3	grow	grow	VERB
ajlsi-3081	133	4	more	more	ADV
ajlsi-3081	133	5	quickly	quickly	ADV
ajlsi-3081	133	6	and	and	CCONJ
ajlsi-3081	133	7	are	be	AUX
ajlsi-3081	133	8	generally	generally	ADV
ajlsi-3081	133	9	more	more	ADV
ajlsi-3081	133	10	aggressive	aggressive	ADJ
ajlsi-3081	133	11	,	,	PUNCT
ajlsi-3081	133	12	postoperative	postoperative	ADJ
ajlsi-3081	133	13	care	care	NOUN
ajlsi-3081	133	14	is	be	AUX
ajlsi-3081	133	15	frequently	frequently	ADV
ajlsi-3081	133	16	needed	need	VERB
ajlsi-3081	133	17	(	(	PUNCT
ajlsi-3081	133	18	siddiqui	siddiqui	NOUN
ajlsi-3081	133	19	et	et	PROPN
ajlsi-3081	133	20	al	al	PROPN
ajlsi-3081	133	21	.	.	PROPN
ajlsi-3081	133	22	,	,	PUNCT
ajlsi-3081	133	23	2020	2020	NUM
ajlsi-3081	133	24	)	)	PUNCT
ajlsi-3081	133	25	.	.	PUNCT
ajlsi-3081	134	1	seminomas	seminomas	PROPN
ajlsi-3081	134	2	may	may	AUX
ajlsi-3081	134	3	not	not	PART
ajlsi-3081	134	4	require	require	VERB
ajlsi-3081	134	5	further	further	ADJ
ajlsi-3081	134	6	procedures	procedure	NOUN
ajlsi-3081	134	7	since	since	SCONJ
ajlsi-3081	134	8	they	they	PRON
ajlsi-3081	134	9	grow	grow	VERB
ajlsi-3081	134	10	more	more	ADV
ajlsi-3081	134	11	slowly	slowly	ADV
ajlsi-3081	134	12	and	and	CCONJ
ajlsi-3081	134	13	are	be	AUX
ajlsi-3081	134	14	less	less	ADV
ajlsi-3081	134	15	aggressive	aggressive	ADJ
ajlsi-3081	134	16	(	(	PUNCT
ajlsi-3081	134	17	bray	bray	PROPN
ajlsi-3081	134	18	et	et	PROPN
ajlsi-3081	134	19	al	al	PROPN
ajlsi-3081	134	20	.	.	PROPN
ajlsi-3081	134	21	,	,	PUNCT
ajlsi-3081	134	22	2006	2006	NUM
ajlsi-3081	134	23	)	)	PUNCT
ajlsi-3081	134	24	.	.	PUNCT
ajlsi-3081	135	1	to	to	PART
ajlsi-3081	135	2	diagnose	diagnose	VERB
ajlsi-3081	135	3	and	and	CCONJ
ajlsi-3081	135	4	treat	treat	VERB
ajlsi-3081	135	5	both	both	PRON
ajlsi-3081	135	6	,	,	PUNCT
ajlsi-3081	135	7	the	the	DET
ajlsi-3081	135	8	first	first	ADJ
ajlsi-3081	135	9	step	step	NOUN
ajlsi-3081	135	10	is	be	AUX
ajlsi-3081	135	11	usually	usually	ADV
ajlsi-3081	135	12	orchiectomy	orchiectomy	ADJ
ajlsi-3081	135	13	(	(	PUNCT
ajlsi-3081	135	14	testicle	testicle	NOUN
ajlsi-3081	135	15	removal	removal	NOUN
ajlsi-3081	135	16	)	)	PUNCT
ajlsi-3081	135	17	.	.	PUNCT
ajlsi-3081	136	1	orchiectomy	orchiectomy	NOUN
ajlsi-3081	136	2	is	be	AUX
ajlsi-3081	136	3	a	a	DET
ajlsi-3081	136	4	surgical	surgical	ADJ
ajlsi-3081	136	5	method	method	NOUN
ajlsi-3081	136	6	and	and	CCONJ
ajlsi-3081	136	7	is	be	AUX
ajlsi-3081	136	8	known	know	VERB
ajlsi-3081	136	9	as	as	ADP
ajlsi-3081	136	10	the	the	DET
ajlsi-3081	136	11	gold	gold	NOUN
ajlsi-3081	136	12	standard	standard	NOUN
ajlsi-3081	136	13	for	for	ADP
ajlsi-3081	136	14	treating	treat	VERB
ajlsi-3081	136	15	testicular	testicular	ADJ
ajlsi-3081	136	16	cancer	cancer	NOUN
ajlsi-3081	136	17	.	.	PUNCT
ajlsi-3081	137	1	post	post	ADJ
ajlsi-3081	137	2	-	-	ADJ
ajlsi-3081	137	3	orchiectomy	orchiectomy	ADJ
ajlsi-3081	137	4	treatment	treatment	NOUN
ajlsi-3081	137	5	plans	plan	NOUN
ajlsi-3081	137	6	are	be	AUX
ajlsi-3081	137	7	tailored	tailor	VERB
ajlsi-3081	137	8	for	for	ADP
ajlsi-3081	137	9	the	the	DET
ajlsi-3081	137	10	specific	specific	ADJ
ajlsi-3081	137	11	stage	stage	NOUN
ajlsi-3081	137	12	of	of	ADP
ajlsi-3081	137	13	the	the	DET
ajlsi-3081	137	14	tumor	tumor	NOUN
ajlsi-3081	137	15	identified	identify	VERB
ajlsi-3081	137	16	after	after	ADP
ajlsi-3081	137	17	surgery	surgery	NOUN
ajlsi-3081	137	18	(	(	PUNCT
ajlsi-3081	137	19	stephenson	stephenson	PROPN
ajlsi-3081	137	20	et	et	PROPN
ajlsi-3081	137	21	al	al	PROPN
ajlsi-3081	137	22	.	.	PROPN
ajlsi-3081	137	23	,	,	PUNCT
ajlsi-3081	137	24	2019	2019	NUM
ajlsi-3081	137	25	)	)	PUNCT
ajlsi-3081	137	26	.	.	PUNCT
ajlsi-3081	138	1	our	our	PRON
ajlsi-3081	138	2	study	study	NOUN
ajlsi-3081	138	3	assessed	assess	VERB
ajlsi-3081	138	4	the	the	DET
ajlsi-3081	138	5	survival	survival	NOUN
ajlsi-3081	138	6	rate	rate	NOUN
ajlsi-3081	138	7	regarding	regard	VERB
ajlsi-3081	138	8	disease	disease	NOUN
ajlsi-3081	138	9	recurrence	recurrence	NOUN
ajlsi-3081	138	10	,	,	PUNCT
ajlsi-3081	138	11	pathology	pathology	NOUN
ajlsi-3081	138	12	type	type	NOUN
ajlsi-3081	138	13	,	,	PUNCT
ajlsi-3081	138	14	patients	patient	NOUN
ajlsi-3081	138	15	with	with	ADP
ajlsi-3081	138	16	risk	risk	NOUN
ajlsi-3081	138	17	factors	factor	NOUN
ajlsi-3081	138	18	,	,	PUNCT
ajlsi-3081	138	19	and	and	CCONJ
ajlsi-3081	138	20	stage	stage	NOUN
ajlsi-3081	138	21	presentation	presentation	NOUN
ajlsi-3081	138	22	between	between	ADP
ajlsi-3081	138	23	patients	patient	NOUN
ajlsi-3081	138	24	living	live	VERB
ajlsi-3081	138	25	in	in	ADP
ajlsi-3081	138	26	riyadh	riyadh	PROPN
ajlsi-3081	138	27	,	,	PUNCT
ajlsi-3081	138	28	treated	treat	VERB
ajlsi-3081	138	29	at	at	ADP
ajlsi-3081	138	30	kfshrc	kfshrc	NOUN
ajlsi-3081	138	31	,	,	PUNCT
ajlsi-3081	138	32	and	and	CCONJ
ajlsi-3081	138	33	patients	patient	NOUN
ajlsi-3081	138	34	from	from	ADP
ajlsi-3081	138	35	different	different	ADJ
ajlsi-3081	138	36	kingdom	kingdom	NOUN
ajlsi-3081	138	37	regions	region	NOUN
ajlsi-3081	138	38	.	.	PUNCT
ajlsi-3081	139	1	we	we	PRON
ajlsi-3081	139	2	retrospectively	retrospectively	ADV
ajlsi-3081	139	3	went	go	VERB
ajlsi-3081	139	4	through	through	ADP
ajlsi-3081	139	5	our	our	PRON
ajlsi-3081	139	6	patient	patient	NOUN
ajlsi-3081	139	7	’s	’s	PART
ajlsi-3081	139	8	records	record	NOUN
ajlsi-3081	139	9	from	from	ADP
ajlsi-3081	139	10	2010	2010	NUM
ajlsi-3081	139	11	-	-	SYM
ajlsi-3081	139	12	2017	2017	NUM
ajlsi-3081	139	13	.	.	PUNCT
ajlsi-3081	140	1	subsequently	subsequently	ADV
ajlsi-3081	140	2	,	,	PUNCT
ajlsi-3081	140	3	our	our	PRON
ajlsi-3081	140	4	follow	follow	NOUN
ajlsi-3081	140	5	-	-	PUNCT
ajlsi-3081	140	6	up	up	NOUN
ajlsi-3081	140	7	with	with	ADP
ajlsi-3081	140	8	the	the	DET
ajlsi-3081	140	9	patients	patient	NOUN
ajlsi-3081	140	10	post	post	ADJ
ajlsi-3081	140	11	-	-	ADJ
ajlsi-3081	140	12	orchiectomy	orchiectomy	ADJ
ajlsi-3081	140	13	included	include	VERB
ajlsi-3081	140	14	radiological	radiological	ADJ
ajlsi-3081	140	15	images	image	NOUN
ajlsi-3081	140	16	and	and	CCONJ
ajlsi-3081	140	17	tumor	tumor	NOUN
ajlsi-3081	140	18	markers	marker	NOUN
ajlsi-3081	140	19	(	(	PUNCT
ajlsi-3081	140	20	chavarriaga	chavarriaga	PROPN
ajlsi-3081	140	21	et	et	PROPN
ajlsi-3081	140	22	al	al	PROPN
ajlsi-3081	140	23	.	.	PROPN
ajlsi-3081	140	24	,	,	PUNCT
ajlsi-3081	140	25	2023	2023	NUM
ajlsi-3081	140	26	)	)	PUNCT
ajlsi-3081	140	27	.	.	PUNCT
ajlsi-3081	141	1	the	the	DET
ajlsi-3081	141	2	study	study	NOUN
ajlsi-3081	141	3	showed	show	VERB
ajlsi-3081	141	4	that	that	SCONJ
ajlsi-3081	141	5	the	the	DET
ajlsi-3081	141	6	frequency	frequency	NOUN
ajlsi-3081	141	7	of	of	ADP
ajlsi-3081	141	8	incidence	incidence	NOUN
ajlsi-3081	141	9	of	of	ADP
ajlsi-3081	141	10	testicular	testicular	ADJ
ajlsi-3081	141	11	cancer	cancer	NOUN
ajlsi-3081	141	12	showed	show	VERB
ajlsi-3081	141	13	a	a	DET
ajlsi-3081	141	14	significant	significant	ADJ
ajlsi-3081	141	15	relation	relation	NOUN
ajlsi-3081	141	16	with	with	ADP
ajlsi-3081	141	17	the	the	DET
ajlsi-3081	141	18	age	age	NOUN
ajlsi-3081	141	19	of	of	ADP
ajlsi-3081	141	20	the	the	DET
ajlsi-3081	141	21	patients	patient	NOUN
ajlsi-3081	141	22	,	,	PUNCT
ajlsi-3081	141	23	as	as	SCONJ
ajlsi-3081	141	24	most	most	ADJ
ajlsi-3081	141	25	of	of	ADP
ajlsi-3081	141	26	the	the	DET
ajlsi-3081	141	27	studied	study	VERB
ajlsi-3081	141	28	patients	patient	NOUN
ajlsi-3081	141	29	were	be	AUX
ajlsi-3081	141	30	in	in	ADP
ajlsi-3081	141	31	the	the	DET
ajlsi-3081	141	32	age	age	NOUN
ajlsi-3081	141	33	group	group	NOUN
ajlsi-3081	141	34	of	of	ADP
ajlsi-3081	141	35	26	26	NUM
ajlsi-3081	141	36	-	-	SYM
ajlsi-3081	141	37	35	35	NUM
ajlsi-3081	141	38	years	year	NOUN
ajlsi-3081	141	39	.	.	PUNCT
ajlsi-3081	142	1	our	our	PRON
ajlsi-3081	142	2	retrospective	retrospective	ADJ
ajlsi-3081	142	3	cohort	cohort	NOUN
ajlsi-3081	142	4	study	study	NOUN
ajlsi-3081	142	5	found	find	VERB
ajlsi-3081	142	6	no	no	DET
ajlsi-3081	142	7	statistically	statistically	ADV
ajlsi-3081	142	8	significant	significant	ADJ
ajlsi-3081	142	9	variations	variation	NOUN
ajlsi-3081	142	10	in	in	ADP
ajlsi-3081	142	11	overall	overall	ADJ
ajlsi-3081	142	12	survival	survival	NOUN
ajlsi-3081	142	13	between	between	ADP
ajlsi-3081	142	14	patients	patient	NOUN
ajlsi-3081	142	15	residing	reside	VERB
ajlsi-3081	142	16	in	in	ADP
ajlsi-3081	142	17	and	and	CCONJ
ajlsi-3081	142	18	outside	outside	ADP
ajlsi-3081	142	19	of	of	ADP
ajlsi-3081	142	20	riyadh	riyadh	NOUN
ajlsi-3081	142	21	,	,	PUNCT
ajlsi-3081	142	22	indicating	indicate	VERB
ajlsi-3081	142	23	that	that	SCONJ
ajlsi-3081	142	24	geographic	geographic	ADJ
ajlsi-3081	142	25	location	location	NOUN
ajlsi-3081	142	26	may	may	AUX
ajlsi-3081	142	27	not	not	PART
ajlsi-3081	142	28	be	be	AUX
ajlsi-3081	142	29	a	a	DET
ajlsi-3081	142	30	relevant	relevant	ADJ
ajlsi-3081	142	31	factor	factor	NOUN
ajlsi-3081	142	32	in	in	ADP
ajlsi-3081	142	33	the	the	DET
ajlsi-3081	142	34	prognosis	prognosis	NOUN
ajlsi-3081	142	35	of	of	ADP
ajlsi-3081	142	36	seminoma	seminoma	NOUN
ajlsi-3081	142	37	and	and	CCONJ
ajlsi-3081	142	38	nonseminoma	nonseminoma	ADJ
ajlsi-3081	142	39	germ	germ	NOUN
ajlsi-3081	142	40	cell	cell	NOUN
ajlsi-3081	142	41	tumors	tumor	NOUN
ajlsi-3081	142	42	(	(	PUNCT
ajlsi-3081	142	43	gcts	gct	NOUN
ajlsi-3081	142	44	)	)	PUNCT
ajlsi-3081	142	45	.	.	PUNCT
ajlsi-3081	143	1	furthermore	furthermore	ADV
ajlsi-3081	143	2	,	,	PUNCT
ajlsi-3081	143	3	the	the	DET
ajlsi-3081	143	4	assessed	assessed	ADJ
ajlsi-3081	143	5	risk	risk	NOUN
ajlsi-3081	143	6	factors	factor	NOUN
ajlsi-3081	143	7	affected	affect	VERB
ajlsi-3081	143	8	neither	neither	CCONJ
ajlsi-3081	143	9	the	the	DET
ajlsi-3081	143	10	seminoma	seminoma	NOUN
ajlsi-3081	143	11	nor	nor	CCONJ
ajlsi-3081	143	12	the	the	DET
ajlsi-3081	143	13	nsgct	nsgct	PROPN
ajlsi-3081	143	14	groups	group	NOUN
ajlsi-3081	143	15	’	’	PART
ajlsi-3081	143	16	overall	overall	ADJ
ajlsi-3081	143	17	survival	survival	NOUN
ajlsi-3081	143	18	.	.	PUNCT
ajlsi-3081	144	1	the	the	DET
ajlsi-3081	144	2	results	result	NOUN
ajlsi-3081	144	3	revealed	reveal	VERB
ajlsi-3081	144	4	that	that	SCONJ
ajlsi-3081	144	5	patients	patient	NOUN
ajlsi-3081	144	6	with	with	ADP
ajlsi-3081	144	7	pure	pure	ADJ
ajlsi-3081	144	8	seminomas	seminoma	NOUN
ajlsi-3081	144	9	had	have	AUX
ajlsi-3081	144	10	improved	improve	VERB
ajlsi-3081	144	11	overall	overall	ADJ
ajlsi-3081	144	12	survival	survival	NOUN
ajlsi-3081	144	13	rates	rate	NOUN
ajlsi-3081	144	14	than	than	ADP
ajlsi-3081	144	15	those	those	PRON
ajlsi-3081	144	16	with	with	ADP
ajlsi-3081	144	17	pure	pure	ADJ
ajlsi-3081	144	18	nsgcts	nsgct	NOUN
ajlsi-3081	144	19	,	,	PUNCT
ajlsi-3081	144	20	which	which	PRON
ajlsi-3081	144	21	suggests	suggest	VERB
ajlsi-3081	144	22	that	that	SCONJ
ajlsi-3081	144	23	nonseminoma	nonseminoma	ADJ
ajlsi-3081	144	24	variations	variation	NOUN
ajlsi-3081	144	25	were	be	AUX
ajlsi-3081	144	26	naturally	naturally	ADV
ajlsi-3081	144	27	more	more	ADV
ajlsi-3081	144	28	aggressive	aggressive	ADJ
ajlsi-3081	144	29	(	(	PUNCT
ajlsi-3081	144	30	fero	fero	PROPN
ajlsi-3081	144	31	et	et	PROPN
ajlsi-3081	144	32	al	al	PROPN
ajlsi-3081	144	33	.	.	PROPN
ajlsi-3081	144	34	,	,	PUNCT
ajlsi-3081	144	35	2021	2021	NUM
ajlsi-3081	144	36	)	)	PUNCT
ajlsi-3081	144	37	.	.	PUNCT
ajlsi-3081	145	1	stage	stage	NOUN
ajlsi-3081	145	2	3	3	NUM
ajlsi-3081	145	3	presentations	presentation	NOUN
ajlsi-3081	145	4	showed	show	VERB
ajlsi-3081	145	5	noticeably	noticeably	ADV
ajlsi-3081	145	6	worse	bad	ADJ
ajlsi-3081	145	7	survival	survival	NOUN
ajlsi-3081	145	8	rates	rate	NOUN
ajlsi-3081	145	9	,	,	PUNCT
ajlsi-3081	145	10	underscoring	underscore	VERB
ajlsi-3081	145	11	the	the	DET
ajlsi-3081	145	12	significance	significance	NOUN
ajlsi-3081	145	13	of	of	ADP
ajlsi-3081	145	14	early	early	ADJ
ajlsi-3081	145	15	discovery	discovery	NOUN
ajlsi-3081	145	16	and	and	CCONJ
ajlsi-3081	145	17	care	care	NOUN
ajlsi-3081	145	18	,	,	PUNCT
ajlsi-3081	145	19	while	while	SCONJ
ajlsi-3081	145	20	stage	stage	NOUN
ajlsi-3081	145	21	1a–2c	1a–2c	NOUN
ajlsi-3081	145	22	gcts	gct	NOUN
ajlsi-3081	145	23	showed	show	VERB
ajlsi-3081	145	24	similar	similar	ADJ
ajlsi-3081	145	25	survival	survival	NOUN
ajlsi-3081	145	26	outcomes	outcome	NOUN
ajlsi-3081	145	27	(	(	PUNCT
ajlsi-3081	145	28	abdul	abdul	PROPN
ajlsi-3081	145	29	-	-	PUNCT
ajlsi-3081	145	30	muhsin	muhsin	PROPN
ajlsi-3081	145	31	et	et	PROPN
ajlsi-3081	145	32	al	al	PROPN
ajlsi-3081	145	33	.	.	PROPN
ajlsi-3081	145	34	,	,	PUNCT
ajlsi-3081	145	35	2021	2021	NUM
ajlsi-3081	145	36	)	)	PUNCT
ajlsi-3081	145	37	.	.	PUNCT
ajlsi-3081	146	1	one	one	NUM
ajlsi-3081	146	2	of	of	ADP
ajlsi-3081	146	3	the	the	DET
ajlsi-3081	146	4	main	main	ADJ
ajlsi-3081	146	5	reasons	reason	NOUN
ajlsi-3081	146	6	no	no	DET
ajlsi-3081	146	7	significant	significant	ADJ
ajlsi-3081	146	8	difference	difference	NOUN
ajlsi-3081	146	9	was	be	AUX
ajlsi-3081	146	10	seen	see	VERB
ajlsi-3081	146	11	in	in	ADP
ajlsi-3081	146	12	patients	patient	NOUN
ajlsi-3081	146	13	living	live	VERB
ajlsi-3081	146	14	inside	inside	ADP
ajlsi-3081	146	15	riyadh	riyadh	NOUN
ajlsi-3081	146	16	and	and	CCONJ
ajlsi-3081	146	17	receiving	receive	VERB
ajlsi-3081	146	18	the	the	DET
ajlsi-3081	146	19	best	good	ADJ
ajlsi-3081	146	20	treatment	treatment	NOUN
ajlsi-3081	146	21	at	at	ADP
ajlsi-3081	146	22	king	king	PROPN
ajlsi-3081	146	23	faisal	faisal	PROPN
ajlsi-3081	146	24	specialist	specialist	PROPN
ajlsi-3081	146	25	hospital	hospital	PROPN
ajlsi-3081	146	26	&	&	CCONJ
ajlsi-3081	146	27	research	research	PROPN
ajlsi-3081	146	28	center	center	PROPN
ajlsi-3081	146	29	(	(	PUNCT
ajlsi-3081	146	30	kfshrc	kfshrc	PROPN
ajlsi-3081	146	31	)	)	PUNCT
ajlsi-3081	146	32	and	and	CCONJ
ajlsi-3081	146	33	outside	outside	ADP
ajlsi-3081	146	34	riyadh	riyadh	NOUN
ajlsi-3081	146	35	is	be	AUX
ajlsi-3081	146	36	that	that	SCONJ
ajlsi-3081	146	37	patients	patient	NOUN
ajlsi-3081	146	38	across	across	ADP
ajlsi-3081	146	39	the	the	DET
ajlsi-3081	146	40	kingdom	kingdom	NOUN
ajlsi-3081	146	41	were	be	AUX
ajlsi-3081	146	42	able	able	ADJ
ajlsi-3081	146	43	to	to	PART
ajlsi-3081	146	44	receive	receive	VERB
ajlsi-3081	146	45	timely	timely	ADJ
ajlsi-3081	146	46	diagnosis	diagnosis	NOUN
ajlsi-3081	146	47	and	and	CCONJ
ajlsi-3081	146	48	treatment	treatment	NOUN
ajlsi-3081	146	49	.	.	PUNCT
ajlsi-3081	147	1	the	the	DET
ajlsi-3081	147	2	lack	lack	NOUN
ajlsi-3081	147	3	of	of	ADP
ajlsi-3081	147	4	correlation	correlation	NOUN
ajlsi-3081	147	5	between	between	ADP
ajlsi-3081	147	6	the	the	DET
ajlsi-3081	147	7	risk	risk	NOUN
ajlsi-3081	147	8	factors	factor	NOUN
ajlsi-3081	147	9	under	under	ADP
ajlsi-3081	147	10	study	study	NOUN
ajlsi-3081	147	11	and	and	CCONJ
ajlsi-3081	147	12	survival	survival	NOUN
ajlsi-3081	147	13	highlights	highlight	NOUN
ajlsi-3081	147	14	the	the	DET
ajlsi-3081	147	15	need	need	NOUN
ajlsi-3081	147	16	for	for	ADP
ajlsi-3081	147	17	more	more	ADJ
ajlsi-3081	147	18	research	research	NOUN
ajlsi-3081	147	19	into	into	ADP
ajlsi-3081	147	20	more	more	ADV
ajlsi-3081	147	21	comprehensive	comprehensive	ADJ
ajlsi-3081	147	22	risk	risk	NOUN
ajlsi-3081	147	23	profiles	profile	NOUN
ajlsi-3081	147	24	that	that	PRON
ajlsi-3081	147	25	affect	affect	VERB
ajlsi-3081	147	26	the	the	DET
ajlsi-3081	147	27	progression	progression	NOUN
ajlsi-3081	147	28	of	of	ADP
ajlsi-3081	147	29	tumors	tumor	NOUN
ajlsi-3081	147	30	.	.	PUNCT
ajlsi-3081	148	1	another	another	DET
ajlsi-3081	148	2	explanation	explanation	NOUN
ajlsi-3081	148	3	is	be	AUX
ajlsi-3081	148	4	that	that	SCONJ
ajlsi-3081	148	5	risk	risk	NOUN
ajlsi-3081	148	6	factors	factor	NOUN
ajlsi-3081	148	7	mentioned	mention	VERB
ajlsi-3081	148	8	in	in	ADP
ajlsi-3081	148	9	the	the	DET
ajlsi-3081	148	10	study	study	NOUN
ajlsi-3081	148	11	are	be	AUX
ajlsi-3081	148	12	not	not	PART
ajlsi-3081	148	13	associated	associate	VERB
ajlsi-3081	148	14	with	with	ADP
ajlsi-3081	148	15	a	a	DET
ajlsi-3081	148	16	worse	bad	ADJ
ajlsi-3081	148	17	prognosis	prognosis	NOUN
ajlsi-3081	148	18	.	.	PUNCT
ajlsi-3081	149	1	therefore	therefore	ADV
ajlsi-3081	149	2	,	,	PUNCT
ajlsi-3081	149	3	neither	neither	CCONJ
ajlsi-3081	149	4	the	the	DET
ajlsi-3081	149	5	treatment	treatment	NOUN
ajlsi-3081	149	6	regimen	regiman	NOUN
ajlsi-3081	149	7	nor	nor	CCONJ
ajlsi-3081	149	8	the	the	DET
ajlsi-3081	149	9	follow	follow	NOUN
ajlsi-3081	149	10	-	-	PUNCT
ajlsi-3081	149	11	up	up	NOUN
ajlsi-3081	149	12	should	should	AUX
ajlsi-3081	149	13	be	be	AUX
ajlsi-3081	149	14	changed	change	VERB
ajlsi-3081	149	15	for	for	ADP
ajlsi-3081	149	16	patients	patient	NOUN
ajlsi-3081	149	17	with	with	ADP
ajlsi-3081	149	18	testicular	testicular	ADJ
ajlsi-3081	149	19	cancer	cancer	NOUN
ajlsi-3081	149	20	and	and	CCONJ
ajlsi-3081	149	21	for	for	ADP
ajlsi-3081	149	22	patients	patient	NOUN
ajlsi-3081	149	23	who	who	PRON
ajlsi-3081	149	24	have	have	VERB
ajlsi-3081	149	25	risk	risk	NOUN
ajlsi-3081	149	26	factors	factor	NOUN
ajlsi-3081	149	27	.	.	PUNCT
ajlsi-3081	150	1	furthermore	furthermore	ADV
ajlsi-3081	150	2	,	,	PUNCT
ajlsi-3081	150	3	our	our	PRON
ajlsi-3081	150	4	findings	finding	NOUN
ajlsi-3081	150	5	converge	converge	VERB
ajlsi-3081	150	6	with	with	ADP
ajlsi-3081	150	7	previous	previous	ADJ
ajlsi-3081	150	8	studies	study	NOUN
ajlsi-3081	150	9	showing	show	VERB
ajlsi-3081	150	10	that	that	SCONJ
ajlsi-3081	150	11	seminoma	seminoma	NOUN
ajlsi-3081	150	12	had	have	VERB
ajlsi-3081	150	13	better	well	ADJ
ajlsi-3081	150	14	survival	survival	NOUN
ajlsi-3081	150	15	overall	overall	ADV
ajlsi-3081	150	16	than	than	ADP
ajlsi-3081	150	17	nsgct	nsgct	PROPN
ajlsi-3081	150	18	.	.	PUNCT
ajlsi-3081	151	1	at	at	ADP
ajlsi-3081	151	2	the	the	DET
ajlsi-3081	151	3	end	end	NOUN
ajlsi-3081	151	4	of	of	ADP
ajlsi-3081	151	5	the	the	DET
ajlsi-3081	151	6	study	study	NOUN
ajlsi-3081	151	7	,	,	PUNCT
ajlsi-3081	151	8	out	out	ADP
ajlsi-3081	151	9	of	of	ADP
ajlsi-3081	151	10	125	125	NUM
ajlsi-3081	151	11	patients	patient	NOUN
ajlsi-3081	151	12	,	,	PUNCT
ajlsi-3081	151	13	115(92	115(92	NUM
ajlsi-3081	151	14	%	%	NOUN
ajlsi-3081	151	15	)	)	PUNCT
ajlsi-3081	151	16	were	be	AUX
ajlsi-3081	151	17	in	in	ADP
ajlsi-3081	151	18	remission	remission	NOUN
ajlsi-3081	151	19	,	,	PUNCT
ajlsi-3081	151	20	4	4	NUM
ajlsi-3081	151	21	passed	pass	VERB
ajlsi-3081	151	22	away	away	ADV
ajlsi-3081	151	23	and	and	CCONJ
ajlsi-3081	151	24	6	6	NUM
ajlsi-3081	151	25	had	have	VERB
ajlsi-3081	151	26	recurrence	recurrence	NOUN
ajlsi-3081	151	27	.	.	PUNCT
ajlsi-3081	152	1	these	these	DET
ajlsi-3081	152	2	findings	finding	NOUN
ajlsi-3081	152	3	show	show	VERB
ajlsi-3081	152	4	that	that	SCONJ
ajlsi-3081	152	5	testicular	testicular	ADJ
ajlsi-3081	152	6	cancer	cancer	NOUN
ajlsi-3081	152	7	has	have	VERB
ajlsi-3081	152	8	a	a	DET
ajlsi-3081	152	9	good	good	ADJ
ajlsi-3081	152	10	prognosis	prognosis	NOUN
ajlsi-3081	152	11	if	if	SCONJ
ajlsi-3081	152	12	treated	treat	VERB
ajlsi-3081	152	13	properly	properly	ADV
ajlsi-3081	152	14	(	(	PUNCT
ajlsi-3081	152	15	cassell	cassell	PROPN
ajlsi-3081	152	16	et	et	PROPN
ajlsi-3081	152	17	al	al	PROPN
ajlsi-3081	152	18	.	.	PROPN
ajlsi-3081	152	19	,	,	PUNCT
ajlsi-3081	152	20	2020	2020	NUM
ajlsi-3081	152	21	)	)	PUNCT
ajlsi-3081	152	22	.	.	PUNCT
ajlsi-3081	153	1	our	our	PRON
ajlsi-3081	153	2	finding	find	VERB
ajlsi-3081	153	3	that	that	SCONJ
ajlsi-3081	153	4	pure	pure	ADJ
ajlsi-3081	153	5	seminomas	seminoma	NOUN
ajlsi-3081	153	6	have	have	VERB
ajlsi-3081	153	7	a	a	DET
ajlsi-3081	153	8	higher	high	ADJ
ajlsi-3081	153	9	survival	survival	NOUN
ajlsi-3081	153	10	rate	rate	NOUN
ajlsi-3081	153	11	than	than	ADP
ajlsi-3081	153	12	nsgcts	nsgct	NOUN
ajlsi-3081	153	13	corresponds	correspond	NOUN
ajlsi-3081	153	14	with	with	ADP
ajlsi-3081	153	15	previous	previous	ADJ
ajlsi-3081	153	16	studies	study	NOUN
ajlsi-3081	153	17	and	and	CCONJ
ajlsi-3081	153	18	highlights	highlight	NOUN
ajlsi-3081	153	19	the	the	DET
ajlsi-3081	153	20	intrinsic	intrinsic	ADJ
ajlsi-3081	153	21	aggressiveness	aggressiveness	NOUN
ajlsi-3081	153	22	of	of	ADP
ajlsi-3081	153	23	nonseminoma	nonseminoma	ADJ
ajlsi-3081	153	24	variations	variation	NOUN
ajlsi-3081	153	25	.	.	PUNCT
ajlsi-3081	154	1	this	this	DET
ajlsi-3081	154	2	knowledge	knowledge	NOUN
ajlsi-3081	154	3	can	can	AUX
ajlsi-3081	154	4	inform	inform	VERB
ajlsi-3081	154	5	strategies	strategy	NOUN
ajlsi-3081	154	6	for	for	ADP
ajlsi-3081	154	7	targeted	target	VERB
ajlsi-3081	154	8	treatment	treatment	NOUN
ajlsi-3081	154	9	and	and	CCONJ
ajlsi-3081	154	10	risk	risk	NOUN
ajlsi-3081	154	11	stratification	stratification	NOUN
ajlsi-3081	154	12	.	.	PUNCT
ajlsi-3081	155	1	in	in	ADP
ajlsi-3081	155	2	our	our	PRON
ajlsi-3081	155	3	tumors	tumor	NOUN
ajlsi-3081	155	4	staging	stage	VERB
ajlsi-3081	155	5	sub	sub	NOUN
ajlsi-3081	155	6	-	-	NOUN
ajlsi-3081	155	7	group	group	NOUN
ajlsi-3081	155	8	,	,	PUNCT
ajlsi-3081	155	9	it	it	PRON
ajlsi-3081	155	10	was	be	AUX
ajlsi-3081	155	11	seen	see	VERB
ajlsi-3081	155	12	that	that	SCONJ
ajlsi-3081	155	13	group	group	NOUN
ajlsi-3081	155	14	2c	2c	NOUN
ajlsi-3081	155	15	had	have	VERB
ajlsi-3081	155	16	4	4	NUM
ajlsi-3081	155	17	patients	patient	NOUN
ajlsi-3081	155	18	only	only	ADV
ajlsi-3081	155	19	,	,	PUNCT
ajlsi-3081	155	20	making	make	VERB
ajlsi-3081	155	21	the	the	DET
ajlsi-3081	155	22	results	result	NOUN
ajlsi-3081	155	23	significant	significant	ADJ
ajlsi-3081	155	24	.	.	PUNCT
ajlsi-3081	156	1	although	although	SCONJ
ajlsi-3081	156	2	our	our	PRON
ajlsi-3081	156	3	study	study	NOUN
ajlsi-3081	156	4	was	be	AUX
ajlsi-3081	156	5	conducted	conduct	VERB
ajlsi-3081	156	6	at	at	ADP
ajlsi-3081	156	7	kfshrc	kfshrc	NOUN
ajlsi-3081	156	8	,	,	PUNCT
ajlsi-3081	156	9	we	we	PRON
ajlsi-3081	156	10	did	do	AUX
ajlsi-3081	156	11	not	not	PART
ajlsi-3081	156	12	limit	limit	VERB
ajlsi-3081	156	13	ourselves	ourselves	PRON
ajlsi-3081	156	14	to	to	ADP
ajlsi-3081	156	15	the	the	DET
ajlsi-3081	156	16	samples	sample	NOUN
ajlsi-3081	156	17	of	of	ADP
ajlsi-3081	156	18	patients	patient	NOUN
ajlsi-3081	156	19	treated	treat	VERB
ajlsi-3081	156	20	at	at	ADP
ajlsi-3081	156	21	kfshrc	kfshrc	NOUN
ajlsi-3081	156	22	only	only	ADV
ajlsi-3081	156	23	;	;	PUNCT
ajlsi-3081	156	24	we	we	PRON
ajlsi-3081	156	25	included	include	VERB
ajlsi-3081	156	26	patients	patient	NOUN
ajlsi-3081	156	27	from	from	ADP
ajlsi-3081	156	28	other	other	ADJ
ajlsi-3081	156	29	tertiary	tertiary	ADJ
ajlsi-3081	156	30	hospitals	hospital	NOUN
ajlsi-3081	156	31	across	across	ADP
ajlsi-3081	156	32	the	the	DET
ajlsi-3081	156	33	kingdom	kingdom	NOUN
ajlsi-3081	156	34	.	.	PUNCT
ajlsi-3081	157	1	the	the	DET
ajlsi-3081	157	2	number	number	NOUN
ajlsi-3081	157	3	of	of	ADP
ajlsi-3081	157	4	testicular	testicular	ADJ
ajlsi-3081	157	5	cancer	cancer	NOUN
ajlsi-3081	157	6	patients	patient	NOUN
ajlsi-3081	157	7	in	in	ADP
ajlsi-3081	157	8	the	the	DET
ajlsi-3081	157	9	kingdom	kingdom	NOUN
ajlsi-3081	157	10	has	have	AUX
ajlsi-3081	157	11	been	be	AUX
ajlsi-3081	157	12	rising	rise	VERB
ajlsi-3081	157	13	recently	recently	ADV
ajlsi-3081	157	14	;	;	PUNCT
ajlsi-3081	157	15	during	during	ADP
ajlsi-3081	157	16	our	our	PRON
ajlsi-3081	157	17	study	study	NOUN
ajlsi-3081	157	18	,	,	PUNCT
ajlsi-3081	157	19	we	we	PRON
ajlsi-3081	157	20	analyzed	analyze	VERB
ajlsi-3081	157	21	125	125	NUM
ajlsi-3081	157	22	cases	case	NOUN
ajlsi-3081	157	23	from	from	ADP
ajlsi-3081	157	24	2010	2010	NUM
ajlsi-3081	157	25	to	to	ADP
ajlsi-3081	157	26	2017	2017	NUM
ajlsi-3081	157	27	.	.	PUNCT
ajlsi-3081	158	1	even	even	ADV
ajlsi-3081	158	2	though	though	SCONJ
ajlsi-3081	158	3	our	our	PRON
ajlsi-3081	158	4	sample	sample	NOUN
ajlsi-3081	158	5	size	size	NOUN
ajlsi-3081	158	6	is	be	AUX
ajlsi-3081	158	7	small	small	ADJ
ajlsi-3081	158	8	compared	compare	VERB
ajlsi-3081	158	9	to	to	ADP
ajlsi-3081	158	10	the	the	DET
ajlsi-3081	158	11	entire	entire	ADJ
ajlsi-3081	158	12	population	population	NOUN
ajlsi-3081	158	13	,	,	PUNCT
ajlsi-3081	158	14	it	it	PRON
ajlsi-3081	158	15	can	can	AUX
ajlsi-3081	158	16	still	still	ADV
ajlsi-3081	158	17	serve	serve	VERB
ajlsi-3081	158	18	as	as	ADP
ajlsi-3081	158	19	a	a	DET
ajlsi-3081	158	20	starting	starting	NOUN
ajlsi-3081	158	21	point	point	NOUN
ajlsi-3081	158	22	for	for	ADP
ajlsi-3081	158	23	more	more	ADV
ajlsi-3081	158	24	extensive	extensive	ADJ
ajlsi-3081	158	25	research	research	NOUN
ajlsi-3081	158	26	that	that	PRON
ajlsi-3081	158	27	can	can	AUX
ajlsi-3081	158	28	be	be	AUX
ajlsi-3081	158	29	carried	carry	VERB
ajlsi-3081	158	30	out	out	ADP
ajlsi-3081	158	31	soon	soon	ADV
ajlsi-3081	158	32	.	.	PUNCT
ajlsi-3081	159	1	as	as	ADP
ajlsi-3081	159	2	per	per	ADP
ajlsi-3081	159	3	our	our	PRON
ajlsi-3081	159	4	best	good	ADJ
ajlsi-3081	159	5	knowledge	knowledge	NOUN
ajlsi-3081	159	6	and	and	CCONJ
ajlsi-3081	159	7	extensive	extensive	ADJ
ajlsi-3081	159	8	research	research	NOUN
ajlsi-3081	159	9	,	,	PUNCT
ajlsi-3081	159	10	we	we	PRON
ajlsi-3081	159	11	can	can	AUX
ajlsi-3081	159	12	surely	surely	ADV
ajlsi-3081	159	13	state	state	VERB
ajlsi-3081	159	14	that	that	SCONJ
ajlsi-3081	159	15	there	there	PRON
ajlsi-3081	159	16	is	be	VERB
ajlsi-3081	159	17	not	not	PART
ajlsi-3081	159	18	enough	enough	ADJ
ajlsi-3081	159	19	research	research	NOUN
ajlsi-3081	159	20	conducted	conduct	VERB
ajlsi-3081	159	21	in	in	ADP
ajlsi-3081	159	22	saudi	saudi	PROPN
ajlsi-3081	159	23	arabia	arabia	PROPN
ajlsi-3081	159	24	on	on	ADP
ajlsi-3081	159	25	testicular	testicular	ADJ
ajlsi-3081	159	26	cancer	cancer	NOUN
ajlsi-3081	159	27	.	.	PUNCT
ajlsi-3081	160	1	we	we	PRON
ajlsi-3081	160	2	selected	select	VERB
ajlsi-3081	160	3	king	king	NOUN
ajlsi-3081	160	4	faisal	faisal	PROPN
ajlsi-3081	160	5	specialist	specialist	PROPN
ajlsi-3081	160	6	hospital	hospital	PROPN
ajlsi-3081	160	7	&	&	CCONJ
ajlsi-3081	160	8	research	research	PROPN
ajlsi-3081	160	9	center	center	PROPN
ajlsi-3081	160	10	(	(	PUNCT
ajlsi-3081	160	11	kfshrc	kfshrc	PROPN
ajlsi-3081	160	12	)	)	PUNCT
ajlsi-3081	160	13	as	as	ADP
ajlsi-3081	160	14	our	our	PRON
ajlsi-3081	160	15	referral	referral	ADJ
ajlsi-3081	160	16	hospital	hospital	NOUN
ajlsi-3081	160	17	because	because	SCONJ
ajlsi-3081	160	18	it	it	PRON
ajlsi-3081	160	19	is	be	AUX
ajlsi-3081	160	20	the	the	DET
ajlsi-3081	160	21	primary	primary	ADJ
ajlsi-3081	160	22	national	national	ADJ
ajlsi-3081	160	23	referral	referral	NOUN
ajlsi-3081	160	24	cancer	cancer	NOUN
ajlsi-3081	160	25	center	center	NOUN
ajlsi-3081	160	26	,	,	PUNCT
ajlsi-3081	160	27	receiving	receive	VERB
ajlsi-3081	160	28	about	about	ADV
ajlsi-3081	160	29	22	22	NUM
ajlsi-3081	160	30	%	%	NOUN
ajlsi-3081	160	31	of	of	ADP
ajlsi-3081	160	32	all	all	DET
ajlsi-3081	160	33	cancer	cancer	NOUN
ajlsi-3081	160	34	cases	case	NOUN
ajlsi-3081	160	35	nationwide	nationwide	ADV
ajlsi-3081	160	36	.	.	PUNCT
ajlsi-3081	161	1	our	our	PRON
ajlsi-3081	161	2	results	result	NOUN
ajlsi-3081	161	3	provide	provide	VERB
ajlsi-3081	161	4	new	new	ADJ
ajlsi-3081	161	5	insight	insight	NOUN
ajlsi-3081	161	6	into	into	ADP
ajlsi-3081	161	7	the	the	DET
ajlsi-3081	161	8	kfshrc	kfshrc	NOUN
ajlsi-3081	161	9	’s	’s	PART
ajlsi-3081	161	10	strategy	strategy	NOUN
ajlsi-3081	161	11	regarding	regard	VERB
ajlsi-3081	161	12	the	the	DET
ajlsi-3081	161	13	pattern	pattern	NOUN
ajlsi-3081	161	14	of	of	ADP
ajlsi-3081	161	15	tumor	tumor	NOUN
ajlsi-3081	161	16	progression	progression	NOUN
ajlsi-3081	161	17	and	and	CCONJ
ajlsi-3081	161	18	treatment	treatment	NOUN
ajlsi-3081	161	19	outcomes	outcome	NOUN
ajlsi-3081	161	20	for	for	ADP
ajlsi-3081	161	21	patients	patient	NOUN
ajlsi-3081	161	22	with	with	ADP
ajlsi-3081	161	23	testicular	testicular	ADJ
ajlsi-3081	161	24	cancer	cancer	NOUN
ajlsi-3081	161	25	.	.	PUNCT
ajlsi-3081	162	1	furthermore	furthermore	ADV
ajlsi-3081	162	2	,	,	PUNCT
ajlsi-3081	162	3	this	this	PRON
ajlsi-3081	162	4	will	will	AUX
ajlsi-3081	162	5	contribute	contribute	VERB
ajlsi-3081	162	6	to	to	ADP
ajlsi-3081	162	7	the	the	DET
ajlsi-3081	162	8	body	body	NOUN
ajlsi-3081	162	9	of	of	ADP
ajlsi-3081	162	10	knowledge	knowledge	NOUN
ajlsi-3081	162	11	regarding	regard	VERB
ajlsi-3081	162	12	the	the	DET
ajlsi-3081	162	13	management	management	NOUN
ajlsi-3081	162	14	and	and	CCONJ
ajlsi-3081	162	15	surveillance	surveillance	NOUN
ajlsi-3081	162	16	of	of	ADP
ajlsi-3081	162	17	testicular	testicular	ADJ
ajlsi-3081	162	18	cancer	cancer	NOUN
ajlsi-3081	162	19	,	,	PUNCT
ajlsi-3081	162	20	namely	namely	ADV
ajlsi-3081	162	21	gcts	gct	VERB
ajlsi-3081	162	22	,	,	PUNCT
ajlsi-3081	162	23	in	in	ADP
ajlsi-3081	162	24	saudi	saudi	PROPN
ajlsi-3081	162	25	arabia	arabia	PROPN
ajlsi-3081	162	26	.	.	PUNCT
ajlsi-3081	163	1	future	future	ADJ
ajlsi-3081	163	2	directions	direction	NOUN
ajlsi-3081	163	3	despite	despite	SCONJ
ajlsi-3081	163	4	the	the	DET
ajlsi-3081	163	5	sample	sample	NOUN
ajlsi-3081	163	6	size	size	NOUN
ajlsi-3081	163	7	constraints	constraint	NOUN
ajlsi-3081	163	8	,	,	PUNCT
ajlsi-3081	163	9	the	the	DET
ajlsi-3081	163	10	study	study	NOUN
ajlsi-3081	163	11	establishes	establish	VERB
ajlsi-3081	163	12	the	the	DET
ajlsi-3081	163	13	foundation	foundation	NOUN
ajlsi-3081	163	14	for	for	ADP
ajlsi-3081	163	15	additional	additional	ADJ
ajlsi-3081	163	16	research	research	NOUN
ajlsi-3081	163	17	on	on	ADP
ajlsi-3081	163	18	testicular	testicular	ADJ
ajlsi-3081	163	19	cancer	cancer	NOUN
ajlsi-3081	163	20	in	in	ADP
ajlsi-3081	163	21	saudi	saudi	PROPN
ajlsi-3081	163	22	arabia	arabia	PROPN
ajlsi-3081	163	23	.	.	PUNCT
ajlsi-3081	164	1	we	we	PRON
ajlsi-3081	164	2	must	must	AUX
ajlsi-3081	164	3	evaluate	evaluate	VERB
ajlsi-3081	164	4	risk	risk	NOUN
ajlsi-3081	164	5	profiles	profile	NOUN
ajlsi-3081	164	6	more	more	ADV
ajlsi-3081	164	7	extensively	extensively	ADV
ajlsi-3081	164	8	,	,	PUNCT
ajlsi-3081	164	9	as	as	SCONJ
ajlsi-3081	164	10	the	the	DET
ajlsi-3081	164	11	study	study	NOUN
ajlsi-3081	164	12	indicates	indicate	VERB
ajlsi-3081	164	13	that	that	SCONJ
ajlsi-3081	164	14	some	some	DET
ajlsi-3081	164	15	risk	risk	NOUN
ajlsi-3081	164	16	factors	factor	NOUN
ajlsi-3081	164	17	and	and	CCONJ
ajlsi-3081	164	18	survival	survival	NOUN
ajlsi-3081	164	19	are	be	AUX
ajlsi-3081	164	20	unrelated	unrelated	ADJ
ajlsi-3081	164	21	.	.	PUNCT
ajlsi-3081	165	1	understanding	understand	VERB
ajlsi-3081	165	2	the	the	DET
ajlsi-3081	165	3	intrinsic	intrinsic	ADJ
ajlsi-3081	165	4	aggressiveness	aggressiveness	NOUN
ajlsi-3081	165	5	of	of	ADP
ajlsi-3081	165	6	nonseminoma	nonseminoma	ADJ
ajlsi-3081	165	7	variants	variant	NOUN
ajlsi-3081	165	8	should	should	AUX
ajlsi-3081	165	9	be	be	AUX
ajlsi-3081	165	10	useful	useful	ADJ
ajlsi-3081	165	11	in	in	ADP
ajlsi-3081	165	12	developing	develop	VERB
ajlsi-3081	165	13	strategies	strategy	NOUN
ajlsi-3081	165	14	for	for	ADP
ajlsi-3081	165	15	focused	focused	ADJ
ajlsi-3081	165	16	treatment	treatment	NOUN
ajlsi-3081	165	17	and	and	CCONJ
ajlsi-3081	165	18	risk	risk	NOUN
ajlsi-3081	165	19	classification	classification	NOUN
ajlsi-3081	165	20	.	.	PUNCT
ajlsi-3081	166	1	research	research	NOUN
ajlsi-3081	166	2	on	on	ADP
ajlsi-3081	166	3	tumor	tumor	NOUN
ajlsi-3081	166	4	progression	progression	NOUN
ajlsi-3081	166	5	and	and	CCONJ
ajlsi-3081	166	6	pa	pa	PROPN
ajlsi-3081	166	7	ge	ge	PROPN
ajlsi-3081	166	8	62	62	NUM
ajlsi-3081	166	9	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-3081	166	10	am	am	NOUN
ajlsi-3081	166	11	.	.	PUNCT
ajlsi-3081	167	1	j.	j.	PROPN
ajlsi-3081	167	2	life	life	PROPN
ajlsi-3081	167	3	sci	sci	PROPN
ajlsi-3081	167	4	.	.	PUNCT
ajlsi-3081	167	5	innov	innov	PROPN
ajlsi-3081	167	6	.	.	PUNCT
ajlsi-3081	168	1	3(2	3(2	NUM
ajlsi-3081	168	2	)	)	PUNCT
ajlsi-3081	168	3	57	57	NUM
ajlsi-3081	168	4	-	-	SYM
ajlsi-3081	168	5	63	63	NUM
ajlsi-3081	168	6	,	,	PUNCT
ajlsi-3081	168	7	2024	2024	NUM
ajlsi-3081	168	8	treatment	treatment	NOUN
ajlsi-3081	168	9	outcomes	outcome	NOUN
ajlsi-3081	168	10	is	be	AUX
ajlsi-3081	168	11	essential	essential	ADJ
ajlsi-3081	168	12	as	as	SCONJ
ajlsi-3081	168	13	the	the	DET
ajlsi-3081	168	14	number	number	NOUN
ajlsi-3081	168	15	of	of	ADP
ajlsi-3081	168	16	instances	instance	NOUN
ajlsi-3081	168	17	of	of	ADP
ajlsi-3081	168	18	testicular	testicular	ADJ
ajlsi-3081	168	19	cancer	cancer	NOUN
ajlsi-3081	168	20	in	in	ADP
ajlsi-3081	168	21	the	the	DET
ajlsi-3081	168	22	kingdom	kingdom	NOUN
ajlsi-3081	168	23	rises	rise	VERB
ajlsi-3081	168	24	.	.	PUNCT
ajlsi-3081	169	1	the	the	DET
ajlsi-3081	169	2	correlations	correlation	NOUN
ajlsi-3081	169	3	between	between	ADP
ajlsi-3081	169	4	various	various	ADJ
ajlsi-3081	169	5	parameters	parameter	NOUN
ajlsi-3081	169	6	reviewed	review	VERB
ajlsi-3081	169	7	in	in	ADP
ajlsi-3081	169	8	this	this	DET
ajlsi-3081	169	9	retrospective	retrospective	ADJ
ajlsi-3081	169	10	provide	provide	NOUN
ajlsi-3081	169	11	light	light	NOUN
ajlsi-3081	169	12	on	on	ADP
ajlsi-3081	169	13	trends	trend	NOUN
ajlsi-3081	169	14	and	and	CCONJ
ajlsi-3081	169	15	results	result	NOUN
ajlsi-3081	169	16	at	at	ADP
ajlsi-3081	169	17	a	a	DET
ajlsi-3081	169	18	national	national	ADJ
ajlsi-3081	169	19	referral	referral	ADJ
ajlsi-3081	169	20	center	center	NOUN
ajlsi-3081	169	21	,	,	PUNCT
ajlsi-3081	169	22	which	which	PRON
ajlsi-3081	169	23	helps	help	VERB
ajlsi-3081	169	24	with	with	ADP
ajlsi-3081	169	25	the	the	DET
ajlsi-3081	169	26	care	care	NOUN
ajlsi-3081	169	27	and	and	CCONJ
ajlsi-3081	169	28	surveillance	surveillance	NOUN
ajlsi-3081	169	29	of	of	ADP
ajlsi-3081	169	30	testicular	testicular	ADJ
ajlsi-3081	169	31	cancer	cancer	NOUN
ajlsi-3081	169	32	in	in	ADP
ajlsi-3081	169	33	saudi	saudi	PROPN
ajlsi-3081	169	34	arabia	arabia	PROPN
ajlsi-3081	169	35	,	,	PUNCT
ajlsi-3081	169	36	particularly	particularly	ADV
ajlsi-3081	169	37	germ	germ	NOUN
ajlsi-3081	169	38	cell	cell	NOUN
ajlsi-3081	169	39	tumors	tumor	NOUN
ajlsi-3081	169	40	.	.	PUNCT
ajlsi-3081	170	1	additional	additional	ADJ
ajlsi-3081	170	2	comprehensive	comprehensive	ADJ
ajlsi-3081	170	3	study	study	NOUN
ajlsi-3081	170	4	is	be	AUX
ajlsi-3081	170	5	necessary	necessary	ADJ
ajlsi-3081	170	6	to	to	PART
ajlsi-3081	170	7	enhance	enhance	VERB
ajlsi-3081	170	8	comprehension	comprehension	NOUN
ajlsi-3081	170	9	and	and	CCONJ
ajlsi-3081	170	10	direct	direct	ADJ
ajlsi-3081	170	11	advancements	advancement	NOUN
ajlsi-3081	170	12	in	in	ADP
ajlsi-3081	170	13	diagnosis	diagnosis	NOUN
ajlsi-3081	170	14	,	,	PUNCT
ajlsi-3081	170	15	therapy	therapy	NOUN
ajlsi-3081	170	16	,	,	PUNCT
ajlsi-3081	170	17	and	and	CCONJ
ajlsi-3081	170	18	patient	patient	ADJ
ajlsi-3081	170	19	management	management	NOUN
ajlsi-3081	170	20	.	.	PUNCT
ajlsi-3081	171	1	conclusion	conclusion	NOUN
ajlsi-3081	171	2	this	this	PRON
ajlsi-3081	171	3	retrospective	retrospective	ADJ
ajlsi-3081	171	4	research	research	NOUN
ajlsi-3081	171	5	challenges	challenge	VERB
ajlsi-3081	171	6	geographical	geographical	ADJ
ajlsi-3081	171	7	assumptions	assumption	NOUN
ajlsi-3081	171	8	regarding	regard	VERB
ajlsi-3081	171	9	testicular	testicular	ADJ
ajlsi-3081	171	10	cancer	cancer	NOUN
ajlsi-3081	171	11	in	in	ADP
ajlsi-3081	171	12	riyadh	riyadh	PROPN
ajlsi-3081	171	13	and	and	CCONJ
ajlsi-3081	171	14	surrounding	surround	VERB
ajlsi-3081	171	15	areas	area	NOUN
ajlsi-3081	171	16	.	.	PUNCT
ajlsi-3081	172	1	no	no	DET
ajlsi-3081	172	2	significant	significant	ADJ
ajlsi-3081	172	3	differences	difference	NOUN
ajlsi-3081	172	4	in	in	ADP
ajlsi-3081	172	5	stage	stage	NOUN
ajlsi-3081	172	6	were	be	AUX
ajlsi-3081	172	7	found	find	VERB
ajlsi-3081	172	8	between	between	ADP
ajlsi-3081	172	9	riyadh	riyadh	PROPN
ajlsi-3081	172	10	and	and	CCONJ
ajlsi-3081	172	11	residents	resident	NOUN
ajlsi-3081	172	12	living	live	VERB
ajlsi-3081	172	13	outside	outside	ADP
ajlsi-3081	172	14	riyadh	riyadh	NOUN
ajlsi-3081	172	15	.	.	PUNCT
ajlsi-3081	173	1	it	it	PRON
ajlsi-3081	173	2	also	also	ADV
ajlsi-3081	173	3	revealed	reveal	VERB
ajlsi-3081	173	4	that	that	SCONJ
ajlsi-3081	173	5	factors	factor	NOUN
ajlsi-3081	173	6	such	such	ADJ
ajlsi-3081	173	7	as	as	ADP
ajlsi-3081	173	8	genetics	genetic	NOUN
ajlsi-3081	173	9	,	,	PUNCT
ajlsi-3081	173	10	smoking	smoking	NOUN
ajlsi-3081	173	11	,	,	PUNCT
ajlsi-3081	173	12	and	and	CCONJ
ajlsi-3081	173	13	family	family	NOUN
ajlsi-3081	173	14	history	history	NOUN
ajlsi-3081	173	15	did	do	AUX
ajlsi-3081	173	16	not	not	PART
ajlsi-3081	173	17	affect	affect	VERB
ajlsi-3081	173	18	survival	survival	NOUN
ajlsi-3081	173	19	in	in	ADP
ajlsi-3081	173	20	seminoma	seminoma	NOUN
ajlsi-3081	173	21	or	or	CCONJ
ajlsi-3081	173	22	nonseminoma	nonseminoma	ADJ
ajlsi-3081	173	23	germ	germ	NOUN
ajlsi-3081	173	24	cell	cell	NOUN
ajlsi-3081	173	25	tumors	tumor	NOUN
ajlsi-3081	173	26	.	.	PUNCT
ajlsi-3081	174	1	seminoma	seminoma	NOUN
ajlsi-3081	174	2	showed	show	VERB
ajlsi-3081	174	3	a	a	DET
ajlsi-3081	174	4	higher	high	ADJ
ajlsi-3081	174	5	overall	overall	ADJ
ajlsi-3081	174	6	survival	survival	NOUN
ajlsi-3081	174	7	,	,	PUNCT
ajlsi-3081	174	8	indicating	indicate	VERB
ajlsi-3081	174	9	differences	difference	NOUN
ajlsi-3081	174	10	in	in	ADP
ajlsi-3081	174	11	treatment	treatment	NOUN
ajlsi-3081	174	12	response	response	NOUN
ajlsi-3081	174	13	.	.	PUNCT
ajlsi-3081	175	1	it	it	PRON
ajlsi-3081	175	2	is	be	AUX
ajlsi-3081	175	3	important	important	ADJ
ajlsi-3081	175	4	to	to	PART
ajlsi-3081	175	5	detect	detect	VERB
ajlsi-3081	175	6	testicular	testicular	ADJ
ajlsi-3081	175	7	cancer	cancer	NOUN
ajlsi-3081	175	8	early	early	ADV
ajlsi-3081	175	9	,	,	PUNCT
ajlsi-3081	175	10	as	as	SCONJ
ajlsi-3081	175	11	stage	stage	NOUN
ajlsi-3081	175	12	3	3	NUM
ajlsi-3081	175	13	presentations	presentation	NOUN
ajlsi-3081	175	14	correlated	correlate	VERB
ajlsi-3081	175	15	with	with	ADP
ajlsi-3081	175	16	the	the	DET
ajlsi-3081	175	17	lowest	low	ADJ
ajlsi-3081	175	18	survival	survival	NOUN
ajlsi-3081	175	19	.	.	PUNCT
ajlsi-3081	176	1	although	although	SCONJ
ajlsi-3081	176	2	this	this	DET
ajlsi-3081	176	3	study	study	NOUN
ajlsi-3081	176	4	was	be	AUX
ajlsi-3081	176	5	conducted	conduct	VERB
ajlsi-3081	176	6	in	in	ADP
ajlsi-3081	176	7	riyadh	riyadh	PROPN
ajlsi-3081	176	8	,	,	PUNCT
ajlsi-3081	176	9	future	future	ADJ
ajlsi-3081	176	10	research	research	NOUN
ajlsi-3081	176	11	should	should	AUX
ajlsi-3081	176	12	involve	involve	VERB
ajlsi-3081	176	13	diverse	diverse	ADJ
ajlsi-3081	176	14	tertiary	tertiary	ADJ
ajlsi-3081	176	15	care	care	NOUN
ajlsi-3081	176	16	facilities	facility	NOUN
ajlsi-3081	176	17	nationwide	nationwide	ADV
ajlsi-3081	176	18	.	.	PUNCT
ajlsi-3081	177	1	finally	finally	ADV
ajlsi-3081	177	2	,	,	PUNCT
ajlsi-3081	177	3	this	this	DET
ajlsi-3081	177	4	study	study	NOUN
ajlsi-3081	177	5	challenges	challenge	VERB
ajlsi-3081	177	6	geographical	geographical	ADJ
ajlsi-3081	177	7	assumptions	assumption	NOUN
ajlsi-3081	177	8	and	and	CCONJ
ajlsi-3081	177	9	opens	open	VERB
ajlsi-3081	177	10	avenues	avenue	NOUN
ajlsi-3081	177	11	for	for	ADP
ajlsi-3081	177	12	improving	improve	VERB
ajlsi-3081	177	13	testicular	testicular	ADJ
ajlsi-3081	177	14	cancer	cancer	NOUN
ajlsi-3081	177	15	treatment	treatment	NOUN
ajlsi-3081	177	16	strategies	strategy	NOUN
ajlsi-3081	177	17	.	.	PUNCT
ajlsi-3081	178	1	references	reference	NOUN
ajlsi-3081	178	2	abdul	abdul	PROPN
ajlsi-3081	178	3	-	-	PUNCT
ajlsi-3081	178	4	muhsin	muhsin	PROPN
ajlsi-3081	178	5	,	,	PUNCT
ajlsi-3081	178	6	h.	h.	PROPN
ajlsi-3081	178	7	,	,	PUNCT
ajlsi-3081	178	8	rocco	rocco	NOUN
ajlsi-3081	178	9	,	,	PUNCT
ajlsi-3081	178	10	n.	n.	NOUN
ajlsi-3081	178	11	,	,	PUNCT
ajlsi-3081	178	12	navaratnam	navaratnam	PROPN
ajlsi-3081	178	13	,	,	PUNCT
ajlsi-3081	178	14	a.	a.	NOUN
ajlsi-3081	178	15	,	,	PUNCT
ajlsi-3081	178	16	woods	wood	NOUN
ajlsi-3081	178	17	,	,	PUNCT
ajlsi-3081	178	18	m.	m.	NOUN
ajlsi-3081	178	19	,	,	PUNCT
ajlsi-3081	178	20	l’esperance	l’esperance	PROPN
ajlsi-3081	178	21	,	,	PUNCT
ajlsi-3081	178	22	j.	j.	PROPN
ajlsi-3081	178	23	,	,	PUNCT
ajlsi-3081	178	24	castle	castle	PROPN
ajlsi-3081	178	25	,	,	PUNCT
ajlsi-3081	178	26	e.	e.	PROPN
ajlsi-3081	178	27	,	,	PUNCT
ajlsi-3081	178	28	&	&	CCONJ
ajlsi-3081	178	29	stroup	stroup	PROPN
ajlsi-3081	178	30	,	,	PUNCT
ajlsi-3081	178	31	s.	s.	PROPN
ajlsi-3081	178	32	(	(	PUNCT
ajlsi-3081	178	33	2021	2021	NUM
ajlsi-3081	178	34	)	)	PUNCT
ajlsi-3081	178	35	.	.	PUNCT
ajlsi-3081	179	1	outcomes	outcome	NOUN
ajlsi-3081	179	2	of	of	ADP
ajlsi-3081	179	3	post	post	ADJ
ajlsi-3081	179	4	-	-	ADJ
ajlsi-3081	179	5	chemotherapy	chemotherapy	ADJ
ajlsi-3081	179	6	robot	robot	NOUN
ajlsi-3081	179	7	-	-	PUNCT
ajlsi-3081	179	8	assisted	assist	VERB
ajlsi-3081	179	9	retroperitoneal	retroperitoneal	ADJ
ajlsi-3081	179	10	lymph	lymph	NOUN
ajlsi-3081	179	11	node	node	NOUN
ajlsi-3081	179	12	dissection	dissection	NOUN
ajlsi-3081	179	13	in	in	ADP
ajlsi-3081	179	14	testicular	testicular	ADJ
ajlsi-3081	179	15	cancer	cancer	NOUN
ajlsi-3081	179	16	:	:	PUNCT
ajlsi-3081	179	17	multi	multi	ADJ
ajlsi-3081	179	18	-	-	ADJ
ajlsi-3081	179	19	institutional	institutional	ADJ
ajlsi-3081	179	20	study	study	NOUN
ajlsi-3081	179	21	.	.	PUNCT
ajlsi-3081	180	1	world	world	PROPN
ajlsi-3081	180	2	journal	journal	PROPN
ajlsi-3081	180	3	of	of	ADP
ajlsi-3081	180	4	urology	urology	NOUN
ajlsi-3081	180	5	,	,	PUNCT
ajlsi-3081	180	6	39	39	NUM
ajlsi-3081	180	7	,	,	PUNCT
ajlsi-3081	180	8	3833	3833	NUM
ajlsi-3081	180	9	-	-	SYM
ajlsi-3081	180	10	3838	3838	NUM
ajlsi-3081	180	11	.	.	PUNCT
ajlsi-3081	181	1	abomelha	abomelha	NOUN
ajlsi-3081	181	2	,	,	PUNCT
ajlsi-3081	181	3	m.	m.	NOUN
ajlsi-3081	181	4	(	(	PUNCT
ajlsi-3081	181	5	2017	2017	NUM
ajlsi-3081	181	6	)	)	PUNCT
ajlsi-3081	181	7	.	.	PUNCT
ajlsi-3081	182	1	adult	adult	NOUN
ajlsi-3081	182	2	testicular	testicular	NOUN
ajlsi-3081	182	3	cancer	cancer	NOUN
ajlsi-3081	182	4	:	:	PUNCT
ajlsi-3081	182	5	two	two	NUM
ajlsi-3081	182	6	decades	decade	NOUN
ajlsi-3081	182	7	of	of	ADP
ajlsi-3081	182	8	saudi	saudi	ADJ
ajlsi-3081	182	9	national	national	ADJ
ajlsi-3081	182	10	data	data	PROPN
ajlsi-3081	182	11	.	.	PUNCT
ajlsi-3081	183	1	urology	urology	NOUN
ajlsi-3081	183	2	annals	annal	NOUN
ajlsi-3081	183	3	,	,	PUNCT
ajlsi-3081	183	4	9(4	9(4	NUM
ajlsi-3081	183	5	)	)	PUNCT
ajlsi-3081	183	6	,	,	PUNCT
ajlsi-3081	183	7	305	305	NUM
ajlsi-3081	183	8	-	-	SYM
ajlsi-3081	183	9	309	309	NUM
ajlsi-3081	183	10	.	.	PUNCT
ajlsi-3081	184	1	alghamdi	alghamdi	NOUN
ajlsi-3081	184	2	,	,	PUNCT
ajlsi-3081	184	3	i.	i.	PROPN
ajlsi-3081	184	4	g.	g.	PROPN
ajlsi-3081	184	5	(	(	PUNCT
ajlsi-3081	184	6	2023	2023	NUM
ajlsi-3081	184	7	)	)	PUNCT
ajlsi-3081	184	8	.	.	PUNCT
ajlsi-3081	185	1	testicular	testicular	ADJ
ajlsi-3081	185	2	cancer	cancer	NOUN
ajlsi-3081	185	3	in	in	ADP
ajlsi-3081	185	4	saudi	saudi	PROPN
ajlsi-3081	185	5	arabia	arabia	PROPN
ajlsi-3081	185	6	between	between	ADP
ajlsi-3081	185	7	2004	2004	NUM
ajlsi-3081	185	8	and	and	CCONJ
ajlsi-3081	185	9	2017	2017	NUM
ajlsi-3081	185	10	.	.	PUNCT
ajlsi-3081	186	1	research	research	NOUN
ajlsi-3081	186	2	and	and	CCONJ
ajlsi-3081	186	3	reports	report	NOUN
ajlsi-3081	186	4	in	in	ADP
ajlsi-3081	186	5	urology	urology	NOUN
ajlsi-3081	186	6	,	,	PUNCT
ajlsi-3081	186	7	37	37	NUM
ajlsi-3081	186	8	-	-	SYM
ajlsi-3081	186	9	45	45	NUM
ajlsi-3081	186	10	.	.	PUNCT
ajlsi-3081	187	1	altunkurek	altunkurek	PROPN
ajlsi-3081	187	2	,	,	PUNCT
ajlsi-3081	187	3	s.	s.	PROPN
ajlsi-3081	187	4	z.	z.	PROPN
ajlsi-3081	187	5	(	(	PUNCT
ajlsi-3081	187	6	2020	2020	NUM
ajlsi-3081	187	7	)	)	PUNCT
ajlsi-3081	187	8	.	.	PUNCT
ajlsi-3081	188	1	testicular	testicular	ADJ
ajlsi-3081	188	2	cancer	cancer	NOUN
ajlsi-3081	188	3	and	and	CCONJ
ajlsi-3081	188	4	the	the	DET
ajlsi-3081	188	5	importance	importance	NOUN
ajlsi-3081	188	6	of	of	ADP
ajlsi-3081	188	7	early	early	ADJ
ajlsi-3081	188	8	diagnosis	diagnosis	NOUN
ajlsi-3081	188	9	.	.	PUNCT
ajlsi-3081	189	1	male	male	ADJ
ajlsi-3081	189	2	reproductive	reproductive	ADJ
ajlsi-3081	189	3	health	health	NOUN
ajlsi-3081	189	4	,	,	PUNCT
ajlsi-3081	189	5	115	115	NUM
ajlsi-3081	189	6	.	.	PUNCT
ajlsi-3081	189	7	bahrami	bahrami	PROPN
ajlsi-3081	189	8	,	,	PUNCT
ajlsi-3081	189	9	a.	a.	NOUN
ajlsi-3081	189	10	,	,	PUNCT
ajlsi-3081	189	11	ro	ro	PROPN
ajlsi-3081	189	12	,	,	PUNCT
ajlsi-3081	189	13	j.	j.	PROPN
ajlsi-3081	189	14	y.	y.	PROPN
ajlsi-3081	189	15	,	,	PUNCT
ajlsi-3081	189	16	&	&	CCONJ
ajlsi-3081	189	17	ayala	ayala	PROPN
ajlsi-3081	189	18	,	,	PUNCT
ajlsi-3081	189	19	a.	a.	NOUN
ajlsi-3081	189	20	g.	g.	PROPN
ajlsi-3081	189	21	(	(	PUNCT
ajlsi-3081	189	22	2007	2007	NUM
ajlsi-3081	189	23	)	)	PUNCT
ajlsi-3081	189	24	.	.	PUNCT
ajlsi-3081	190	1	an	an	DET
ajlsi-3081	190	2	overview	overview	NOUN
ajlsi-3081	190	3	of	of	ADP
ajlsi-3081	190	4	testicular	testicular	ADJ
ajlsi-3081	190	5	germ	germ	NOUN
ajlsi-3081	190	6	cell	cell	NOUN
ajlsi-3081	190	7	tumors	tumor	NOUN
ajlsi-3081	190	8	.	.	PUNCT
ajlsi-3081	191	1	archives	archive	NOUN
ajlsi-3081	191	2	of	of	ADP
ajlsi-3081	191	3	pathology	pathology	PROPN
ajlsi-3081	191	4	&	&	CCONJ
ajlsi-3081	191	5	laboratory	laboratory	PROPN
ajlsi-3081	191	6	medicine	medicine	NOUN
ajlsi-3081	191	7	,	,	PUNCT
ajlsi-3081	191	8	131(8	131(8	NUM
ajlsi-3081	191	9	)	)	PUNCT
ajlsi-3081	191	10	,	,	PUNCT
ajlsi-3081	191	11	1267	1267	NUM
ajlsi-3081	191	12	-	-	SYM
ajlsi-3081	191	13	1280	1280	NUM
ajlsi-3081	191	14	.	.	PUNCT
ajlsi-3081	192	1	baird	baird	PROPN
ajlsi-3081	192	2	,	,	PUNCT
ajlsi-3081	192	3	d.	d.	PROPN
ajlsi-3081	192	4	c.	c.	PROPN
ajlsi-3081	192	5	,	,	PUNCT
ajlsi-3081	192	6	meyers	meyers	PROPN
ajlsi-3081	192	7	,	,	PUNCT
ajlsi-3081	192	8	g.	g.	PROPN
ajlsi-3081	192	9	j.	j.	PROPN
ajlsi-3081	192	10	,	,	PUNCT
ajlsi-3081	192	11	&	&	CCONJ
ajlsi-3081	192	12	hu	hu	PROPN
ajlsi-3081	192	13	,	,	PUNCT
ajlsi-3081	192	14	j.	j.	PROPN
ajlsi-3081	192	15	s.	s.	PROPN
ajlsi-3081	192	16	(	(	PUNCT
ajlsi-3081	192	17	2018	2018	NUM
ajlsi-3081	192	18	)	)	PUNCT
ajlsi-3081	192	19	.	.	PUNCT
ajlsi-3081	193	1	testicular	testicular	ADJ
ajlsi-3081	193	2	cancer	cancer	NOUN
ajlsi-3081	193	3	:	:	PUNCT
ajlsi-3081	193	4	diagnosis	diagnosis	NOUN
ajlsi-3081	193	5	and	and	CCONJ
ajlsi-3081	193	6	treatment	treatment	NOUN
ajlsi-3081	193	7	.	.	PUNCT
ajlsi-3081	194	1	american	american	ADJ
ajlsi-3081	194	2	family	family	PROPN
ajlsi-3081	194	3	physician	physician	NOUN
ajlsi-3081	194	4	,	,	PUNCT
ajlsi-3081	194	5	97(4	97(4	NUM
ajlsi-3081	194	6	)	)	PUNCT
ajlsi-3081	194	7	,	,	PUNCT
ajlsi-3081	194	8	261	261	NUM
ajlsi-3081	194	9	-	-	SYM
ajlsi-3081	194	10	268	268	NUM
ajlsi-3081	194	11	.	.	PUNCT
ajlsi-3081	195	1	bleyer	bleyer	PROPN
ajlsi-3081	195	2	,	,	PUNCT
ajlsi-3081	195	3	a.	a.	NOUN
ajlsi-3081	195	4	(	(	PUNCT
ajlsi-3081	195	5	2007	2007	NUM
ajlsi-3081	195	6	)	)	PUNCT
ajlsi-3081	195	7	.	.	PUNCT
ajlsi-3081	196	1	young	young	ADJ
ajlsi-3081	196	2	adult	adult	NOUN
ajlsi-3081	196	3	oncology	oncology	NOUN
ajlsi-3081	196	4	:	:	PUNCT
ajlsi-3081	196	5	the	the	DET
ajlsi-3081	196	6	patients	patient	NOUN
ajlsi-3081	196	7	and	and	CCONJ
ajlsi-3081	196	8	their	their	PRON
ajlsi-3081	196	9	survival	survival	NOUN
ajlsi-3081	196	10	challenges	challenge	NOUN
ajlsi-3081	196	11	.	.	PUNCT
ajlsi-3081	197	1	ca	ca	NOUN
ajlsi-3081	197	2	:	:	PUNCT
ajlsi-3081	197	3	a	a	DET
ajlsi-3081	197	4	cancer	cancer	NOUN
ajlsi-3081	197	5	journal	journal	NOUN
ajlsi-3081	197	6	for	for	ADP
ajlsi-3081	197	7	clinicians	clinician	NOUN
ajlsi-3081	197	8	,	,	PUNCT
ajlsi-3081	197	9	57(4	57(4	NUM
ajlsi-3081	197	10	)	)	PUNCT
ajlsi-3081	197	11	,	,	PUNCT
ajlsi-3081	197	12	242	242	NUM
ajlsi-3081	197	13	-	-	SYM
ajlsi-3081	197	14	255	255	NUM
ajlsi-3081	197	15	.	.	PUNCT
ajlsi-3081	198	1	bray	bray	PROPN
ajlsi-3081	198	2	,	,	PUNCT
ajlsi-3081	198	3	f.	f.	PROPN
ajlsi-3081	198	4	,	,	PUNCT
ajlsi-3081	198	5	ferlay	ferlay	PROPN
ajlsi-3081	198	6	,	,	PUNCT
ajlsi-3081	198	7	j.	j.	PROPN
ajlsi-3081	198	8	,	,	PUNCT
ajlsi-3081	198	9	devesa	devesa	PROPN
ajlsi-3081	198	10	,	,	PUNCT
ajlsi-3081	198	11	s.	s.	PROPN
ajlsi-3081	198	12	s.	s.	PROPN
ajlsi-3081	198	13	,	,	PUNCT
ajlsi-3081	198	14	mcglynn	mcglynn	PROPN
ajlsi-3081	198	15	,	,	PUNCT
ajlsi-3081	198	16	k.	k.	PROPN
ajlsi-3081	198	17	a.	a.	PROPN
ajlsi-3081	198	18	,	,	PUNCT
ajlsi-3081	198	19	&	&	CCONJ
ajlsi-3081	198	20	møller	møller	PROPN
ajlsi-3081	198	21	,	,	PUNCT
ajlsi-3081	198	22	h.	h.	PROPN
ajlsi-3081	198	23	(	(	PUNCT
ajlsi-3081	198	24	2006	2006	NUM
ajlsi-3081	198	25	)	)	PUNCT
ajlsi-3081	198	26	.	.	PUNCT
ajlsi-3081	199	1	interpreting	interpret	VERB
ajlsi-3081	199	2	the	the	DET
ajlsi-3081	199	3	international	international	ADJ
ajlsi-3081	199	4	trends	trend	NOUN
ajlsi-3081	199	5	in	in	ADP
ajlsi-3081	199	6	testicular	testicular	ADJ
ajlsi-3081	199	7	seminoma	seminoma	NOUN
ajlsi-3081	199	8	and	and	CCONJ
ajlsi-3081	199	9	nonseminoma	nonseminoma	ADJ
ajlsi-3081	199	10	incidence	incidence	NOUN
ajlsi-3081	199	11	.	.	PUNCT
ajlsi-3081	200	1	nature	nature	NOUN
ajlsi-3081	200	2	clinical	clinical	ADJ
ajlsi-3081	200	3	practice	practice	NOUN
ajlsi-3081	200	4	urology	urology	NOUN
ajlsi-3081	200	5	,	,	PUNCT
ajlsi-3081	200	6	3(10	3(10	NUM
ajlsi-3081	200	7	)	)	PUNCT
ajlsi-3081	200	8	,	,	PUNCT
ajlsi-3081	200	9	532	532	NUM
ajlsi-3081	200	10	-	-	SYM
ajlsi-3081	200	11	543	543	NUM
ajlsi-3081	200	12	.	.	PUNCT
ajlsi-3081	201	1	bray	bray	PROPN
ajlsi-3081	201	2	,	,	PUNCT
ajlsi-3081	201	3	f.	f.	PROPN
ajlsi-3081	201	4	,	,	PUNCT
ajlsi-3081	201	5	ren	ren	PROPN
ajlsi-3081	201	6	,	,	PUNCT
ajlsi-3081	201	7	j.	j.	PROPN
ajlsi-3081	201	8	s.	s.	PROPN
ajlsi-3081	201	9	,	,	PUNCT
ajlsi-3081	201	10	masuyer	masuyer	PROPN
ajlsi-3081	201	11	,	,	PUNCT
ajlsi-3081	201	12	e.	e.	PROPN
ajlsi-3081	201	13	,	,	PUNCT
ajlsi-3081	201	14	&	&	CCONJ
ajlsi-3081	201	15	ferlay	ferlay	PROPN
ajlsi-3081	201	16	,	,	PUNCT
ajlsi-3081	201	17	j.	j.	PROPN
ajlsi-3081	201	18	(	(	PUNCT
ajlsi-3081	201	19	2013	2013	NUM
ajlsi-3081	201	20	)	)	PUNCT
ajlsi-3081	201	21	.	.	PUNCT
ajlsi-3081	202	1	global	global	ADJ
ajlsi-3081	202	2	estimates	estimate	NOUN
ajlsi-3081	202	3	of	of	ADP
ajlsi-3081	202	4	cancer	cancer	NOUN
ajlsi-3081	202	5	prevalence	prevalence	NOUN
ajlsi-3081	202	6	for	for	ADP
ajlsi-3081	202	7	27	27	NUM
ajlsi-3081	202	8	sites	site	NOUN
ajlsi-3081	202	9	in	in	ADP
ajlsi-3081	202	10	the	the	DET
ajlsi-3081	202	11	adult	adult	NOUN
ajlsi-3081	202	12	population	population	NOUN
ajlsi-3081	202	13	in	in	ADP
ajlsi-3081	202	14	2008	2008	NUM
ajlsi-3081	202	15	.	.	PUNCT
ajlsi-3081	203	1	international	international	ADJ
ajlsi-3081	203	2	journal	journal	PROPN
ajlsi-3081	203	3	of	of	ADP
ajlsi-3081	203	4	cancer	cancer	NOUN
ajlsi-3081	203	5	,	,	PUNCT
ajlsi-3081	203	6	132(5	132(5	NUM
ajlsi-3081	203	7	)	)	PUNCT
ajlsi-3081	203	8	,	,	PUNCT
ajlsi-3081	203	9	1133	1133	NUM
ajlsi-3081	203	10	-	-	SYM
ajlsi-3081	203	11	1145	1145	NUM
ajlsi-3081	203	12	.	.	PUNCT
ajlsi-3081	204	1	cannarella	cannarella	NOUN
ajlsi-3081	204	2	,	,	PUNCT
ajlsi-3081	204	3	r.	r.	PROPN
ajlsi-3081	204	4	,	,	PUNCT
ajlsi-3081	204	5	gül	gül	PROPN
ajlsi-3081	204	6	,	,	PUNCT
ajlsi-3081	204	7	m.	m.	NOUN
ajlsi-3081	204	8	,	,	PUNCT
ajlsi-3081	204	9	rambhatla	rambhatla	NOUN
ajlsi-3081	204	10	,	,	PUNCT
ajlsi-3081	204	11	a.	a.	NOUN
ajlsi-3081	204	12	,	,	PUNCT
ajlsi-3081	204	13	&	&	CCONJ
ajlsi-3081	204	14	agarwal	agarwal	PROPN
ajlsi-3081	204	15	,	,	PUNCT
ajlsi-3081	204	16	a.	a.	NOUN
ajlsi-3081	204	17	(	(	PUNCT
ajlsi-3081	204	18	2023	2023	NUM
ajlsi-3081	204	19	)	)	PUNCT
ajlsi-3081	204	20	.	.	PUNCT
ajlsi-3081	205	1	temporal	temporal	ADJ
ajlsi-3081	205	2	decline	decline	NOUN
ajlsi-3081	205	3	of	of	ADP
ajlsi-3081	205	4	sperm	sperm	NOUN
ajlsi-3081	205	5	concentration	concentration	NOUN
ajlsi-3081	205	6	:	:	PUNCT
ajlsi-3081	205	7	role	role	NOUN
ajlsi-3081	205	8	of	of	ADP
ajlsi-3081	205	9	endocrine	endocrine	ADJ
ajlsi-3081	205	10	disruptors	disruptor	NOUN
ajlsi-3081	205	11	.	.	PUNCT
ajlsi-3081	206	1	endocrine	endocrine	NOUN
ajlsi-3081	206	2	,	,	PUNCT
ajlsi-3081	206	3	79(1	79(1	NOUN
ajlsi-3081	206	4	)	)	PUNCT
ajlsi-3081	206	5	,	,	PUNCT
ajlsi-3081	206	6	1	1	NUM
ajlsi-3081	206	7	-	-	SYM
ajlsi-3081	206	8	16	16	NUM
ajlsi-3081	206	9	.	.	PUNCT
ajlsi-3081	207	1	cassell	cassell	PROPN
ajlsi-3081	207	2	,	,	PUNCT
ajlsi-3081	207	3	a.	a.	NOUN
ajlsi-3081	207	4	,	,	PUNCT
ajlsi-3081	207	5	jalloh	jalloh	PROPN
ajlsi-3081	207	6	,	,	PUNCT
ajlsi-3081	207	7	m.	m.	NOUN
ajlsi-3081	207	8	,	,	PUNCT
ajlsi-3081	207	9	ndoye	ndoye	VERB
ajlsi-3081	207	10	,	,	PUNCT
ajlsi-3081	207	11	m.	m.	NOUN
ajlsi-3081	207	12	,	,	PUNCT
ajlsi-3081	207	13	yunusa	yunusa	NOUN
ajlsi-3081	207	14	,	,	PUNCT
ajlsi-3081	207	15	b.	b.	PROPN
ajlsi-3081	207	16	,	,	PUNCT
ajlsi-3081	207	17	mbodji	mbodji	PROPN
ajlsi-3081	207	18	,	,	PUNCT
ajlsi-3081	207	19	m.	m.	NOUN
ajlsi-3081	207	20	,	,	PUNCT
ajlsi-3081	207	21	diallo	diallo	PROPN
ajlsi-3081	207	22	,	,	PUNCT
ajlsi-3081	207	23	a.	a.	PROPN
ajlsi-3081	207	24	,	,	PUNCT
ajlsi-3081	207	25	gaye	gaye	PROPN
ajlsi-3081	207	26	,	,	PUNCT
ajlsi-3081	207	27	o.	o.	PROPN
ajlsi-3081	207	28	,	,	PUNCT
ajlsi-3081	207	29	labou	labou	PROPN
ajlsi-3081	207	30	,	,	PUNCT
ajlsi-3081	207	31	i.	i.	PROPN
ajlsi-3081	207	32	,	,	PUNCT
ajlsi-3081	207	33	niang	niang	PROPN
ajlsi-3081	207	34	,	,	PUNCT
ajlsi-3081	207	35	l.	l.	PROPN
ajlsi-3081	207	36	,	,	PUNCT
ajlsi-3081	207	37	&	&	CCONJ
ajlsi-3081	207	38	gueye	gueye	PROPN
ajlsi-3081	207	39	,	,	PUNCT
ajlsi-3081	207	40	s.	s.	PROPN
ajlsi-3081	207	41	(	(	PUNCT
ajlsi-3081	207	42	2020	2020	NUM
ajlsi-3081	207	43	)	)	PUNCT
ajlsi-3081	207	44	.	.	PUNCT
ajlsi-3081	208	1	review	review	NOUN
ajlsi-3081	208	2	of	of	ADP
ajlsi-3081	208	3	testicular	testicular	ADJ
ajlsi-3081	208	4	tumor	tumor	NOUN
ajlsi-3081	208	5	:	:	PUNCT
ajlsi-3081	208	6	diagnostic	diagnostic	ADJ
ajlsi-3081	208	7	approach	approach	NOUN
ajlsi-3081	208	8	and	and	CCONJ
ajlsi-3081	208	9	management	management	NOUN
ajlsi-3081	208	10	outcome	outcome	NOUN
ajlsi-3081	208	11	in	in	ADP
ajlsi-3081	208	12	africa	africa	PROPN
ajlsi-3081	208	13	.	.	PUNCT
ajlsi-3081	209	1	research	research	NOUN
ajlsi-3081	209	2	and	and	CCONJ
ajlsi-3081	209	3	reports	report	NOUN
ajlsi-3081	209	4	in	in	ADP
ajlsi-3081	209	5	urology	urology	NOUN
ajlsi-3081	209	6	,	,	PUNCT
ajlsi-3081	209	7	35	35	NUM
ajlsi-3081	209	8	-	-	SYM
ajlsi-3081	209	9	42	42	NUM
ajlsi-3081	209	10	.	.	PUNCT
ajlsi-3081	209	11	chavarriaga	chavarriaga	PROPN
ajlsi-3081	209	12	,	,	PUNCT
ajlsi-3081	209	13	j.	j.	PROPN
ajlsi-3081	209	14	,	,	PUNCT
ajlsi-3081	209	15	bobrowski	bobrowski	NOUN
ajlsi-3081	209	16	,	,	PUNCT
ajlsi-3081	209	17	a.	a.	PROPN
ajlsi-3081	209	18	,	,	PUNCT
ajlsi-3081	209	19	&	&	CCONJ
ajlsi-3081	209	20	hamilton	hamilton	PROPN
ajlsi-3081	209	21	,	,	PUNCT
ajlsi-3081	209	22	r.	r.	PROPN
ajlsi-3081	209	23	j.	j.	PROPN
ajlsi-3081	209	24	(	(	PUNCT
ajlsi-3081	209	25	2023	2023	NUM
ajlsi-3081	209	26	)	)	PUNCT
ajlsi-3081	209	27	.	.	PUNCT
ajlsi-3081	210	1	guideline	guideline	NOUN
ajlsi-3081	210	2	of	of	ADP
ajlsi-3081	210	3	guidelines	guideline	NOUN
ajlsi-3081	210	4	:	:	PUNCT
ajlsi-3081	210	5	follow	follow	VERB
ajlsi-3081	210	6	up	up	ADP
ajlsi-3081	210	7	after	after	ADP
ajlsi-3081	210	8	orchidectomy	orchidectomy	NOUN
ajlsi-3081	210	9	for	for	ADP
ajlsi-3081	210	10	clinical	clinical	ADJ
ajlsi-3081	210	11	stage	stage	NOUN
ajlsi-3081	210	12	1	1	NUM
ajlsi-3081	210	13	testicular	testicular	NOUN
ajlsi-3081	210	14	cancer	cancer	NOUN
ajlsi-3081	210	15	.	.	PUNCT
ajlsi-3081	211	1	bju	bju	PROPN
ajlsi-3081	211	2	international	international	PROPN
ajlsi-3081	211	3	,	,	PUNCT
ajlsi-3081	211	4	132(5	132(5	NUM
ajlsi-3081	211	5	)	)	PUNCT
ajlsi-3081	211	6	,	,	PUNCT
ajlsi-3081	211	7	485	485	NUM
ajlsi-3081	211	8	-	-	SYM
ajlsi-3081	211	9	495	495	NUM
ajlsi-3081	211	10	.	.	PUNCT
ajlsi-3081	212	1	ergül	ergül	PROPN
ajlsi-3081	212	2	,	,	PUNCT
ajlsi-3081	212	3	r.	r.	PROPN
ajlsi-3081	212	4	b.	b.	PROPN
ajlsi-3081	212	5	,	,	PUNCT
ajlsi-3081	212	6	bayramoğlu	bayramoğlu	PROPN
ajlsi-3081	212	7	,	,	PUNCT
ajlsi-3081	212	8	z.	z.	PROPN
ajlsi-3081	212	9	,	,	PUNCT
ajlsi-3081	212	10	keçeli	keçeli	PROPN
ajlsi-3081	212	11	,	,	PUNCT
ajlsi-3081	212	12	a.	a.	NOUN
ajlsi-3081	212	13	m.	m.	NOUN
ajlsi-3081	212	14	,	,	PUNCT
ajlsi-3081	212	15	&	&	CCONJ
ajlsi-3081	212	16	dönmez	dönmez	PROPN
ajlsi-3081	212	17	,	,	PUNCT
ajlsi-3081	212	18	m.	m.	NOUN
ajlsi-3081	212	19	i̇.	i̇.	PROPN
ajlsi-3081	212	20	(	(	PUNCT
ajlsi-3081	212	21	2024	2024	NUM
ajlsi-3081	212	22	)	)	PUNCT
ajlsi-3081	212	23	.	.	PUNCT
ajlsi-3081	213	1	risk	risk	NOUN
ajlsi-3081	213	2	for	for	ADP
ajlsi-3081	213	3	testicular	testicular	ADJ
ajlsi-3081	213	4	germ	germ	NOUN
ajlsi-3081	213	5	cell	cell	NOUN
ajlsi-3081	213	6	tumors	tumor	NOUN
ajlsi-3081	213	7	and	and	CCONJ
ajlsi-3081	213	8	spermatogenesis	spermatogenesis	NOUN
ajlsi-3081	213	9	failure	failure	NOUN
ajlsi-3081	213	10	in	in	ADP
ajlsi-3081	213	11	post	post	ADJ
ajlsi-3081	213	12	-	-	ADJ
ajlsi-3081	213	13	pubertal	pubertal	ADJ
ajlsi-3081	213	14	undescended	undescended	ADJ
ajlsi-3081	213	15	testes	testis	NOUN
ajlsi-3081	213	16	.	.	PUNCT
ajlsi-3081	214	1	international	international	ADJ
ajlsi-3081	214	2	urology	urology	NOUN
ajlsi-3081	214	3	and	and	CCONJ
ajlsi-3081	214	4	nephrology	nephrology	NOUN
ajlsi-3081	214	5	,	,	PUNCT
ajlsi-3081	214	6	1	1	NUM
ajlsi-3081	214	7	-	-	SYM
ajlsi-3081	214	8	6	6	NUM
ajlsi-3081	214	9	.	.	PUNCT
ajlsi-3081	214	10	fero	fero	PROPN
ajlsi-3081	214	11	,	,	PUNCT
ajlsi-3081	214	12	k.	k.	PROPN
ajlsi-3081	214	13	e.	e.	PROPN
ajlsi-3081	214	14	,	,	PUNCT
ajlsi-3081	214	15	lec	lec	PROPN
ajlsi-3081	214	16	,	,	PUNCT
ajlsi-3081	214	17	p.	p.	NOUN
ajlsi-3081	214	18	m.	m.	NOUN
ajlsi-3081	214	19	,	,	PUNCT
ajlsi-3081	214	20	sharma	sharma	PROPN
ajlsi-3081	214	21	,	,	PUNCT
ajlsi-3081	214	22	v.	v.	PROPN
ajlsi-3081	214	23	,	,	PUNCT
ajlsi-3081	214	24	lenis	lenis	PROPN
ajlsi-3081	214	25	,	,	PUNCT
ajlsi-3081	214	26	a.	a.	NOUN
ajlsi-3081	214	27	t.	t.	PROPN
ajlsi-3081	214	28	,	,	PUNCT
ajlsi-3081	214	29	low	low	ADJ
ajlsi-3081	214	30	,	,	PUNCT
ajlsi-3081	214	31	j.	j.	PROPN
ajlsi-3081	214	32	,	,	PUNCT
ajlsi-3081	214	33	litwin	litwin	PROPN
ajlsi-3081	214	34	,	,	PUNCT
ajlsi-3081	214	35	m.	m.	NOUN
ajlsi-3081	214	36	s.	s.	PROPN
ajlsi-3081	214	37	,	,	PUNCT
ajlsi-3081	214	38	leapman	leapman	NOUN
ajlsi-3081	214	39	,	,	PUNCT
ajlsi-3081	214	40	m.	m.	NOUN
ajlsi-3081	214	41	s.	s.	PROPN
ajlsi-3081	214	42	,	,	PUNCT
ajlsi-3081	214	43	&	&	CCONJ
ajlsi-3081	214	44	chamie	chamie	PROPN
ajlsi-3081	214	45	,	,	PUNCT
ajlsi-3081	214	46	k.	k.	PROPN
ajlsi-3081	214	47	(	(	PUNCT
ajlsi-3081	214	48	2021	2021	NUM
ajlsi-3081	214	49	)	)	PUNCT
ajlsi-3081	214	50	.	.	PUNCT
ajlsi-3081	215	1	when	when	SCONJ
ajlsi-3081	215	2	is	be	AUX
ajlsi-3081	215	3	a	a	DET
ajlsi-3081	215	4	seminoma	seminoma	NOUN
ajlsi-3081	215	5	not	not	PART
ajlsi-3081	215	6	a	a	DET
ajlsi-3081	215	7	seminoma	seminoma	NOUN
ajlsi-3081	215	8	?	?	PUNCT
ajlsi-3081	216	1	the	the	DET
ajlsi-3081	216	2	incidence	incidence	NOUN
ajlsi-3081	216	3	,	,	PUNCT
ajlsi-3081	216	4	risk	risk	NOUN
ajlsi-3081	216	5	factors	factor	NOUN
ajlsi-3081	216	6	and	and	CCONJ
ajlsi-3081	216	7	management	management	NOUN
ajlsi-3081	216	8	of	of	ADP
ajlsi-3081	216	9	patients	patient	NOUN
ajlsi-3081	216	10	with	with	ADP
ajlsi-3081	216	11	testicular	testicular	ADJ
ajlsi-3081	216	12	seminoma	seminoma	NOUN
ajlsi-3081	216	13	with	with	ADP
ajlsi-3081	216	14	discordant	discordant	ADJ
ajlsi-3081	216	15	elevated	elevate	VERB
ajlsi-3081	216	16	serum	serum	NOUN
ajlsi-3081	216	17	alpha	alpha	NOUN
ajlsi-3081	216	18	-	-	PUNCT
ajlsi-3081	216	19	fetoprotein	fetoprotein	ADJ
ajlsi-3081	216	20	.	.	PUNCT
ajlsi-3081	217	1	urology	urology	NOUN
ajlsi-3081	217	2	,	,	PUNCT
ajlsi-3081	217	3	157	157	NUM
ajlsi-3081	217	4	,	,	PUNCT
ajlsi-3081	217	5	188	188	NUM
ajlsi-3081	217	6	-	-	SYM
ajlsi-3081	217	7	196	196	NUM
ajlsi-3081	217	8	.	.	PUNCT
ajlsi-3081	218	1	franco	franco	PROPN
ajlsi-3081	218	2	,	,	PUNCT
ajlsi-3081	218	3	a.	a.	PROPN
ajlsi-3081	218	4	p.	p.	PROPN
ajlsi-3081	218	5	d.	d.	PROPN
ajlsi-3081	218	6	s.	s.	PROPN
ajlsi-3081	218	7	,	,	PUNCT
ajlsi-3081	218	8	lima	lima	PROPN
ajlsi-3081	218	9	figueiredo	figueiredo	PROPN
ajlsi-3081	218	10	,	,	PUNCT
ajlsi-3081	218	11	e.	e.	PROPN
ajlsi-3081	218	12	r.	r.	PROPN
ajlsi-3081	218	13	,	,	PUNCT
ajlsi-3081	218	14	melo	melo	PROPN
ajlsi-3081	218	15	,	,	PUNCT
ajlsi-3081	218	16	g.	g.	PROPN
ajlsi-3081	218	17	s.	s.	PROPN
ajlsi-3081	218	18	,	,	PUNCT
ajlsi-3081	218	19	souza	souza	PROPN
ajlsi-3081	218	20	,	,	PUNCT
ajlsi-3081	218	21	j.	j.	PROPN
ajlsi-3081	218	22	d.	d.	PROPN
ajlsi-3081	218	23	s.	s.	PROPN
ajlsi-3081	218	24	e.	e.	PROPN
ajlsi-3081	218	25	,	,	PUNCT
ajlsi-3081	218	26	gonçalves	gonçalves	PROPN
ajlsi-3081	218	27	,	,	PUNCT
ajlsi-3081	218	28	n.	n.	PROPN
ajlsi-3081	218	29	v.	v.	PROPN
ajlsi-3081	218	30	,	,	PUNCT
ajlsi-3081	218	31	gomes	gome	NOUN
ajlsi-3081	218	32	,	,	PUNCT
ajlsi-3081	218	33	f.	f.	PROPN
ajlsi-3081	218	34	d.	d.	PROPN
ajlsi-3081	218	35	c.	c.	PROPN
ajlsi-3081	218	36	,	,	PUNCT
ajlsi-3081	218	37	&	&	CCONJ
ajlsi-3081	218	38	neto	neto	PROPN
ajlsi-3081	218	39	,	,	PUNCT
ajlsi-3081	218	40	j.	j.	PROPN
ajlsi-3081	218	41	s.	s.	PROPN
ajlsi-3081	218	42	d.	d.	PROPN
ajlsi-3081	218	43	m.	m.	PROPN
ajlsi-3081	218	44	(	(	PUNCT
ajlsi-3081	218	45	2023	2023	NUM
ajlsi-3081	218	46	)	)	PUNCT
ajlsi-3081	218	47	.	.	PUNCT
ajlsi-3081	219	1	predictors	predictor	NOUN
ajlsi-3081	219	2	of	of	ADP
ajlsi-3081	219	3	testicular	testicular	ADJ
ajlsi-3081	219	4	cancer	cancer	NOUN
ajlsi-3081	219	5	mortality	mortality	NOUN
ajlsi-3081	219	6	in	in	ADP
ajlsi-3081	219	7	brazil	brazil	PROPN
ajlsi-3081	219	8	:	:	PUNCT
ajlsi-3081	219	9	a	a	DET
ajlsi-3081	219	10	20	20	NUM
ajlsi-3081	219	11	-	-	PUNCT
ajlsi-3081	219	12	year	year	NOUN
ajlsi-3081	219	13	ecological	ecological	ADJ
ajlsi-3081	219	14	study	study	NOUN
ajlsi-3081	219	15	.	.	PUNCT
ajlsi-3081	220	1	cancers	cancer	NOUN
ajlsi-3081	220	2	,	,	PUNCT
ajlsi-3081	220	3	15(16	15(16	NOUN
ajlsi-3081	220	4	)	)	PUNCT
ajlsi-3081	220	5	,	,	PUNCT
ajlsi-3081	220	6	4149	4149	NUM
ajlsi-3081	220	7	.	.	PUNCT
ajlsi-3081	221	1	ghazarian	ghazarian	ADJ
ajlsi-3081	221	2	,	,	PUNCT
ajlsi-3081	221	3	a.	a.	NOUN
ajlsi-3081	221	4	a.	a.	PROPN
ajlsi-3081	221	5	,	,	PUNCT
ajlsi-3081	221	6	trabert	trabert	PROPN
ajlsi-3081	221	7	,	,	PUNCT
ajlsi-3081	221	8	b.	b.	PROPN
ajlsi-3081	221	9	,	,	PUNCT
ajlsi-3081	221	10	devesa	devesa	PROPN
ajlsi-3081	221	11	,	,	PUNCT
ajlsi-3081	221	12	s.	s.	PROPN
ajlsi-3081	221	13	s.	s.	PROPN
ajlsi-3081	221	14	,	,	PUNCT
ajlsi-3081	221	15	&	&	CCONJ
ajlsi-3081	221	16	mcglynn	mcglynn	PROPN
ajlsi-3081	221	17	,	,	PUNCT
ajlsi-3081	221	18	k.	k.	PROPN
ajlsi-3081	221	19	a.	a.	PROPN
ajlsi-3081	221	20	(	(	PUNCT
ajlsi-3081	221	21	2015	2015	NUM
ajlsi-3081	221	22	)	)	PUNCT
ajlsi-3081	221	23	.	.	PUNCT
ajlsi-3081	222	1	recent	recent	ADJ
ajlsi-3081	222	2	trends	trend	NOUN
ajlsi-3081	222	3	in	in	ADP
ajlsi-3081	222	4	the	the	DET
ajlsi-3081	222	5	incidence	incidence	NOUN
ajlsi-3081	222	6	of	of	ADP
ajlsi-3081	222	7	testicular	testicular	ADJ
ajlsi-3081	222	8	germ	germ	NOUN
ajlsi-3081	222	9	cell	cell	NOUN
ajlsi-3081	222	10	tumors	tumor	NOUN
ajlsi-3081	222	11	in	in	ADP
ajlsi-3081	222	12	the	the	DET
ajlsi-3081	222	13	united	united	PROPN
ajlsi-3081	222	14	states	states	PROPN
ajlsi-3081	222	15	.	.	PUNCT
ajlsi-3081	223	1	andrology	andrology	PROPN
ajlsi-3081	223	2	,	,	PUNCT
ajlsi-3081	223	3	3(1	3(1	NUM
ajlsi-3081	223	4	)	)	PUNCT
ajlsi-3081	223	5	,	,	PUNCT
ajlsi-3081	223	6	13	13	NUM
ajlsi-3081	223	7	-	-	SYM
ajlsi-3081	223	8	18	18	NUM
ajlsi-3081	223	9	.	.	PUNCT
ajlsi-3081	224	1	gilligan	gilligan	NOUN
ajlsi-3081	224	2	,	,	PUNCT
ajlsi-3081	224	3	t.	t.	PROPN
ajlsi-3081	224	4	,	,	PUNCT
ajlsi-3081	224	5	lin	lin	PROPN
ajlsi-3081	224	6	,	,	PUNCT
ajlsi-3081	224	7	d.	d.	PROPN
ajlsi-3081	224	8	w.	w.	PROPN
ajlsi-3081	224	9	,	,	PUNCT
ajlsi-3081	224	10	aggarwal	aggarwal	PROPN
ajlsi-3081	224	11	,	,	PUNCT
ajlsi-3081	224	12	r.	r.	PROPN
ajlsi-3081	224	13	,	,	PUNCT
ajlsi-3081	224	14	chism	chism	PROPN
ajlsi-3081	224	15	,	,	PUNCT
ajlsi-3081	224	16	d.	d.	PROPN
ajlsi-3081	224	17	,	,	PUNCT
ajlsi-3081	224	18	cost	cost	NOUN
ajlsi-3081	224	19	,	,	PUNCT
ajlsi-3081	224	20	n.	n.	NOUN
ajlsi-3081	224	21	,	,	PUNCT
ajlsi-3081	224	22	derweesh	derweesh	PROPN
ajlsi-3081	224	23	,	,	PUNCT
ajlsi-3081	224	24	i.	i.	PROPN
ajlsi-3081	224	25	h.	h.	PROPN
ajlsi-3081	224	26	,	,	PUNCT
ajlsi-3081	224	27	emamekhoo	emamekhoo	VERB
ajlsi-3081	224	28	,	,	PUNCT
ajlsi-3081	224	29	h.	h.	PROPN
ajlsi-3081	224	30	,	,	PUNCT
ajlsi-3081	224	31	feldman	feldman	PROPN
ajlsi-3081	224	32	,	,	PUNCT
ajlsi-3081	224	33	d.	d.	PROPN
ajlsi-3081	224	34	r.	r.	PROPN
ajlsi-3081	224	35	,	,	PUNCT
ajlsi-3081	224	36	geynisman	geynisman	PROPN
ajlsi-3081	224	37	,	,	PUNCT
ajlsi-3081	224	38	d.	d.	PROPN
ajlsi-3081	224	39	m.	m.	PROPN
ajlsi-3081	224	40	,	,	PUNCT
ajlsi-3081	224	41	&	&	CCONJ
ajlsi-3081	224	42	hancock	hancock	PROPN
ajlsi-3081	224	43	,	,	PUNCT
ajlsi-3081	224	44	s.	s.	PROPN
ajlsi-3081	224	45	l.	l.	PROPN
ajlsi-3081	224	46	(	(	PUNCT
ajlsi-3081	224	47	2019	2019	NUM
ajlsi-3081	224	48	)	)	PUNCT
ajlsi-3081	224	49	.	.	PUNCT
ajlsi-3081	225	1	testicular	testicular	ADJ
ajlsi-3081	225	2	cancer	cancer	NOUN
ajlsi-3081	225	3	,	,	PUNCT
ajlsi-3081	225	4	version	version	NOUN
ajlsi-3081	225	5	2.2020	2.2020	NUM
ajlsi-3081	225	6	,	,	PUNCT
ajlsi-3081	225	7	nccn	nccn	ADJ
ajlsi-3081	225	8	clinical	clinical	ADJ
ajlsi-3081	225	9	practice	practice	NOUN
ajlsi-3081	225	10	guidelines	guideline	NOUN
ajlsi-3081	225	11	in	in	ADP
ajlsi-3081	225	12	oncology	oncology	NOUN
ajlsi-3081	225	13	.	.	PUNCT
ajlsi-3081	226	1	journal	journal	PROPN
ajlsi-3081	226	2	of	of	ADP
ajlsi-3081	226	3	the	the	DET
ajlsi-3081	226	4	national	national	ADJ
ajlsi-3081	226	5	comprehensive	comprehensive	ADJ
ajlsi-3081	226	6	cancer	cancer	NOUN
ajlsi-3081	226	7	network	network	NOUN
ajlsi-3081	226	8	,	,	PUNCT
ajlsi-3081	226	9	17(12	17(12	NUM
ajlsi-3081	226	10	)	)	PUNCT
ajlsi-3081	226	11	,	,	PUNCT
ajlsi-3081	226	12	1529	1529	NUM
ajlsi-3081	226	13	-	-	SYM
ajlsi-3081	226	14	1554	1554	NUM
ajlsi-3081	226	15	.	.	PUNCT
ajlsi-3081	227	1	giona	giona	NOUN
ajlsi-3081	227	2	,	,	PUNCT
ajlsi-3081	227	3	s.	s.	PROPN
ajlsi-3081	227	4	(	(	PUNCT
ajlsi-3081	227	5	2022	2022	NUM
ajlsi-3081	227	6	)	)	PUNCT
ajlsi-3081	227	7	.	.	PUNCT
ajlsi-3081	228	1	the	the	DET
ajlsi-3081	228	2	epidemiology	epidemiology	NOUN
ajlsi-3081	228	3	of	of	ADP
ajlsi-3081	228	4	testicular	testicular	ADJ
ajlsi-3081	228	5	cancer	cancer	NOUN
ajlsi-3081	228	6	.	.	PUNCT
ajlsi-3081	229	1	exon	exon	NOUN
ajlsi-3081	229	2	publications	publication	NOUN
ajlsi-3081	229	3	,	,	PUNCT
ajlsi-3081	229	4	107	107	NUM
ajlsi-3081	229	5	-	-	SYM
ajlsi-3081	229	6	116	116	NUM
ajlsi-3081	229	7	.	.	PUNCT
ajlsi-3081	230	1	huyghe	huyghe	PROPN
ajlsi-3081	230	2	,	,	PUNCT
ajlsi-3081	230	3	e.	e.	PROPN
ajlsi-3081	230	4	,	,	PUNCT
ajlsi-3081	230	5	matsuda	matsuda	PROPN
ajlsi-3081	230	6	,	,	PUNCT
ajlsi-3081	230	7	t.	t.	PROPN
ajlsi-3081	230	8	,	,	PUNCT
ajlsi-3081	230	9	&	&	CCONJ
ajlsi-3081	230	10	thonneau	thonneau	PROPN
ajlsi-3081	230	11	,	,	PUNCT
ajlsi-3081	230	12	p.	p.	NOUN
ajlsi-3081	230	13	(	(	PUNCT
ajlsi-3081	230	14	2003	2003	NUM
ajlsi-3081	230	15	)	)	PUNCT
ajlsi-3081	230	16	.	.	PUNCT
ajlsi-3081	231	1	increasing	increase	VERB
ajlsi-3081	231	2	incidence	incidence	NOUN
ajlsi-3081	231	3	of	of	ADP
ajlsi-3081	231	4	testicular	testicular	ADJ
ajlsi-3081	231	5	cancer	cancer	NOUN
ajlsi-3081	231	6	worldwide	worldwide	ADV
ajlsi-3081	231	7	:	:	PUNCT
ajlsi-3081	231	8	a	a	DET
ajlsi-3081	231	9	review	review	NOUN
ajlsi-3081	231	10	.	.	PUNCT
ajlsi-3081	232	1	the	the	DET
ajlsi-3081	232	2	journal	journal	NOUN
ajlsi-3081	232	3	of	of	ADP
ajlsi-3081	232	4	urology	urology	NOUN
ajlsi-3081	232	5	,	,	PUNCT
ajlsi-3081	232	6	170(1	170(1	NUM
ajlsi-3081	232	7	)	)	PUNCT
ajlsi-3081	232	8	,	,	PUNCT
ajlsi-3081	232	9	5	5	NUM
ajlsi-3081	232	10	-	-	SYM
ajlsi-3081	232	11	11	11	NUM
ajlsi-3081	232	12	.	.	PUNCT
ajlsi-3081	233	1	nigam	nigam	PROPN
ajlsi-3081	233	2	,	,	PUNCT
ajlsi-3081	233	3	m.	m.	NOUN
ajlsi-3081	233	4	,	,	PUNCT
ajlsi-3081	233	5	aschebrook	aschebrook	ADJ
ajlsi-3081	233	6	-	-	PUNCT
ajlsi-3081	233	7	kilfoy	kilfoy	NOUN
ajlsi-3081	233	8	,	,	PUNCT
ajlsi-3081	233	9	b.	b.	PROPN
ajlsi-3081	233	10	,	,	PUNCT
ajlsi-3081	233	11	shikanov	shikanov	PROPN
ajlsi-3081	233	12	,	,	PUNCT
ajlsi-3081	233	13	s.	s.	PROPN
ajlsi-3081	233	14	,	,	PUNCT
ajlsi-3081	233	15	&	&	CCONJ
ajlsi-3081	233	16	eggener	eggener	NOUN
ajlsi-3081	233	17	,	,	PUNCT
ajlsi-3081	233	18	s.	s.	PROPN
ajlsi-3081	233	19	(	(	PUNCT
ajlsi-3081	233	20	2015	2015	NUM
ajlsi-3081	233	21	)	)	PUNCT
ajlsi-3081	233	22	.	.	PUNCT
ajlsi-3081	234	1	increasing	increase	VERB
ajlsi-3081	234	2	incidence	incidence	NOUN
ajlsi-3081	234	3	of	of	ADP
ajlsi-3081	234	4	testicular	testicular	ADJ
ajlsi-3081	234	5	cancer	cancer	NOUN
ajlsi-3081	234	6	in	in	ADP
ajlsi-3081	234	7	the	the	DET
ajlsi-3081	234	8	united	united	PROPN
ajlsi-3081	234	9	states	states	PROPN
ajlsi-3081	234	10	and	and	CCONJ
ajlsi-3081	234	11	europe	europe	PROPN
ajlsi-3081	234	12	between	between	ADP
ajlsi-3081	234	13	1992	1992	NUM
ajlsi-3081	234	14	and	and	CCONJ
ajlsi-3081	234	15	2009	2009	NUM
ajlsi-3081	234	16	.	.	PUNCT
ajlsi-3081	235	1	world	world	PROPN
ajlsi-3081	235	2	journal	journal	PROPN
ajlsi-3081	235	3	of	of	ADP
ajlsi-3081	235	4	urology	urology	NOUN
ajlsi-3081	235	5	,	,	PUNCT
ajlsi-3081	235	6	33	33	NUM
ajlsi-3081	235	7	,	,	PUNCT
ajlsi-3081	235	8	623	623	NUM
ajlsi-3081	235	9	-	-	SYM
ajlsi-3081	235	10	631	631	NUM
ajlsi-3081	235	11	.	.	PUNCT
ajlsi-3081	236	1	pyle	pyle	PROPN
ajlsi-3081	236	2	,	,	PUNCT
ajlsi-3081	236	3	l.	l.	PROPN
ajlsi-3081	236	4	c.	c.	PROPN
ajlsi-3081	236	5	,	,	PUNCT
ajlsi-3081	236	6	kim	kim	PROPN
ajlsi-3081	236	7	,	,	PUNCT
ajlsi-3081	236	8	j.	j.	PROPN
ajlsi-3081	236	9	,	,	PUNCT
ajlsi-3081	236	10	bradfield	bradfield	PROPN
ajlsi-3081	236	11	,	,	PUNCT
ajlsi-3081	236	12	j.	j.	PROPN
ajlsi-3081	236	13	,	,	PUNCT
ajlsi-3081	236	14	damrauer	damrauer	PROPN
ajlsi-3081	236	15	,	,	PUNCT
ajlsi-3081	236	16	s.	s.	PROPN
ajlsi-3081	236	17	m.	m.	PROPN
ajlsi-3081	236	18	,	,	PUNCT
ajlsi-3081	236	19	d’andrea	d’andrea	PROPN
ajlsi-3081	236	20	,	,	PUNCT
ajlsi-3081	236	21	k.	k.	PROPN
ajlsi-3081	236	22	,	,	PUNCT
ajlsi-3081	236	23	einhorn	einhorn	PROPN
ajlsi-3081	236	24	,	,	PUNCT
ajlsi-3081	236	25	l.	l.	PROPN
ajlsi-3081	236	26	h.	h.	PROPN
ajlsi-3081	236	27	,	,	PUNCT
ajlsi-3081	236	28	godse	godse	PROPN
ajlsi-3081	236	29	,	,	PUNCT
ajlsi-3081	236	30	r.	r.	PROPN
ajlsi-3081	236	31	,	,	PUNCT
ajlsi-3081	236	32	hakonarson	hakonarson	PROPN
ajlsi-3081	236	33	,	,	PUNCT
ajlsi-3081	236	34	h.	h.	PROPN
ajlsi-3081	236	35	,	,	PUNCT
ajlsi-3081	236	36	kanetsky	kanetsky	PROPN
ajlsi-3081	236	37	,	,	PUNCT
ajlsi-3081	236	38	p.	p.	NOUN
ajlsi-3081	236	39	a.	a.	NOUN
ajlsi-3081	236	40	,	,	PUNCT
ajlsi-3081	236	41	&	&	CCONJ
ajlsi-3081	236	42	kember	kember	PROPN
ajlsi-3081	236	43	,	,	PUNCT
ajlsi-3081	236	44	r.	r.	PROPN
ajlsi-3081	236	45	l.	l.	PROPN
ajlsi-3081	236	46	(	(	PUNCT
ajlsi-3081	236	47	2024	2024	NUM
ajlsi-3081	236	48	)	)	PUNCT
ajlsi-3081	236	49	.	.	PUNCT
ajlsi-3081	237	1	germline	germline	NOUN
ajlsi-3081	237	2	exome	exome	NOUN
ajlsi-3081	237	3	sequencing	sequence	VERB
ajlsi-3081	237	4	for	for	ADP
ajlsi-3081	237	5	men	man	NOUN
ajlsi-3081	237	6	with	with	ADP
ajlsi-3081	237	7	testicular	testicular	ADJ
ajlsi-3081	237	8	germ	germ	NOUN
ajlsi-3081	237	9	cell	cell	NOUN
ajlsi-3081	237	10	tumor	tumor	NOUN
ajlsi-3081	237	11	reveals	reveal	VERB
ajlsi-3081	237	12	coding	code	VERB
ajlsi-3081	237	13	defects	defect	NOUN
ajlsi-3081	237	14	in	in	ADP
ajlsi-3081	237	15	chromosomal	chromosomal	ADJ
ajlsi-3081	237	16	segregation	segregation	NOUN
ajlsi-3081	237	17	and	and	CCONJ
ajlsi-3081	237	18	protein	protein	NOUN
ajlsi-3081	237	19	-	-	PUNCT
ajlsi-3081	237	20	targeting	target	VERB
ajlsi-3081	237	21	genes	gene	NOUN
ajlsi-3081	237	22	.	.	PUNCT
ajlsi-3081	238	1	european	european	ADJ
ajlsi-3081	238	2	urology	urology	NOUN
ajlsi-3081	238	3	,	,	PUNCT
ajlsi-3081	238	4	85(4	85(4	NUM
ajlsi-3081	238	5	)	)	PUNCT
ajlsi-3081	238	6	,	,	PUNCT
ajlsi-3081	238	7	337	337	NUM
ajlsi-3081	238	8	-	-	SYM
ajlsi-3081	238	9	345	345	NUM
ajlsi-3081	238	10	.	.	PUNCT
ajlsi-3081	239	1	s.	s.	PROPN
ajlsi-3081	239	2	,	,	PUNCT
ajlsi-3081	239	3	e.	e.	PROPN
ajlsi-3081	239	4	(	(	PUNCT
ajlsi-3081	239	5	2007	2007	NUM
ajlsi-3081	239	6	)	)	PUNCT
ajlsi-3081	239	7	.	.	PUNCT
ajlsi-3081	240	1	cancer	cancer	NOUN
ajlsi-3081	240	2	incidence	incidence	NOUN
ajlsi-3081	240	3	and	and	CCONJ
ajlsi-3081	240	4	survival	survival	NOUN
ajlsi-3081	240	5	report	report	PROPN
ajlsi-3081	240	6	saudi	saudi	PROPN
ajlsi-3081	240	7	arabia	arabia	PROPN
ajlsi-3081	240	8	.	.	PUNCT
ajlsi-3081	241	1	safiri	safiri	PROPN
ajlsi-3081	241	2	,	,	PUNCT
ajlsi-3081	241	3	s.	s.	PROPN
ajlsi-3081	241	4	,	,	PUNCT
ajlsi-3081	241	5	hassanzadeh	hassanzadeh	PROPN
ajlsi-3081	241	6	,	,	PUNCT
ajlsi-3081	241	7	k.	k.	PROPN
ajlsi-3081	241	8	,	,	PUNCT
ajlsi-3081	241	9	janbaz	janbaz	PROPN
ajlsi-3081	241	10	alamdary	alamdary	PROPN
ajlsi-3081	241	11	,	,	PUNCT
ajlsi-3081	241	12	s.	s.	PROPN
ajlsi-3081	241	13	,	,	PUNCT
ajlsi-3081	241	14	mousavi	mousavi	PROPN
ajlsi-3081	241	15	,	,	PUNCT
ajlsi-3081	241	16	pa	pa	PROPN
ajlsi-3081	241	17	ge	ge	PROPN
ajlsi-3081	241	18	63	63	NUM
ajlsi-3081	241	19	https://journals.e-palli.com/home/index.php/ajlsi	https://journals.e-palli.com/home/index.php/ajlsi	PROPN
ajlsi-3081	241	20	am	am	NOUN
ajlsi-3081	241	21	.	.	PUNCT
ajlsi-3081	242	1	j.	j.	PROPN
ajlsi-3081	242	2	life	life	PROPN
ajlsi-3081	242	3	sci	sci	PROPN
ajlsi-3081	242	4	.	.	PUNCT
ajlsi-3081	242	5	innov	innov	PROPN
ajlsi-3081	242	6	.	.	PUNCT
ajlsi-3081	243	1	3(2	3(2	NUM
ajlsi-3081	243	2	)	)	PUNCT
ajlsi-3081	243	3	57	57	NUM
ajlsi-3081	243	4	-	-	SYM
ajlsi-3081	243	5	63	63	NUM
ajlsi-3081	243	6	,	,	PUNCT
ajlsi-3081	243	7	2024	2024	NUM
ajlsi-3081	243	8	s.	s.	PROPN
ajlsi-3081	243	9	e.	e.	PROPN
ajlsi-3081	243	10	,	,	PUNCT
ajlsi-3081	243	11	nejadghaderi	nejadghaderi	PROPN
ajlsi-3081	243	12	,	,	PUNCT
ajlsi-3081	243	13	s.	s.	PROPN
ajlsi-3081	243	14	a.	a.	PROPN
ajlsi-3081	243	15	,	,	PUNCT
ajlsi-3081	243	16	sullman	sullman	PROPN
ajlsi-3081	243	17	,	,	PUNCT
ajlsi-3081	243	18	m.	m.	PROPN
ajlsi-3081	243	19	j.	j.	PROPN
ajlsi-3081	243	20	,	,	PUNCT
ajlsi-3081	243	21	naghdisedeh	naghdisedeh	PROPN
ajlsi-3081	243	22	,	,	PUNCT
ajlsi-3081	243	23	n.	n.	NOUN
ajlsi-3081	243	24	,	,	PUNCT
ajlsi-3081	243	25	&	&	CCONJ
ajlsi-3081	243	26	kolahi	kolahi	PROPN
ajlsi-3081	243	27	,	,	PUNCT
ajlsi-3081	243	28	a.-a	a.-a	PROPN
ajlsi-3081	243	29	.	.	PUNCT
ajlsi-3081	243	30	(	(	PUNCT
ajlsi-3081	243	31	2023	2023	NUM
ajlsi-3081	243	32	)	)	PUNCT
ajlsi-3081	243	33	.	.	PUNCT
ajlsi-3081	244	1	the	the	DET
ajlsi-3081	244	2	burden	burden	NOUN
ajlsi-3081	244	3	of	of	ADP
ajlsi-3081	244	4	testicular	testicular	ADJ
ajlsi-3081	244	5	cancer	cancer	NOUN
ajlsi-3081	244	6	from	from	ADP
ajlsi-3081	244	7	1990	1990	NUM
ajlsi-3081	244	8	to	to	ADP
ajlsi-3081	244	9	2019	2019	NUM
ajlsi-3081	244	10	in	in	ADP
ajlsi-3081	244	11	the	the	DET
ajlsi-3081	244	12	middle	middle	PROPN
ajlsi-3081	244	13	east	east	PROPN
ajlsi-3081	244	14	and	and	CCONJ
ajlsi-3081	244	15	north	north	PROPN
ajlsi-3081	244	16	africa	africa	PROPN
ajlsi-3081	244	17	region	region	PROPN
ajlsi-3081	244	18	.	.	PUNCT
ajlsi-3081	245	1	frontiers	frontier	NOUN
ajlsi-3081	245	2	in	in	ADP
ajlsi-3081	245	3	oncology	oncology	NOUN
ajlsi-3081	245	4	,	,	PUNCT
ajlsi-3081	245	5	13	13	NUM
ajlsi-3081	245	6	,	,	PUNCT
ajlsi-3081	245	7	1276965	1276965	NUM
ajlsi-3081	245	8	.	.	PUNCT
ajlsi-3081	246	1	shanmugalingam	shanmugalingam	NOUN
ajlsi-3081	246	2	,	,	PUNCT
ajlsi-3081	246	3	t.	t.	PROPN
ajlsi-3081	246	4	,	,	PUNCT
ajlsi-3081	246	5	soultati	soultati	NOUN
ajlsi-3081	246	6	,	,	PUNCT
ajlsi-3081	246	7	a.	a.	NOUN
ajlsi-3081	246	8	,	,	PUNCT
ajlsi-3081	246	9	chowdhury	chowdhury	PROPN
ajlsi-3081	246	10	,	,	PUNCT
ajlsi-3081	246	11	s.	s.	PROPN
ajlsi-3081	246	12	,	,	PUNCT
ajlsi-3081	246	13	rudman	rudman	PROPN
ajlsi-3081	246	14	,	,	PUNCT
ajlsi-3081	246	15	s.	s.	PROPN
ajlsi-3081	246	16	,	,	PUNCT
ajlsi-3081	246	17	&	&	CCONJ
ajlsi-3081	246	18	van	van	PROPN
ajlsi-3081	246	19	hemelrijck	hemelrijck	PROPN
ajlsi-3081	246	20	,	,	PUNCT
ajlsi-3081	246	21	m.	m.	NOUN
ajlsi-3081	246	22	(	(	PUNCT
ajlsi-3081	246	23	2013	2013	NUM
ajlsi-3081	246	24	)	)	PUNCT
ajlsi-3081	246	25	.	.	PUNCT
ajlsi-3081	247	1	global	global	ADJ
ajlsi-3081	247	2	incidence	incidence	NOUN
ajlsi-3081	247	3	and	and	CCONJ
ajlsi-3081	247	4	outcome	outcome	NOUN
ajlsi-3081	247	5	of	of	ADP
ajlsi-3081	247	6	testicular	testicular	ADJ
ajlsi-3081	247	7	cancer	cancer	NOUN
ajlsi-3081	247	8	.	.	PUNCT
ajlsi-3081	248	1	clinical	clinical	ADJ
ajlsi-3081	248	2	epidemiology	epidemiology	NOUN
ajlsi-3081	248	3	,	,	PUNCT
ajlsi-3081	248	4	417	417	NUM
ajlsi-3081	248	5	-	-	SYM
ajlsi-3081	248	6	427	427	NUM
ajlsi-3081	248	7	.	.	PUNCT
ajlsi-3081	249	1	siddiqui	siddiqui	NOUN
ajlsi-3081	249	2	,	,	PUNCT
ajlsi-3081	249	3	b.	b.	PROPN
ajlsi-3081	249	4	a.	a.	PROPN
ajlsi-3081	249	5	,	,	PUNCT
ajlsi-3081	249	6	zhang	zhang	PROPN
ajlsi-3081	249	7	,	,	PUNCT
ajlsi-3081	249	8	m.	m.	NOUN
ajlsi-3081	249	9	,	,	PUNCT
ajlsi-3081	249	10	pisters	pister	NOUN
ajlsi-3081	249	11	,	,	PUNCT
ajlsi-3081	249	12	l.	l.	PROPN
ajlsi-3081	249	13	l.	l.	PROPN
ajlsi-3081	249	14	,	,	PUNCT
ajlsi-3081	249	15	&	&	CCONJ
ajlsi-3081	249	16	tu	tu	PROPN
ajlsi-3081	249	17	,	,	PUNCT
ajlsi-3081	249	18	s.-m	s.-m	PROPN
ajlsi-3081	249	19	.	.	PUNCT
ajlsi-3081	250	1	(	(	PUNCT
ajlsi-3081	250	2	2020	2020	NUM
ajlsi-3081	250	3	)	)	PUNCT
ajlsi-3081	250	4	.	.	PUNCT
ajlsi-3081	251	1	systemic	systemic	ADJ
ajlsi-3081	251	2	therapy	therapy	NOUN
ajlsi-3081	251	3	for	for	ADP
ajlsi-3081	251	4	primary	primary	ADJ
ajlsi-3081	251	5	and	and	CCONJ
ajlsi-3081	251	6	extragonadal	extragonadal	ADJ
ajlsi-3081	251	7	germ	germ	NOUN
ajlsi-3081	251	8	cell	cell	NOUN
ajlsi-3081	251	9	tumors	tumor	NOUN
ajlsi-3081	251	10	:	:	PUNCT
ajlsi-3081	251	11	prognosis	prognosis	NOUN
ajlsi-3081	251	12	and	and	CCONJ
ajlsi-3081	251	13	nuances	nuance	NOUN
ajlsi-3081	251	14	of	of	ADP
ajlsi-3081	251	15	treatment	treatment	NOUN
ajlsi-3081	251	16	.	.	PUNCT
ajlsi-3081	252	1	translational	translational	ADJ
ajlsi-3081	252	2	andrology	andrology	NOUN
ajlsi-3081	252	3	and	and	CCONJ
ajlsi-3081	252	4	urology	urology	NOUN
ajlsi-3081	252	5	,	,	PUNCT
ajlsi-3081	252	6	9(suppl	9(suppl	NUM
ajlsi-3081	252	7	1	1	NUM
ajlsi-3081	252	8	)	)	PUNCT
ajlsi-3081	252	9	,	,	PUNCT
ajlsi-3081	252	10	s56	s56	NOUN
ajlsi-3081	252	11	.	.	PUNCT
ajlsi-3081	253	1	siegel	siegel	PROPN
ajlsi-3081	253	2	,	,	PUNCT
ajlsi-3081	253	3	r.	r.	PROPN
ajlsi-3081	253	4	l.	l.	PROPN
ajlsi-3081	253	5	,	,	PUNCT
ajlsi-3081	253	6	miller	miller	PROPN
ajlsi-3081	253	7	,	,	PUNCT
ajlsi-3081	253	8	k.	k.	PROPN
ajlsi-3081	253	9	d.	d.	PROPN
ajlsi-3081	253	10	,	,	PUNCT
ajlsi-3081	253	11	&	&	CCONJ
ajlsi-3081	253	12	jemal	jemal	ADJ
ajlsi-3081	253	13	,	,	PUNCT
ajlsi-3081	253	14	a.	a.	NOUN
ajlsi-3081	253	15	(	(	PUNCT
ajlsi-3081	253	16	2018	2018	NUM
ajlsi-3081	253	17	)	)	PUNCT
ajlsi-3081	253	18	.	.	PUNCT
ajlsi-3081	254	1	cancer	cancer	NOUN
ajlsi-3081	254	2	statistics	statistic	NOUN
ajlsi-3081	254	3	,	,	PUNCT
ajlsi-3081	254	4	2018	2018	NUM
ajlsi-3081	254	5	.	.	PUNCT
ajlsi-3081	255	1	ca	ca	NOUN
ajlsi-3081	255	2	:	:	PUNCT
ajlsi-3081	255	3	a	a	DET
ajlsi-3081	255	4	cancer	cancer	NOUN
ajlsi-3081	255	5	journal	journal	NOUN
ajlsi-3081	255	6	for	for	ADP
ajlsi-3081	255	7	clinicians	clinician	NOUN
ajlsi-3081	255	8	,	,	PUNCT
ajlsi-3081	255	9	68(1	68(1	NOUN
ajlsi-3081	255	10	)	)	PUNCT
ajlsi-3081	255	11	,	,	PUNCT
ajlsi-3081	255	12	7	7	NUM
ajlsi-3081	255	13	-	-	SYM
ajlsi-3081	255	14	30	30	NUM
ajlsi-3081	255	15	.	.	PUNCT
ajlsi-3081	256	1	stephenson	stephenson	PROPN
ajlsi-3081	256	2	,	,	PUNCT
ajlsi-3081	256	3	a.	a.	NOUN
ajlsi-3081	256	4	,	,	PUNCT
ajlsi-3081	256	5	eggener	eggener	NOUN
ajlsi-3081	256	6	,	,	PUNCT
ajlsi-3081	256	7	s.	s.	PROPN
ajlsi-3081	256	8	e.	e.	PROPN
ajlsi-3081	256	9	,	,	PUNCT
ajlsi-3081	256	10	bass	bass	PROPN
ajlsi-3081	256	11	,	,	PUNCT
ajlsi-3081	256	12	e.	e.	PROPN
ajlsi-3081	256	13	b.	b.	PROPN
ajlsi-3081	256	14	,	,	PUNCT
ajlsi-3081	256	15	chelnick	chelnick	PROPN
ajlsi-3081	256	16	,	,	PUNCT
ajlsi-3081	256	17	d.	d.	PROPN
ajlsi-3081	256	18	m.	m.	PROPN
ajlsi-3081	256	19	,	,	PUNCT
ajlsi-3081	256	20	daneshmand	daneshmand	PROPN
ajlsi-3081	256	21	,	,	PUNCT
ajlsi-3081	256	22	s.	s.	PROPN
ajlsi-3081	256	23	,	,	PUNCT
ajlsi-3081	256	24	feldman	feldman	PROPN
ajlsi-3081	256	25	,	,	PUNCT
ajlsi-3081	256	26	d.	d.	PROPN
ajlsi-3081	256	27	,	,	PUNCT
ajlsi-3081	256	28	gilligan	gilligan	NOUN
ajlsi-3081	256	29	,	,	PUNCT
ajlsi-3081	256	30	t.	t.	PROPN
ajlsi-3081	256	31	,	,	PUNCT
ajlsi-3081	256	32	karam	karam	PROPN
ajlsi-3081	256	33	,	,	PUNCT
ajlsi-3081	256	34	j.	j.	PROPN
ajlsi-3081	256	35	a.	a.	PROPN
ajlsi-3081	256	36	,	,	PUNCT
ajlsi-3081	256	37	leibovich	leibovich	PROPN
ajlsi-3081	256	38	,	,	PUNCT
ajlsi-3081	256	39	b.	b.	PROPN
ajlsi-3081	256	40	,	,	PUNCT
ajlsi-3081	256	41	&	&	CCONJ
ajlsi-3081	256	42	liauw	liauw	PROPN
ajlsi-3081	256	43	,	,	PUNCT
ajlsi-3081	256	44	s.	s.	PROPN
ajlsi-3081	256	45	l.	l.	PROPN
ajlsi-3081	256	46	(	(	PUNCT
ajlsi-3081	256	47	2019	2019	NUM
ajlsi-3081	256	48	)	)	PUNCT
ajlsi-3081	256	49	.	.	PUNCT
ajlsi-3081	257	1	diagnosis	diagnosis	NOUN
ajlsi-3081	257	2	and	and	CCONJ
ajlsi-3081	257	3	treatment	treatment	NOUN
ajlsi-3081	257	4	of	of	ADP
ajlsi-3081	257	5	early	early	ADJ
ajlsi-3081	257	6	stage	stage	NOUN
ajlsi-3081	257	7	testicular	testicular	NOUN
ajlsi-3081	257	8	cancer	cancer	NOUN
ajlsi-3081	257	9	:	:	PUNCT
ajlsi-3081	257	10	aua	aua	PROPN
ajlsi-3081	257	11	guideline	guideline	NOUN
ajlsi-3081	257	12	.	.	PUNCT
ajlsi-3081	258	1	the	the	DET
ajlsi-3081	258	2	journal	journal	NOUN
ajlsi-3081	258	3	of	of	ADP
ajlsi-3081	258	4	urology	urology	NOUN
ajlsi-3081	258	5	,	,	PUNCT
ajlsi-3081	258	6	202(2	202(2	NUM
ajlsi-3081	258	7	)	)	PUNCT
ajlsi-3081	258	8	,	,	PUNCT
ajlsi-3081	258	9	272	272	NUM
ajlsi-3081	258	10	-	-	SYM
ajlsi-3081	258	11	281	281	NUM
ajlsi-3081	258	12	.	.	PUNCT
ajlsi-3081	259	1	swerdlow	swerdlow	NOUN
ajlsi-3081	259	2	,	,	PUNCT
ajlsi-3081	259	3	a.	a.	NOUN
ajlsi-3081	259	4	,	,	PUNCT
ajlsi-3081	259	5	schoemaker	schoemaker	NOUN
ajlsi-3081	259	6	,	,	PUNCT
ajlsi-3081	259	7	m.	m.	NOUN
ajlsi-3081	259	8	,	,	PUNCT
ajlsi-3081	259	9	higgins	higgins	PROPN
ajlsi-3081	259	10	,	,	PUNCT
ajlsi-3081	259	11	c.	c.	PROPN
ajlsi-3081	259	12	,	,	PUNCT
ajlsi-3081	259	13	wright	wright	PROPN
ajlsi-3081	259	14	,	,	PUNCT
ajlsi-3081	259	15	a.	a.	PROPN
ajlsi-3081	259	16	,	,	PUNCT
ajlsi-3081	259	17	jacobs	jacobs	PROPN
ajlsi-3081	259	18	,	,	PUNCT
ajlsi-3081	259	19	p.	p.	PROPN
ajlsi-3081	259	20	,	,	PUNCT
ajlsi-3081	259	21	&	&	CCONJ
ajlsi-3081	259	22	group	group	PROPN
ajlsi-3081	259	23	,	,	PUNCT
ajlsi-3081	259	24	u.	u.	PROPN
ajlsi-3081	259	25	c.	c.	PROPN
ajlsi-3081	259	26	c.	c.	PROPN
ajlsi-3081	259	27	(	(	PUNCT
ajlsi-3081	259	28	2006	2006	NUM
ajlsi-3081	259	29	)	)	PUNCT
ajlsi-3081	259	30	.	.	PUNCT
ajlsi-3081	260	1	cancer	cancer	NOUN
ajlsi-3081	260	2	incidence	incidence	NOUN
ajlsi-3081	260	3	and	and	CCONJ
ajlsi-3081	260	4	mortality	mortality	NOUN
ajlsi-3081	260	5	in	in	ADP
ajlsi-3081	260	6	men	man	NOUN
ajlsi-3081	260	7	with	with	ADP
ajlsi-3081	260	8	klinefelter	klinefelter	NOUN
ajlsi-3081	260	9	syndrome	syndrome	PROPN
ajlsi-3081	260	10	:	:	PUNCT
ajlsi-3081	260	11	a	a	DET
ajlsi-3081	260	12	cohort	cohort	NOUN
ajlsi-3081	260	13	study	study	NOUN
ajlsi-3081	260	14	.	.	PUNCT
ajlsi-3081	261	1	the	the	DET
ajlsi-3081	261	2	journal	journal	NOUN
ajlsi-3081	261	3	of	of	ADP
ajlsi-3081	261	4	urology	urology	NOUN
ajlsi-3081	261	5	,	,	PUNCT
ajlsi-3081	261	6	175(4	175(4	NUM
ajlsi-3081	261	7	)	)	PUNCT
ajlsi-3081	261	8	,	,	PUNCT
ajlsi-3081	261	9	1364	1364	NUM
ajlsi-3081	261	10	-	-	SYM
ajlsi-3081	261	11	1365	1365	NUM
ajlsi-3081	261	12	.	.	PUNCT
ajlsi-3081	262	1	wang	wang	PROPN
ajlsi-3081	262	2	,	,	PUNCT
ajlsi-3081	262	3	s.-c	s.-c	PROPN
ajlsi-3081	262	4	.	.	PROPN
ajlsi-3081	262	5	,	,	PUNCT
ajlsi-3081	262	6	chang	chang	PROPN
ajlsi-3081	262	7	,	,	PUNCT
ajlsi-3081	262	8	n.-w	n.-w	PROPN
ajlsi-3081	262	9	.	.	PROPN
ajlsi-3081	262	10	,	,	PUNCT
ajlsi-3081	262	11	chen	chen	PROPN
ajlsi-3081	262	12	,	,	PUNCT
ajlsi-3081	262	13	w.-j	w.-j	PROPN
ajlsi-3081	262	14	.	.	PROPN
ajlsi-3081	262	15	,	,	PUNCT
ajlsi-3081	262	16	yang	yang	PROPN
ajlsi-3081	262	17	,	,	PUNCT
ajlsi-3081	262	18	m.h	m.h	PROPN
ajlsi-3081	262	19	.	.	PROPN
ajlsi-3081	262	20	,	,	PUNCT
ajlsi-3081	262	21	chen	chen	PROPN
ajlsi-3081	262	22	,	,	PUNCT
ajlsi-3081	262	23	s.-l	s.-l	NOUN
ajlsi-3081	262	24	.	.	PUNCT
ajlsi-3081	262	25	,	,	PUNCT
ajlsi-3081	262	26	&	&	CCONJ
ajlsi-3081	262	27	sung	sung	PROPN
ajlsi-3081	262	28	,	,	PUNCT
ajlsi-3081	262	29	w.-w	w.-w	PROPN
ajlsi-3081	262	30	.	.	PUNCT
ajlsi-3081	262	31	(	(	PUNCT
ajlsi-3081	262	32	2021	2021	NUM
ajlsi-3081	262	33	)	)	PUNCT
ajlsi-3081	262	34	.	.	PUNCT
ajlsi-3081	263	1	trends	trend	NOUN
ajlsi-3081	263	2	of	of	ADP
ajlsi-3081	263	3	testicular	testicular	ADJ
ajlsi-3081	263	4	cancer	cancer	NOUN
ajlsi-3081	263	5	mortality	mortality	NOUN
ajlsi-3081	263	6	-	-	PUNCT
ajlsi-3081	263	7	to	to	ADP
ajlsi-3081	263	8	-	-	PUNCT
ajlsi-3081	263	9	incidence	incidence	NOUN
ajlsi-3081	263	10	ratios	ratio	NOUN
ajlsi-3081	263	11	in	in	ADP
ajlsi-3081	263	12	relation	relation	NOUN
ajlsi-3081	263	13	to	to	ADP
ajlsi-3081	263	14	health	health	NOUN
ajlsi-3081	263	15	expenditure	expenditure	NOUN
ajlsi-3081	263	16	:	:	PUNCT
ajlsi-3081	263	17	an	an	DET
ajlsi-3081	263	18	ecological	ecological	ADJ
ajlsi-3081	263	19	study	study	NOUN
ajlsi-3081	263	20	of	of	ADP
ajlsi-3081	263	21	54	54	NUM
ajlsi-3081	263	22	countries	country	NOUN
ajlsi-3081	263	23	.	.	PUNCT
ajlsi-3081	264	1	international	international	ADJ
ajlsi-3081	264	2	journal	journal	PROPN
ajlsi-3081	264	3	of	of	ADP
ajlsi-3081	264	4	environmental	environmental	ADJ
ajlsi-3081	264	5	research	research	NOUN
ajlsi-3081	264	6	and	and	CCONJ
ajlsi-3081	264	7	public	public	ADJ
ajlsi-3081	264	8	health	health	NOUN
ajlsi-3081	264	9	,	,	PUNCT
ajlsi-3081	264	10	18(4	18(4	NUM
ajlsi-3081	264	11	)	)	PUNCT
ajlsi-3081	264	12	,	,	PUNCT
ajlsi-3081	264	13	1546	1546	NUM
ajlsi-3081	264	14	.	.	PUNCT
ajlsi-3081	265	1	yazici	yazici	NOUN
ajlsi-3081	265	2	,	,	PUNCT
ajlsi-3081	265	3	s.	s.	PROPN
ajlsi-3081	265	4	,	,	PUNCT
ajlsi-3081	265	5	del	del	PROPN
ajlsi-3081	265	6	biondo	biondo	PROPN
ajlsi-3081	265	7	,	,	PUNCT
ajlsi-3081	265	8	d.	d.	PROPN
ajlsi-3081	265	9	,	,	PUNCT
ajlsi-3081	265	10	napodano	napodano	PROPN
ajlsi-3081	265	11	,	,	PUNCT
ajlsi-3081	265	12	g.	g.	PROPN
ajlsi-3081	265	13	,	,	PUNCT
ajlsi-3081	265	14	grillo	grillo	PROPN
ajlsi-3081	265	15	,	,	PUNCT
ajlsi-3081	265	16	m.	m.	NOUN
ajlsi-3081	265	17	,	,	PUNCT
ajlsi-3081	265	18	calace	calace	NOUN
ajlsi-3081	265	19	,	,	PUNCT
ajlsi-3081	265	20	f.	f.	PROPN
ajlsi-3081	265	21	p.	p.	PROPN
ajlsi-3081	265	22	,	,	PUNCT
ajlsi-3081	265	23	prezioso	prezioso	NOUN
ajlsi-3081	265	24	,	,	PUNCT
ajlsi-3081	265	25	d.	d.	PROPN
ajlsi-3081	265	26	,	,	PUNCT
ajlsi-3081	265	27	crocetto	crocetto	PROPN
ajlsi-3081	265	28	,	,	PUNCT
ajlsi-3081	265	29	f.	f.	PROPN
ajlsi-3081	265	30	,	,	PUNCT
ajlsi-3081	265	31	&	&	CCONJ
ajlsi-3081	265	32	barone	barone	PROPN
ajlsi-3081	265	33	,	,	PUNCT
ajlsi-3081	265	34	b.	b.	PROPN
ajlsi-3081	265	35	(	(	PUNCT
ajlsi-3081	265	36	2023	2023	NUM
ajlsi-3081	265	37	)	)	PUNCT
ajlsi-3081	265	38	.	.	PUNCT
ajlsi-3081	266	1	risk	risk	NOUN
ajlsi-3081	266	2	factors	factor	NOUN
ajlsi-3081	266	3	for	for	ADP
ajlsi-3081	266	4	testicular	testicular	ADJ
ajlsi-3081	266	5	cancer	cancer	NOUN
ajlsi-3081	266	6	:	:	PUNCT
ajlsi-3081	266	7	environment	environment	NOUN
ajlsi-3081	266	8	,	,	PUNCT
ajlsi-3081	266	9	genes	gene	NOUN
ajlsi-3081	266	10	and	and	CCONJ
ajlsi-3081	266	11	infections	infection	NOUN
ajlsi-3081	266	12	—	—	PUNCT
ajlsi-3081	266	13	is	be	AUX
ajlsi-3081	266	14	it	it	PRON
ajlsi-3081	266	15	all	all	PRON
ajlsi-3081	266	16	?	?	PUNCT
ajlsi-3081	267	1	medicina	medicina	NOUN
ajlsi-3081	267	2	,	,	PUNCT
ajlsi-3081	267	3	59(4	59(4	NUM
ajlsi-3081	267	4	)	)	PUNCT
ajlsi-3081	267	5	,	,	PUNCT
ajlsi-3081	267	6	724	724	NUM
ajlsi-3081	267	7	.	.	PUNCT
ajlsi-3081	268	1	znaor	znaor	NOUN
ajlsi-3081	268	2	,	,	PUNCT
ajlsi-3081	268	3	a.	a.	PROPN
ajlsi-3081	268	4	,	,	PUNCT
ajlsi-3081	268	5	skakkebæk	skakkebæk	NOUN
ajlsi-3081	268	6	,	,	PUNCT
ajlsi-3081	268	7	n.	n.	PROPN
ajlsi-3081	268	8	e.	e.	PROPN
ajlsi-3081	268	9	,	,	PUNCT
ajlsi-3081	268	10	rajpert	rajpert	PROPN
ajlsi-3081	268	11	de	de	X
ajlsi-3081	268	12	meyts	meyts	PROPN
ajlsi-3081	268	13	,	,	PUNCT
ajlsi-3081	268	14	e.	e.	PROPN
ajlsi-3081	268	15	,	,	PUNCT
ajlsi-3081	268	16	laversanne	laversanne	PROPN
ajlsi-3081	268	17	,	,	PUNCT
ajlsi-3081	268	18	m.	m.	NOUN
ajlsi-3081	268	19	,	,	PUNCT
ajlsi-3081	268	20	kuliš	kuliš	NOUN
ajlsi-3081	268	21	,	,	PUNCT
ajlsi-3081	268	22	t.	t.	PROPN
ajlsi-3081	268	23	,	,	PUNCT
ajlsi-3081	268	24	gurney	gurney	NOUN
ajlsi-3081	268	25	,	,	PUNCT
ajlsi-3081	268	26	j.	j.	PROPN
ajlsi-3081	268	27	,	,	PUNCT
ajlsi-3081	268	28	sarfati	sarfati	PROPN
ajlsi-3081	268	29	,	,	PUNCT
ajlsi-3081	268	30	d.	d.	PROPN
ajlsi-3081	268	31	,	,	PUNCT
ajlsi-3081	268	32	mcglynn	mcglynn	PROPN
ajlsi-3081	268	33	,	,	PUNCT
ajlsi-3081	268	34	k.	k.	PROPN
ajlsi-3081	268	35	a.	a.	PROPN
ajlsi-3081	268	36	,	,	PUNCT
ajlsi-3081	268	37	&	&	CCONJ
ajlsi-3081	268	38	bray	bray	PROPN
ajlsi-3081	268	39	,	,	PUNCT
ajlsi-3081	268	40	f.	f.	PROPN
ajlsi-3081	268	41	(	(	PUNCT
ajlsi-3081	268	42	2020	2020	NUM
ajlsi-3081	268	43	)	)	PUNCT
ajlsi-3081	268	44	.	.	PUNCT
ajlsi-3081	269	1	testicular	testicular	ADJ
ajlsi-3081	269	2	cancer	cancer	NOUN
ajlsi-3081	269	3	incidence	incidence	NOUN
ajlsi-3081	269	4	predictions	prediction	NOUN
ajlsi-3081	269	5	in	in	ADP
ajlsi-3081	269	6	europe	europe	PROPN
ajlsi-3081	269	7	2010–2035	2010–2035	NUM
ajlsi-3081	269	8	:	:	PUNCT
ajlsi-3081	269	9	a	a	DET
ajlsi-3081	269	10	rising	rise	VERB
ajlsi-3081	269	11	burden	burden	NOUN
ajlsi-3081	269	12	despite	despite	SCONJ
ajlsi-3081	269	13	population	population	NOUN
ajlsi-3081	269	14	ageing	ageing	NOUN
ajlsi-3081	269	15	.	.	PUNCT
ajlsi-3081	270	1	international	international	ADJ
ajlsi-3081	270	2	journal	journal	NOUN
ajlsi-3081	270	3	of	of	ADP
ajlsi-3081	270	4	cancer	cancer	NOUN
ajlsi-3081	270	5	,	,	PUNCT
ajlsi-3081	270	6	147(3	147(3	NUM
ajlsi-3081	270	7	)	)	PUNCT
ajlsi-3081	270	8	,	,	PUNCT
ajlsi-3081	270	9	820	820	NUM
ajlsi-3081	270	10	-	-	SYM
ajlsi-3081	270	11	828	828	NUM
ajlsi-3081	270	12	.	.	PUNCT